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 ‘…by the help of microscopes, there is nothing so small as to escape our 
enquiry; hence there is a new visible World discovered’ 
Robert Hooke, 1665  
(in the Preface of Micrographia)  
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Abstract 
The Caliciviridae are a group of small, non-enveloped viruses with a positive 
sense, single stranded RNA genome.  Caliciviruses include the noroviruses, 
responsible for winter vomiting disease, as well as several important veterinary 
pathogens. Feline calicivirus (FCV) is an excellent model for studying calicivirus 
entry, having a known protein receptor and being readily propagated in cell 
culture. Here we explore calicivirus entry, using FCV. Virus entry is the critical 
first step of infection and is therefore an important area of study.  
Both alpha 2-6 linked sialic acid and feline junctional adhesion molecule A 
(fJAM-A) have been identified as receptors for FCV. The attachment of FCV to 
fJAM-A, is followed by uptake via clathrin mediated endocytosis. Little is known, 
however, on the viral escape mechanism leading to delivery of the viral RNA into 
the cytoplasm. We set out to explore the nature of FCV attachment and 
uncoating using structural, biochemical and biophysical analyses. By cryogenic 
electron microscopy we have characterized the virus-receptor interaction at 
high-resolution. Using electron microscopy and an RNA release assay, we have 
investigated virion uncoating. Finally, we have explored the importance of 
receptor glycosylation, and oligomerisation. 
Our analysis has allowed us to construct an atomic model of the major capsid 
protein VP1. Upon binding to fJAM-A, FCV undergoes a conformational change 
(rotation and tilting of the capsomeres). Flexibility in the receptor decorated 
virion has prevented high-resolution structure analysis of the conformational 
change or the virus-receptor interaction.  We have, however, seen that the 
structural changes are limited to the capsid spikes. We hypothesised that the 
conformational change may be a priming step that would prepare the virus for 
uncoating upon internalisation. We found that upon lowering the pH below 5, 
receptor decorated virions disassembled, supporting this hypothesis. Disassembly 
of the virus-receptor complex at low pH presented a tool for estimating the 
quantity of receptor needed to prime the capsid for uncoating.  
Cryo-EM studies reveal that FCV bound fJAM-A is monomeric although the 
receptor was found to be dimeric in solution as previously described for the 
human and murine homologues.  Furthermore, it is hypothesised that this is the 
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form found at tight junctions between cells. We propose that disruption of fJAM-
A homodimers may be the mechanism by which induction of viral uptake by 
endocytosis is triggered. Finally, we have confirmed the presence of an N-linked 
glycosylation on fJAM-A and show that the removal of this carbohydrate moiety 
does not affect viral binding in vitro. 
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1 Introduction 
1.1 Viruses 
Viruses are the smallest class of microorganisms, ranging from 20-400nm in 
diameter, and have been shown to infect all forms of life on earth i.e.) plants, 
animals, humans, bacteria etc. They are composed of a nucleic acid genome 
(ribonucleic acid; RNA or deoxyribonucleic acid; DNA) and a protein coat (capsid) 
which functions to protect the genome and deliver it into the host cell for viral 
replication. The genomes of viruses can be single stranded RNA (positive or 
negative sense), double stranded RNA, single stranded DNA or double stranded 
DNA. Viruses must bind to a cellular receptor on the surface of a cell which 
determines not only the host specificity but also the tissue tropism of the 
microorganism. Viruses may also be enveloped, where the capsid is surrounded 
by a cell-derived lipid bilayer. The capsid proteins of non-enveloped viruses 
contain the specific receptor binding sites whereas in enveloped viruses, viral 
structural proteins containing the receptor binding sites are inserted into the 
lipid envelope to allow entry of the virus into the host cell, often by membrane 
fusion at the plasma membrane. Viral genomes encode both structural proteins 
which make up the progeny viral particles as well as non-structural proteins 
which function to replicate the viral genome and hijack the cellular protein 
translation machinery to do so. Some non-structural proteins have also evolved a 
mechanism/function to evade the host immune response to infection.  
The first virus to be discovered was tobacco mosaic virus (TMV) in the late 
1800’s when Adolf Mayer described a mosaic disease of tobacco plants which 
could be transmitted to other plants by rubbing them with a filtered extract 
from the infected plant (in 1879). Martinus Beijerinck, in 1898, described similar 
findings although went a step further to describe the infectious agent as 
contagious living fluid (‘contagium vivum fluidum’). These contagious living 
fluids were later described/termed as viruses and this particular disease causing 
agent was termed tobacco mosaic virus. The second virus to be discovered, and 
the first animal virus discovered, was foot and mouth disease virus (FMDV) in 
1898 by Friedrich Loeffler and Paul Frosch. These were the first to describe the 
virus as a tiny particle rather than an infectious liquid and even filtered and 
heated (inactivated) the agent before using it to vaccinate cows and sheep. The 
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first human virus to be discovered was the causative agent of yellow fever in 
1901 by Walter Reed, a US army physician. Helmut Ruska proceeded to visualise 
several virus structures in the electron microscope throughout the late 1930’s 
including poxviruses, TMV, varicella zoster virus (VZV) and bacteriophages and 
further proceeded to propose a classification system based on virus structure in 
1943 (Kruger et al., 2000; Rybicki and Kightley, 2015). 
1.2 Virus Structure 
Viruses of different shapes and sizes, regular and irregular have been observed. 
Generally, non-enveloped viruses adopt a more regular conformation than 
enveloped viruses although the inner contents or capsid of enveloped viruses 
often adopt a regular conformation. Some viruses are spherical while others are 
more rod shaped, most of which exhibit high degrees of symmetry. Crick and 
Watson suggested that viral capsids must be formed by multiple copies of a set 
of capsid proteins (Crick and Watson, 1956). This greatly reduces the genome 
requirement for the virus which is pivotal in small viruses with a limited capsid 
volume and therefore coding capacity. Some viruses only encode a single capsid 
protein while some assemble their capsids from more capsid proteins (although 
this requires a larger genome). For these multiple capsid proteins to form an 
intact viral capsid, the capsid must exhibit a degree of symmetry, typically an 
icosahedral shell or a helical tube (Caspar and Klug, 1962; Crick and Watson, 
1956). 
1.2.1 Symmetry 
Caspar was the first to demonstrate that spherical viruses showed icosahedral 
symmetry (with 5, 3 and 2 fold symmetry axes) (Caspar, 1956). Symmetry axes 
are present in polyhedra such as tetrahedrons, cubes, octahedrons, icosahedrons 
and dodecahedrons (see Figure 1). In these structures, each have identical faces, 
edges and vertices. The line where two faces meet is known as an edge whereas 
vertices are known as the point at which a number of faces meet (Prasad and 
Schmid, 2012).  
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Figure 1- Five polyhedra illustrating aspects of symmetry 
Each of the structures in this figure have one of their faces coloured in blue: (a) a tetrahedron, 
(b) a cube, (c) an octahedron, (d) an icosahedron and (e) a dodecahedron. Solid and dotted lines 
represent the edges of the structures. Taken from Prasad and Schmid, 2012. 
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For each of these structures, the number of faces, edges and vertices can be 
calculated using the formula: 𝐹 + 𝑉 = 𝐸 + 2. For example, the tetrahedron has 4 
faces, 6 edges and 4 vertices (4 + 4 = 6 + 2) and has both two and three-fold 
symmetry axes. A cube has 6 faces, 12 edges and 8 vertices and exhibits two, 
three and four-fold symmetry. An octahedron has 8 faces, 12 edges and 6 
vertices with two, three, and four-fold symmetry. An icosahedron contains 20 
faces, 30 edges and 12 vertices and exhibits two, three and five-fold symmetry. 
Finally, a dodecahedron is composed of 12 faces, 30 edges and 20 vertices and 
also has two, three and five-fold symmetry axes. Caspar was the first to 
demonstrate icosahedral symmetry in spherical viruses, showing that the 
characteristic spikes of tomato bushy stunt virus (TBSV) were only present due to 
the five-fold symmetry of the capsid (Caspar, 1956). This was later supported 
when icosahedral symmetry was also observed in another plant virus, turnip 
yellow mosaic virus (TYMV) (Klug et al., 1957). 
Icosahedral symmetry allows the assembly of 60 identical proteins while 
retaining the two, three and five-fold symmetry axes (see Figure 2). As visible in 
Figure 2, the five-fold symmetry axis passes through the vertices of the 
icosahedron while the three-fold axes dissect through the centre of the faces 
and the two-fold axes go through the middle of each edge of the icosahedron.  
While 60 subunits can be assembled identically into an icosahedron, many virus 
particles are composed of more than 60 subunits which cannot form an 
icosahedron if arranged in identical positions. This can, however, be achieved if 
minimal distortions are permitted between each subunit where they are 
arranged in almost identical positions (Caspar and Klug, 1962). The icosahedron 
is first enlarged and then each face/triangle is further divided into more 
triangles (triangulation). Due to this division by triangles, only some 
triangulation numbers can exist: 1, 3, 4, 7 etc as a triangle cannot be divided 
into 2, 5 or 8 smaller triangles. These are referred to as the T numbers of the 
capsids. If a capsid is composed of 60 subunits, it is said to have T=1 icosahedral 
symmetry. 
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Figure 2- Icosahedral symmetry axes 
Icosahedrons displayed looking through the various symmetry axes: (a) five-fold, (b) three-fold 
and (c) two-fold. Taken from Prasad and Schmid, 2012.  
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Likewise, if a capsid is composed of 180 subunits, it has T=3 icosahedral 
symmetry and 240 subunits has T=4 symmetry and so on. A prolate icosahedron 
may also exist, like that seen in the bacteriophage phi29, where the icosahedron 
is stretched in one direction (characterised by T number and an elongation 
number, Q: for phi29 T=3 and Q=5) (Prasad and Schmid, 2012). 
As the three-fold symmetry axis passes through each of the faces of the 
icosahedron, it divides each face into three equal subunits. Each of these 
subunits is termed an asymmetric unit. Equally, these asymmetric units may 
consist of multiple proteins for capsids with triangulation numbers of T>1. As 
mentioned previously, the interacting states of capsid subunits with these 
symmetries cannot be identical/equivalent so they are termed quasi-equivalent. 
Caspar and Klug proposed that in an icosahedral capsid with quasi-equivalent 
subunits, these subunits exhibit similar inter-subunit interactions although show 
some minor distortions to allow for an icosahedral shell to be formed. This quasi-
equivalence results in the formation of three-fold locations/axes on the 
icosahedron as well as the five-fold. Five-fold locations are visible as pentamers 
while three-fold are visible as hexamers. All icosahedra, independent of T 
number, contain 12 pentamers/five-fold positions. The number of 
hexamers/three-fold positions, however, varies with T number and can be 
defined as 10(T – 1). These arrangements were termed morphological units 
(Caspar and Klug, 1962).  
Some capsid proteins contain ‘flexible’ arms which may act as a switch between 
different conformations of the same capsid protein. Many small viruses of 
animals and plants exhibit T=3 icosahedral symmetry with 180 copies of one 
capsid protein. Three quasi-equivalent forms of the capsid protein exist which 
are generally termed A, B and C and together form one asymmetric unit of the 
capsid and allow the formation of an icosahedral structure. These subunits form 
two different types of dimers: A/B and C/C with the A/B dimers located around 
the five-fold symmetry axes and the C/C dimers located in alternating positions 
(with A/B dimers) around the three-fold symmetry axes. This results in the 
capsid comprising 60 A/B dimers and 30 C/C dimers (Prasad and Schmid, 2012). 
These morphological subunits which comprise the viral capsid may also be 
formed of trimers (such as in nodaviruses) or even pentamers/hexamers for 
larger viruses (Ho et al., 2017). 
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Figure 3- A/B and C/C conformations of Feline Calicivirus VP1 capsid protein 
A/B and C/C conformations of the VP1 capsid protein of Feline Calicivirus (FCV) strain 5 
illustrating the bent appearance of the A/B dimer and the flat appearance of the C/C dimer 
enabled by conformational switching induced by the N-terminal arm of the protein. Bending of 
the capsid proteins at the hinge region between the S domain (coloured) and the P domain (grey) 
is illustrated by the appearance of a more extended S domain when comparing that of the A/B 
(red/blue) and C/C (yellow) dimers. Taken from Ossiboff, Zhou et al, 2010. PDB ID: 3M8L.  
 
 
 
 
 
 
 
 
 8 
 
The N-terminal arm of the capsid protein has been implicated in the switch 
between these two conformations. Due to the curvature of the icosahedral 
capsid, the A/B dimers adopt a bent conformation while the C/C dimers adopt a 
flat conformation (see Figure 3). This conformational switching of capsid 
proteins is seen in many viruses including FCV, human norovirus and 
papovaviruses (T=7). 
Picornaviruses present an interesting variation as they exhibit T=3 icosahedral 
symmetry but rather than the three conformations of the one protein, three 
different proteins assemble to form the asymmetric unit: VP1, 2 and 3. The VP1, 
VP3 and VP2 proteins occupy the same coordinates as the A, B and C 
conformations, respectively, although because the capsid is formed of non-
identical subunits, it is termed pseudo T=3. Larger, more complex icosahedral 
viruses often use internal scaffolding proteins as well as other factors including 
maturation-dependent proteolysis to aid in the formation of their capsid e.g. 
double stranded DNA bacteriophages, herpes simplex viruses and adenoviruses 
(Prasad and Schmid, 2012; Rossmann et al., 1986).  
1.2.2 Helical symmetry 
Many rod-shaped viruses adopt helical symmetry, such as rhabdoviruses, and 
some use helical symmetry to assemble nucleocapsids. Helical structures are 
characterised by a number of factors including the location of the subunits in 
relation to the axis, the rotation of each subunit and the axial rise for each 
subunit. The best characterised virus with helical symmetry is tobacco mosaic 
virus (TMV). The genomic RNA of TMV is located within a groove of the 
surrounding capsid proteins which have been shown to form an alpha helical 
structure (Caspar and Klug, 1962; Franklin and Klug, 1956; Namba and Stubbs, 
1986; Prasad and Schmid, 2012).  
1.3 Virus Entry 
Viruses have evolved many ways to hijack cellular functions and machinery in 
order to enter the cell, replicate and release progeny viral particles. Enveloped 
viruses often fuse with the plasma membrane to release the 
capsid/nucleoprotein into the cytoplasm of the target cell. This membrane 
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fusion requires the virus to present a specific type of protein on the viral 
envelope which can insert into the plasma membrane of a target cell and bring 
the two membranes into close proximity for fusion.  Non-enveloped viruses, 
however, mostly rely on binding to a specific receptor (or set of receptors) on 
the cell surface and triggering the cell to internalise the virus where it must 
then escape the internal organelle (e.g. endosome) to deliver its genome into 
the cell for replication to occur. Genome release is often associated with a 
conformational change in the capsid, pore formation and/or membrane lysis. 
Conformational changes usually result in the exposure of hydrophobic regions, 
for example, those induced in the FCV capsid upon fJAM-A engagement (Ossiboff 
et al., 2010). These structural alterations may be triggered by a number of 
factors including receptor binding or a drop in pH (within the endosome) (Cossart 
and Helenius, 2014; Lozach et al., 2011; Marsh and Helenius, 2006). 
Attachment factors on the cell surface, usually carbohydrates such as heparin 
sulphate or sialic acid, may act to capture virus particles and concentrate them 
in an area of the cellular plasma membrane. Unlike receptors, attachment 
factors cannot promote entry into the cell without an interaction with another 
molecule/protein. Receptors have the ability to induce conformational changes 
in some virus particles upon binding, activate specific cellular signalling 
pathways as well as stimulating endocytosis. As receptors play such a key role in 
viral internalisation, species and tissue specificity is determined by binding of a 
virus to a particular receptor(s). It is thought that the affinity of virus particles 
may be low although binding to multiple receptors on the cell surface likely 
serves to increase the affinity of the interaction. This is one possible explanation 
as to why so many viruses use attachment factors to initially capture incoming 
virus particles and then pass them on to receptors for internalisation. For 
example, T=3 virus particles are composed of 180 capsid proteins and therefore 
contain up to 180 possible receptor binding sites. Binding of the virus to multiple 
receptor copies may act to cluster the proteins and trigger a signalling cascade 
such as entry via endocytosis. Some viruses do this by utilising cell signalling 
proteins as receptors, such as integrins (Cossart and Helenius, 2014; Marsh and 
Helenius, 2006).  
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Figure 4- Mechanisms of internalisation utilised by viruses 
A schematic showing the different mechanisms utilised by viruses to mediate internalisation and 
entry into a host cell. Typical ‘cargo’ sizes for each mechanism are listed along with the 
different cellular factors involved in the processes. Abbreviations: CME (clathrin mediated 
endocytosis). Taken from Lozach et al, 2011). 
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Different viruses have evolved to utilise many different cellular internalisation 
pathways. For example, herpes simplex virus-1 enters host cells via 
macropinocytosis, murine polyomavirus utilises lipid rafts and many viruses gain 
entry into cells via clathrin mediated endocytosis (such as feline calicivirus, 
human rhinovirus-2 and influenza A virus) (Devadas et al., 2014; Lozach et al., 
2011; Snyers et al., 2003; Stuart and Brown, 2006). Simian virus-40 is able to 
utilise both lipid rafts and caveolin dependent endocytic pathways while other 
novel entry pathways may still exist for viruses including human papilloma virus-
16 (Lozach et al., 2011; Pelkmans, 2005). An overview of the different entry 
mechanisms utilised by different viruses and the cellular factors involved is 
presented in Figure 4. 
Endocytosis is a general term used to describe the uptake of fluid, 
macromolecules and plasma membrane components from the surface of the cell 
for recycling or degradation via the endosome-lysosome acidification pathway. 
Incredibly, 50-180% of the plasma membrane surface area is recycled into and 
back out of the cell every hour. The early endosomes are considered a ‘sorting 
office’ for incoming cargo, with viruses usually targeted to late endosomes 
which move to the peri-nuclear region where they fuse with lysosomes (Huotari 
and Helenius, 2011). The reduction in pH from endosomes to lysosomes occurs 
due to membrane bound protein complexes known as V-ATPases. V-ATPases are 
proton pumps which form a pore in the organelle (e.g. endosome) membrane to 
allow the passage of protons into the lumen, thereby lowering the pH (Huotari 
and Helenius, 2011). 
1.3.1 Clathrin dependent endocytosis 
The most commonly used method employed by viruses to enter a host cell is 
clathrin-mediated endocytosis. Clathrin mediated endocytosis internalises both 
the virus and the receptor(s) into early and late endosomes where a drop in pH 
may trigger the release of the viral genome. The process is continuous and rapid 
with the virus particles exposed to low pH within minutes after triggering 
internalisation. Some viruses may dissociate from their receptors at this point 
during internalisation although others remain bound within the endocytic 
pathway. Virus particles must then adopt a mechanism to deliver their genome 
from the endosome into the cytoplasm of the cell. Some viruses do this by 
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disrupting the membrane of the endosomes while others form a pore in the 
capsid and endosomal membrane through which transfer of the genome may 
occur. The degree of acidification likely acts as a switch/cue for the virus, 
signalling the appropriate point at which to trigger genome release. This may 
occur in early endosomes with a pH value of approximately 6.0 to 6.5, in late 
endosomes with a pH of approximately 5.0 to 6.0 or in lysosomes with a pH value 
of 4.5 to 5. Differences in pH within the cell have previously been shown to 
regulate the transport of cargo in endocytic and secretory pathways. A drop in 
pH, however, may not be enough to trigger the release of the viral genome and 
another step may be needed such as a conformational change in the capsid 
induced by receptor/protein binding. (Helenius, 2013; Lozach et al., 2011; Marsh 
and Helenius, 2006).  
During clathrin mediated endocytosis, clathrin is recruited to the cytosolic side 
of the plasma membrane where it induces curvature and internalisation of a 
section of plasma membrane to form a vesicle (within approximately 3 minutes). 
The clathrin is then released from the vesicle (within 5 to 20 seconds) which 
fuses with an early endosome to begin the gradual lowering of pH and 
progression towards late endosomes and lysosomes. Many different adaptors, 
cofactors and tethering proteins are involved in the pinching of the membrane 
and formation of the initial vesicle/endosome and over ninety kinases have been 
shown to affect virus internalisation by clathrin mediated endocytosis (Cossart 
and Helenius, 2014; Marsh and Helenius, 2006). 
1.3.2 Clathrin independent endocytosis 
The best characterised mechanisms of clathrin independent endocytosis are 
known as the caveolar/raft pathways. These processes are thought to specialise 
in the internalisation of lipids, lipid rafts and GPI-anchored proteins. Many 
proteins are involved in this internalisation pathway including actin, dynamin 2, 
caveolin-1 and Rho-GTPases. Internalisation may occur independently of 
caveolin-1 or through caveolae activated for transport across longer distances. 
Viruses that are internalised via the caveolar/raft pathway are firstly 
transported to caveosomes which have a neutral pH and following a signalling 
event, traffic via microtubules in a caveolin independent manner to the 
endoplasmic reticulum. Viral genome release may then occur following 
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interaction with specific proteins or due to the different cellular environment. 
Other clathrin independent pathways do not involve trafficking to the 
endoplasmic reticulum and may, instead, traffic to endosomes although this 
pathway is not yet clearly understood. Macropinocytosis is another clathrin 
independent pathway utilised by viruses to gain entry into a host cell. 
Macropinocytosis is both actin and cholesterol dependent and involves either 
caveosomes or endosomes post internalisation (Marsh and Helenius, 2006). 
1.4 Junctional Adhesion Molecule A (JAM-A) 
1.4.1 JAM-A structure 
JAM-A is expressed in a variety of cell types. It is a major component of tight 
junctions between epithelial and endothelial cells and can also be found on the 
surface of platelets and leucocytes (including monocytes, neutrophils, B and T 
cells). JAM-A was the first Ig-like molecule that was identified at tight junctions 
between both epithelial and endothelial cells and was originally characterised as 
a platelet receptor (F11) (Ebnet et al., 2004; Prota et al., 2003). 
Junctional adhesion molecule A (JAM-A) is a member of the immunoglobulin 
superfamily. JAM-A is composed of a short cytoplasmic tail, transmembrane 
domain and an ectodomain present on the surface of the cell which contains two 
immunoglobulin-like (Ig) motifs. The ectodomain can be divided into two 
subdomains, D1 and D2 with D1 forming the most outer portion of the protein 
(furthest away from the plasma membrane) and responsible for dimer formation 
between JAM proteins. D2 also contains an N-linked glycosylation site which may 
serve to regulate protein stability. 
The recombinant soluble ectodomain of murine JAM-A has been shown to form 
U-shaped dimers (as well as some tetramers) in solution. At the centre of the 
dimerisation domain are two stacked salt bridges with a structural motif of 
R(VIL)E identified in this region. These oligomers, however, have been shown to 
dissociate into monomers below pH5, possibly due to the disruption of the salt 
bridges (Kostrewa et al., 2001). The disruption of JAM-A dimers through pH 
reduction is reversible and may inhibit JAM-A dependent signalling during  
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Figure 5 has been removed due to copyright restrictions. 
 
 
 
 
 
 
Figure 5- Structure of human JAM-A 
A ribbon diagram of the human JAM-A dimer is shown with one monomer in orange and another 
monomer in blue. D1 and D2 domains are labelled with salt bridges shown in green. The plasma 
membrane (and JAM-A transmembrane domain) would be located at the bottom of the D2 
domains in this figure. Taken from Prota et al, 2003. PDB ID: 1NBQ.  
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Figure 6- Human JAM-A dimers interacting in trans 
One U-shaped JAM-A dimer is shown in pink and purple while another is shown in green and blue 
(hypothesised to be expressed by an adjacent cell from the other dimer shown). PDB ID: 1NBQ. 
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intracellular trafficking. The assembly into these oligomeric forms is believed to 
occur during or shortly after movement through the secretory pathway. It is 
thought that these U-shaped dimers (formed via cis interactions) may also 
interact with other U-shaped dimers on adjacent cells by forming trans 
interactions as illustrated in Figure 6 (Kostrewa et al., 2001; Monteiro et al., 
2014). 
The human JAM-A ectodomain was predicted to form dimers as seen with murine 
JAM-A by size exclusion chromatography. Crystallography showed U-shaped 
dimers similar to murine JAM-A with the D1 and D2 domains bent at an angle of 
approximately 125 relative to each other within each monomer. This structure 
revealed the presence of four salt bridges within each dimer between positions 
Arg-59 and Glu-61 (and vice versa) and between Lys-63 and Glu-121 (and vice 
versa) as well as surrounding hydrophobic interactions. Prota et al also described 
a model of trans interactions between JAM-A dimers of adjacent cells within 
tight junctions analogous to that proposed for murine JAM-A. This model 
proposes a separation of cells by around 85Å which remains in line with 
predicted distances of 100Å at tight junctions between cells (Prota et al., 2003). 
1.4.2 JAM-A in tight junctions and signalling 
Tight junctions between adjacent cells serve as a barrier mechanism for the 
maintenance of internal and external environments such as that needed in the 
establishment of different tissues. They serve to regulate homeostasis via the 
diffusion of small molecules and ions and enable signal transduction between the 
intracellular and extracellular environments through many different proteins. 
Tight junctions are formed of several types of transmembrane proteins including 
claudins, occludins, coxsackie-adenovirus receptors and JAMs. Many cellular 
processes may be regulated via tight junctions and their associated proteins 
including cell differentiation and proliferation as well as polarity. 
E-cadherin and nectin are proposed to provide initial points of contact between 
neighbouring cells prior to the recruitment of other junctional proteins. After 
the establishment of these puncta, JAM-A and occludin are thought to be  
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Figure 7- Stages of contact formation between cells 
The four stages of cell-cell contact formation from the formation of lamellipodia (A), adhesion 
between the lamellipodia of two cells (B), polarisation of the cells (C) and the formation of fully 
formed tight junctions (TJ) and adherens junctions (AJ) between the cells (D). Taken from Ebnet 
et al, 2004. 
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recruited during tight junction formation (see Figure 7). ZO-1 (Zonula occludens-
1/tight junction protein-1) or ZO-2 are thought to be sufficient for the 
recruitment of tight junction components during barrier formation (Bauer et al., 
2010; Monteiro and Parkos, 2012). 
Many transmembrane proteins are required for tight junction formation and the 
regulation of paracellular permeability. Although many of these proteins exert 
different functions, a common factor is their interactions with extracellular 
proteins on the surface of adjacent cells within tight junctions. These 
interactions may occur in cis (between proteins in the membrane of the same 
cell) or in trans (between proteins in membranes of adjacent cells). Interactions 
also occur with adaptor proteins on the cytoplasmic side of the cell membrane 
which may induce signalling pathways involved in many cellular processes. 
JAM-A contains PDZ-binding motifs in the C-terminal cytoplasmic tail of the 
protein which can interact with six adapter proteins in a PDZ-dependent manner 
(requiring the Phe-Leu-Val motif). JAM-A has the ability to interact with ZO-1, 
MUPP1, afadin, CASK, PICK-1 and Par-3. Interactions of Par-3 with both Par-6 
and aPKC have been suggested to be important in the formation and assembly of 
tight junctions. Due to the strong interaction between Par-3 and JAM-A, JAM-A 
has been hypothesised to act as a docking site for the core complex (including 
Par-3 and aPKC), a step that is crucial for establishing the polarity of cells as 
well as tight junction formation (Paris et al., 2008). The inhibition of PKC has 
also been shown to reduce the expression of JAM-A, possibly through 
phosphorylation as JAM-A in platelets is phosphorylated by PKC. JAM-A 
phosphorylation at serine-285 by PKC has been shown to affect the assembly of 
tight junctions and therefore also epithelial barrier functions (Monteiro and 
Parkos, 2012). 
Knock outs of JAM-A act to enhance the permeability between epithelial cells 
and causes leaky colonic epithelium in JAM-A knock out mice. JAM-A -/- mice 
also present with an altered pro-inflammatory cytokine profile and an increase 
in the infiltration of leucocytes among mucosal epithelia (Gonzalez-Mariscal et 
al., 2014). The addition of the soluble JAM-A ectodomain (herein referred to as 
JAM-A) in rodents acts to reduce leucocyte transmigration between endothelial 
cells (Reglero-Real et al., 2016). JAM-A antibodies have been shown to prevent 
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reassembly of tight junctions and affect the permeability of the junctions. 
Similar effects were also seen when the JAM-A ectodomain was expressed as a 
fusion protein with IgG-Fc. Other evidence also suggests that the disruption of 
the JAM-A dimer interface prevents the clustering of JAM-A within tight 
junctions showing that the protein is dimeric in its active form (Mandell et al., 
2004).  
JAM-A has been found to form not only homophilic interactions but also 
heterophilic through binding to ß1 and 2 integrins as well as LFA-1 within tight 
junctions (Chiba et al., 2008). It has been suggested that the interaction with 
JAM-A maintains the stability of ß1 integrin while at the surface of the cell. The 
interaction between JAM-A and LFA-1 likely mediates transendothelial migration 
of leucocytes during an immune response. Cytokines such as interferon- and 
tumour necrosis factor- have the ability to induce the internalisation of JAM-A 
and therefore enhance the permeability of epithelial and endothelial cell 
barriers (in a clathrin dependent manner in some cases, also affecting other 
proteins with the tight junctions). JAM-A also has the ability to affect cell 
migration through its interaction with afadin and PDZ-GEF2 (guanine nucleotide 
exchange factor) which results in the activation of Rap1a and stabilisation of ß1 
integrins, which in turn enhances migration of the cell. Interestingly, Rap1a also 
plays a role in the trans-dimerisation of E-cadherin and its organisation within 
tight junctions. It has been proposed that PDZ-containing scaffold proteins such 
as ZO-1, afadin and PDZ-GEFs may interact with tight junctional proteins 
containing PDZ binding motifs to direct the maturation of the junctions and 
maintain barrier function (as well as some containing the ability to interact with 
actin and possibly influence cytoskeletal arrangement and barrier integrity) 
(Ebnet et al., 2004; Monteiro and Parkos, 2012).  
A known interacting partner of JAM-A is ZO-1 which, together with ZO-2, can 
associate with a large array of proteins which have regulatory functions in 
cellular processes including transcriptional regulation and cellular proliferation 
such as Jun, Fos and Cyclin D1. JAM-A has been shown to affect the migration of 
cells with JAM-A silencing resulting in reduced migration due to the inability of 
growth factors to activate the ERK pathway (extracellular signal regulated 
kinase) (Gonzalez-Mariscal et al., 2008). Reduced migration in epithelial cells 
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can be observed following reduced expression of JAM-A and decreased Rap1 
activity resulting in reduced levels of 1 integrin. Afadin expression and 
interaction with JAM-A is necessary for the Rap1 interaction and promotion of 
cellular migration (Severson and Parkos, 2009).  
JAM-A dimerisation has been show to regulate cellular proliferation through the 
Akt/-catenin pathway. A loss of JAM-A results in an increase in PIP3 levels (via 
PI3K activation and PTEN inactivation) resulting in the recruitment of Akt to the 
membrane. Akt is phosphorylated and can in turn phosphorylate -catenin 
resulting in its nuclear translocation and activity as a transcription factor 
promoting cellular proliferation. It was therefore concluded that JAM-A cis 
dimerisation decreases proliferation by reducing transcriptional activation via 
the Akt/-catenin pathway (Nava et al., 2011). 
JAM-A also localises to the basolateral membrane, localisation of which may be 
controlled by either JAM-A phosphorylation or dimerisation. A model has been 
proposed where the interactions between dimers may control the localisation of 
JAM-A and its effect on cell migration. Cis-interactions (but not trans) are 
expected in sub-confluent or spreading cells and may favour proliferation, 
however, trans-interactions would be seen in confluent cells with established 
tight junctional barriers and may even play a role in cellular senescence. While 
salt bridges form between two JAM-A proteins interacting in cis, it is thought 
that van der waals forces are responsible for trans interactions. The 
phosphorylation of the cytoplasmic tail of JAM-A at serine-285 results in the re-
localisation to tight junctions rather than the basolateral membrane (Monteiro 
et al., 2014; Monteiro and Parkos, 2012). 
1.4.3 Glycosylation of JAM-A 
Protein glycosylation can affect conformation, stability, protection from 
degradation, intracellular trafficking as well as protein secretion. Glycosylation 
may be N or O-linked. O-glycans are attached to a hydroxyl group of a serine or 
threonine residue although no consensus sequence has been identified for this 
type of glycosylation. In N-linked glycosylation, the oligosaccharide is attached 
to the amine group of an asparagine residue of a protein with the consensus 
motif of NXS/T (with X representing any amino acid except proline). N-linked 
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glycosylation only occurs on proteins that are transported via the secretory 
pathway. The oligosaccharide begins to assemble on the cytoplasmic side of the 
endoplasmic reticulum and is then flipped into the lumen where it is fully 
assembled and added to a protein. Once the protein has folded correctly, it 
passes through the golgi apparatus of the cell where the oligosaccharide may be 
processed further involving the possible addition and removal of glycans. The 
protein folding requirement of N-linked glycans was first demonstrated for the 
glycoproteins of influenza virus (HA) and vesicular stomatitis virus (G) (Roth et 
al., 2012; Schwarz and Aebi, 2011; Xu and Ng, 2015). 
N-linked glycosylation of proteins is initiated within the endoplasmic reticulum 
of mammalian cells where a diverse array of glycans can be added to a newly 
synthesised protein. Glycans can be high mannose, hybrid or complex (see Figure 
8). A terminal N-acetylneuraminic acid (NANA) has been linked to protein half-
life although Chinese hamster ovary (CHO) cells lack the ability to produce 2,6 
linked sialic acid so produce 2,3 linked NANA instead. It has also been 
demonstrated that low temperatures (30C) result in a decrease in sialic acid 
incorporation into proteins. CHO and baby hamster kidney (BHK) cells have been 
shown to process glycoproteins in a similar manner to humans and so are often 
used in the production of recombinant glycoproteins for therapeutics (Hossler et 
al., 2009).  
N-linked glycosylation at position 185 has been shown to regulate human JAM-A 
dimerisation and protein stability/half-life although this glycosylation is not 
required for the transport of JAM-A. The glycosylation of JAM-A, however, 
controls cellular migration and is involved in LFA-1 binding. Among cell lines 
tested, JAM-A glycosylation always contains sialic acid whereas the presence of 
fucose is only observed in epithelial cells. N-glycosylation of D2 of the JAM-A 
ectodomain has been shown to stabilise JAM-A dimers despite the dimerisation 
interface being present only within D1. Glycosylation has previously been shown 
to regulate homodimerisation of E and N-cadherin (Scott et al., 2015). 
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Figure 8- N-glycosylation structures 
The three basic core structures of N-linked glycans: high mannose, complex and hybrid. Glycans 
are linked to proteins via their initial GlcNAc (shown as black squares). Taken from Roth et al, 
2012. 
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1.4.4 JAM-A as a receptor for Reovirus and Hom-1 
JAM-A is the cellular receptor for reovirus which has been shown to bind to JAM-
A at the top of the dimer interface via residues Glu61, Lys63 and Leu72. The 1 
head of reovirus has the ability to bind to monomeric JAM-A as well as disrupt 
JAM-A dimers. Residues Glu61 and Lys63 participate in the stabilisation of JAM-A 
dimers via the salt bridges which illustrates how engagement of JAM-A by 
reovirus 1 results in the destabilisation and monomerisation of JAM-A. Low 
affinity interactions with carbohydrate moieties are hypothesised to localise 
reovirus to the cellular membrane where it can then laterally move within the 
membrane until the virus is able to bind to JAM-A via a much higher affinity 
interaction (a KD of approximately 2.4nM) (Guglielmi et al., 2007). Two 1 
trimers have been observed bound to three D1 JAM-A ectodomain monomers 
although this complex is unstable below pH5. Interestingly, the KD of the JAM-A 
D1-D1 interaction was 11M compared to 2.4nM for 1-D1 interaction which 
suggests that the higher affinity for 1 than other JAM-A monomers may be 
involved in reovirus binding and disruption of JAM-A dimers (Kirchner et al., 
2008). 
Hom-1 was the first calicivirus found to replicate in human cells and was isolated 
following the accidental infection of a laboratory employee with a vesivirus; San 
Miguel sea lion virus (SMSV). JAM-A has been shown to render non-permissive 
cells susceptible to Hom-1 infection although the cytoplasmic domain of JAM-A 
was shown to be dispensable for infection suggesting that it is not involved in 
triggering the entry of the virus. The same was observed with reovirus although 
intracellular FCV could not be detected with these JAM-A mutants showing the 
requirement of the cytoplasmic domain in FCV internalisation and entry. In 
contrast, 1 integrin has been proposed to enhance the internalisation of 
reovirus (Sosnovtsev et al., 2017). 
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1.5 Caliciviridae 
Caliciviruses are non-enveloped, single stranded, positive sense RNA viruses. The 
Caliciviridae are sub-divided into the genera: ‘Norwalk-like viruses’ (Norovirus), 
‘Saporro-like viruses’ (Sapovirus), Lagovirus, Nebovirus and Vesivirus (Green et 
al., 2000).  
Both Noroviruses and Sapoviruses are renowned for causing human 
gastrointestinal disease (with Neboviruses causing bovine enteric disease). The 
prototypical member of the ‘Norwalk-like viruses’ is Norwalk virus which was 
first described following a gastroenteritis outbreak in 1968 in Norwalk, Ohio. The 
virus was initially classified as a picornavirus due to its appearance in electron 
microscopy but later classified as a calicivirus based on its use of a single capsid 
protein. Sapporo virus is the prototype stain of the ‘Sapporo-like viruses’ and 
was associated with an outbreak of gastroenteritis in 1982 in infants in Sapporo, 
Japan (Green et al., 2000).  
Lagoviruses infect lagomorphs (for example, rabbits and hares) such as European 
brown hare syndrome virus (EBHSV) which was found to be the causative agent in 
a disease outbreak in Denmark in 1982. Liver necrosis and intravascular 
coagulation were described as a highly fatal consequence of infection with 
rabbit haemorrhagic disease virus (RHDV) in 1990. The RHDV genome was also 
the first full length sequence of a calicivirus reported (Green et al., 2000). 
Vesiviruses may infect and cause a wide range of symptoms in many animal 
species (Pesavento et al., 2008). The first calicivirus found to cause disease was 
the vesicular exanthema of swine virus (VESV) in the United States and was 
mistaken for foot and mouth disease. VESV in 1968 was shown to be a small virus 
with icosahedral symmetry with no link to foot and mouth disease. A disease 
causing vesicular lesions and abortions in sea lions was later shown to be caused 
by San Miguel sea lion virus (SMSV) and related to VESV. Feline calicivirus (FCV) 
was first isolated in cell culture in New Zealand in 1957 and had been shown to 
cause primarily respiratory illness among cats. FCV was also classified as a 
picornavirus originally (known as feline picornavirus for some time) before 
amendment and inclusion within the vesivirus genus of the Caliciviridae.  
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The third report of the International Committee on Taxonomy of Viruses (ICTV) 
in 1979 was when the family Caliciviridae were first classified. Their 
classification was based on their usage of a single capsid protein which 
assembled to form icosahedral particles with 32 cup shaped depressions on their 
surface. The name calicivirus derives from the latin word for cup, calix. 
Caliciviridae form particles of approximately 30 to 40 nanometres (nm) in 
diameter. Calicivirus genomes are around 7.5 kilobases (kb) in length and 
encode a small virion protein g (Vpg) covalently linked to the viral genomic RNA 
rather than a methylated cap as described for the picornaviruses.  Caliciviruses 
also encode two RNA species during viral replication: one is the full length 
genome while a shorter, sub-genomic strand of RNA is also produced at the 3’ 
end which serves as a translational template for the capsid proteins, VP1 and 
VP2. Picornaviruses, however, do not encode a subgenomic RNA species during 
replication. Another factor where Caliciviruses differ from picornaviruses is the 
position in the genome where the capsid proteins are encoded. The capsid 
proteins are encoded at the 5’ end of picornavirus genomic RNA but caliciviruses 
encode them at the 3’ end of their RNA genome. While ‘Norwalk-like viruses’ 
and vesiviruses encode three open reading frames, lagoviruses and ‘Sapporo-like 
viruses’ encode two open reading frames. The first open reading frame (ORF) for 
all Caliciviruses encodes the non-structural proteins as well as the major capsid 
protein for the lagoviruses and ‘Sapporo-like viruses’ although this is encoded on 
ORF2 for the ‘Norwalk-like viruses’ and vesiviruses. The minor structural protein 
is then encoded on a separate ORF for all Caliciviruses (Clarke and Lambden, 
1997; Green et al., 2000; Thiel and Konig, 1999).   
1.5.1 Feline calicivirus (FCV) 
Feline calicivirus was isolated from cats in New Zealand in 1957 and is readily 
cultured in vitro resulting in cell rounding and death within hours of infection. 
Virus particles are able to survive on surfaces for up to two weeks and are stable 
within a pH range of around 4 to 8.5 (Pesavento et al., 2008). 
Feline calicivirus is a widespread pathogen which primarily causes oral and upper 
respiratory tract disease in cats, however, some strains have the ability to cause 
virulent systemic disease. A variety of clinical signs are associated with FCV 
infection including oral ulceration, ocular and nasal discharge and occasionally  
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Figure 9- Genome organisation of caliciviruses and picornaviruses 
Diagrammatic representation of the open reading frames and proteins encoded by the different 
caliciviruses as well as picornaviruses (Poliovirus type 1). Taken from Lee et al, 2017 and De 
Jesus, 2007. 
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pneumonia. Cats infected with virulent systemic strains of FCV present with 
varying degrees of pyrexia, ulcerative dermatitis, anorexia, cutaneous oedema 
and jaundice with a mortality rate of up to 50% (Pesavento et al., 2008). 
Infection usually occurs via the nasal, oral or conjunctival route with viral 
replication occurring mainly in the oral and respiratory tract. Mixed infections 
are not uncommon which provides the possibility for recombination between 
strains within an infected cell. FCV prevalence among individual households 
remains relatively low although prevalence among cats in rehoming centres is 
much higher. Vaccination with the F9 strain, however, only leads to protection 
against 54% of tested isolates (Coyne et al., 2006; Pesavento et al., 2008; 
Radford et al., 2007). 
FCV encodes a single stranded, positive sense RNA genome of approximately 
7.7kb in length with a 5’ VPg protein, a 3’ polyA tail and three open reading 
frames (see Figure 9). A smaller RNA species of 2.4kb, known as the subgenomic 
mRNA, is also observed which encodes the structural proteins of the virus 
(located at the 3’ end of the genome) (Herbert et al., 1997). Open reading 
frame (ORF) 1 encodes the non-structural proteins of the virus while ORF2 
encodes the major capsid protein, VP1, and ORF3 encodes the minor capsid 
protein, VP2.  
Each viral capsid is assembled from 180 VP1 proteins arranged into A/B and C/C 
capsomeres which form the characteristic arch-like dimers on the capsid 
surface. Although all members of the Caliciviridae show this characteristic 
capsid morphology, members often differ in the structures of their P2 domains 
as seen in Figure 10. For example, some form more rounded structures like those 
seen in RHDV and norovirus GII.10 while others form more rhomboid structures 
like those seen in FCV (Conley et al., 2017).  
Infection with FCV results in the shutdown of cellular protein synthesis via the 
cleavage of eIF4G (eukaryotic initiation factor 4G), as well as formation of 
membrane bound vesicular structures via the rearrangement of intracellular 
membranes (Willcocks et al., 2004). FCV replication has also been shown to 
induce programmed cell death/apoptosis via the activation of caspases 3, 8 and 
9 resulting in the rapid cytopathic effect seen in FCV infected cells in vitro 
(Sosnovtsev et al., 2003). 
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Figure 10- Comparison of calicivirus structures 
Side by side comparison of the structures of vesivirus 2117 (A), a chimeric sapovirus (B), RHDV 
(C), FCV (D), norovirus GII.10 (E) and Norwalk virus (F). Taken from Conley et al, 2017. 
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Mitochondrial membrane potential is initially lost alongside the translocation of 
Bax from the cytosol to the mitochondria within 4 to 6 hours post infection. 
Cytochrome c is then released from mitochondria at 6-8 hours post infection, 
resulting in the activation of caspases and triggering of apoptosis (Natoni et al., 
2006).  
1.5.1.1  Non-Structural Proteins 
Most of the non-structural proteins of FCV have been found to be associated with 
membranous replication complexes including p32/NS2, p39/NS3 (helicase) and 
p76/NS6-7 (protease-RNA dependent RNA polymerase) (Green et al., 2002). 
Virion protein g (VPg/p13/NS5) is a small protein that is covalently linked to the 
5’ end of the viral genome. VPg is not required for FCV infection but must be 
present (or replaced with a cap structure) for translation of the viral RNA to 
occur (Sosnovtsev and Green, 1995). Polypyrimidine tract binding protein (PTB) 
has been shown to redistribute from the nucleus into the cytoplasm (following 
translation of the viral proteins) where it interacts with the 5’ ends of the 
genomic and subgenomic viral RNAs. PTB partially co-localises with replication 
complexes and acts as a switch to inhibit translation and promote viral genome 
replication (Karakasiliotis et al., 2006; Karakasiliotis et al., 2010). VPg is also 
associated with the p30/NS4 protein within replication complexes, suggesting a 
role in anchoring VPg near membranous replication complexes ready for RNA 
replication (Green et al., 2002).  
NS2/p32 interacts with p39/NS3, p30/NS4, p76/NS6-7 and also itself in 
membranous viral replication complexes. NS2/p32, p39/NS3 and p30/NS4 have 
been identified as potential transmembrane proteins which localise to the 
endoplasmic reticulum and lead to membranous rearrangements characteristic 
of FCV infection (Bailey et al., 2010). NS3/p39 has been shown to prevent the 
activation of interferon response factor-3 (IRF3) and therefore supress factors of 
the innate immune response during viral infection (Yumiketa et al., 2016). 
The FCV protease/polymerase (p76/NS6-7) forms homotypic oligomers and also 
interacts with the VPg protein (possibly during the replication of progeny viral 
genomes) as well as ORF2, encoding the major viral capsid protein. A weak 
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interaction with the minor capsid protein, VP2, has also been described (Kaiser 
et al., 2006). The viral protease is responsible for the cis cleavage of the viral 
polyprotein to yield the individual viral proteins outlined above, however, it is 
thought that the full-length protease-polymerase is the active form of the RdRp 
(Sosnovtseva et al., 1999; Wei et al., 2001). The host protein, nucleolin, has 
been described as essential for viral replication due to its interactions with both 
viral RNA and p76/NS6-7 (Cancio-Lonches et al., 2011). The viral protease, NS6, 
appears to reduce cellular protein synthesis by mediating the cleavage of poly A 
binding protein (PABP) and recently, NS6 has been shown to impair the 
formation of stress granules within infected cells, preventing the limitation of 
energy available for virus replication (Humoud et al., 2016; Kuyumcu-Martinez et 
al., 2004). 
1.5.1.2  Structural Proteins 
Caliciviruses encode two structural proteins. The major capsid protein, VP1, 
forms the majority of the viral capsid with the minor capsid protein, VP2 
incorporated to a much lesser extent. 
The major capsid protein, VP1, is translated from the subgenomic RNA and forms 
a 76kDa precursor protein which is cleaved to form the mature capsid protein of 
62kDa. This cleavage event is mediated by the viral protease and is critical for 
the life cycle of the virus (Sosnovtsev et al., 1998). The leader of the capsid 
protein (LC) which is cleaved post-translationally, has been shown to be 
responsible for the cytopathic effect seen in infected cells. LC has also been 
shown to bind to annexin A2, supporting its role in enabling virus spread (Abente 
et al., 2013). VP1 has been shown to interact with the VPg protein as well as the 
protease/polymerase, p76/NS6-7, and the minor capsid protein, VP2 (Kaiser et 
al., 2006). VP1 consists of 2 domains; the S domain forms the shell of the viral 
capsid with the P domain protruding out from the shell. The P domain can be 
further divided into P1 and P2 with P2 being an insertion in P1 (see Figure 11) 
and responsible for receptor binding and therefore tissue tropism (Bhella et al., 
2008; Ossiboff et al., 2010). 
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Figure 11- FCV major capsid protein, VP1 
Ribbon diagram of FCV strain 5 VP1 capsid protein showing the N-terminal arm (green), S domain 
(blue), P1 domain (red) and P2 domain (yellow) with the hinge region highlighted. Taken from 
Ossiboff et al, 2010. 
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The minor capsid protein, VP2, is essential for FCV replication and release of 
progeny viral particles (Sosnovtsev et al., 2005). Each virion is predicted to 
incorporate one or two copies of VP2 and it is involved in the self-assembly of 
the capsid (Di Martino and Marsilio, 2010; Sosnovtsev and Green, 2000). 
1.5.1.3  FCV entry 
FCV has a tropism restricted to cells of feline origin although this restriction is 
overcome when viral RNA is transfected into cells, demonstrating that it is the 
binding and entry of the virus that is restricted (Kreutz and Seal, 1995). Binding 
of FCV to cells is most efficient at pH 6.5 with half maximal binding occurring as 
quickly as after 15 minutes (Kreutz et al., 1994). FCV entry was hypothesised to 
involve a low pH step during the first 2 hours of infection (Kreutz and Seal, 
1995). It has since been shown that acidification of endosomes is required for 
uncoating of the virus and release of the viral genome into the cell for 
replication. FCV entry is mediated by clathrin mediated endocytosis and viral 
genome release may be mediated by permeabilisation of endosomal membranes 
during virus entry (Stuart and Brown, 2006).  
Many viruses have been shown to use carbohydrate moieties such as sialic acid as 
attachment factors or components of their receptors. Treatment of cells with 
neuraminidase (which cleaves terminal sialic acid residues) reduces FCV binding 
to only 23% suggesting a role for sialic acid in FCV binding and entry. It was 
further demonstrated that FCV binds to 2,6-linked sialic acid that is present on 
an N-linked glycoprotein on the surface of feline cells. The type of sialic acid 
linkage may also play a role in tissue specificity and cell tropism (Stuart and 
Brown, 2007). 
A functional receptor for FCV has been identified as feline junctional adhesion 
molecule A (fJAM-A) which can be found in the tight junctions of epithelial and 
endothelial cells as well as on platelets and leucocytes as described for the 
human and murine homologues of the protein. Infection with FCV causes the re-
localisation of fJAM-A away from tight junctions and into the cytosol of the cell 
(Pesavento et al., 2011). Anti-fJAM-A antibodies were shown to decrease FCV 
binding to feline kidney (CrFK) cells and the expression of fJAM-A in non-
permissive cells rendered them susceptible to FCV infection. D1 of the fJAM-A 
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ectodomain is sufficient for virus binding (Ossiboff and Parker, 2007) and feline 
JAM-A shares 75.6% amino acid identity with the human form of the protein with 
a predicted N-glycosylation site at position 185 (Makino et al., 2006). 
1.5.1.4  FCV structure 
In early electron microscopic studies of FCV, small individual particles of 35nm 
in diameter were observed within infected cells (Studdert and O'Shea, 1975). 
Virus particles were also observed in association with smooth membranes (Love 
and Sabine, 1975). 
The major capsid protein, VP1, assembles into arch-like dimers/capsomeres 
which gives rise to the characteristic calicivirus morphology of cup-shaped 
depressions on the virus surface (visible in Figure 12). The major capsid proteins 
differ slightly in their conformations (although not in sequence) to form A, B and 
C isoforms (see Figure 3). A/B (bent) and C/C (flat) dimers are present at 
different positions in the viral capsid in order to allow icosahedral symmetry 
with 180 subunits (T=3). A/B capsomeres are located around the five-fold 
symmetry axes while C/C capsomeres are found at two-fold symmetry axes 
(resulting in the alternation of A/B and C/C capsomeres around the three-fold 
symmetry axes). The S domain of VP1 folds into an eight stranded -barrel 
structure with each strand designated B to I. These eight strands form two, four 
stranded -sheets (BIDG and CHEF) with two alpha helices between strands C 
and D as well as between E and F. The S domain is linked to the P domain of VP1 
via a flexible hinge region, allowing the slightly different conformations adopted 
by the A, B and C structures. The P domain is subdivided into P1 and P2 with P2 
being an insertion into P1 and being responsible for receptor binding. P2 is 
formed of a six stranded -barrel (A’ to F’) with varying lengths and orientations 
and contains hyper-variable regions which can result in high degrees of variation 
between strains. These hyper-variable regions often form the neutralising 
epitopes/antibody binding sites which are targeted by the immune system of the 
host (Bhella et al., 2008; Ossiboff et al., 2010).  
 
 
 34 
 
 
Figure 12- FCV5 structure 
Crystal structure of FCV strain 5 at 3.6Å resolution showing the S domains (blue), P1 domains 
(red) and P2 domains (yellow). Five and three-fold symmetry axes are labelled as well as the 
positions of the A/B and C/C dimers within the capsid. Taken from Ossiboff et al, 2010. 
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1.5.1.5  FCV-fJAM-A interaction 
Residues D42, K43 and S97 of the D1 subdomain of the fJAM-A ectodomain are 
involved in the binding of FCV as mutation resulted in decreased binding (shown 
in pink in Figure 13). In addition, all domains of fJAM-A are necessary for FCV 
infection although the PDZ-binding motif in the cytoplasmic domain is 
dispensable for virus entry. FCV interacts with both monomeric and dimeric 
forms of fJAM-A and this interaction must induce signals through the 
transmembrane or cytoplasmic domains of fJAM-A to coordinate entry and 
infection as when these were replaced with a GPI anchor, no infection was seen 
(Ossiboff and Parker, 2007).  
Interestingly, the FCV binding site and fJAM-A dimerisation interface do not 
overlap, suggesting that FCV does not compete for binding which may be 
independent of dimerisation. The potential N-linked glycosylation site of fJAM-A 
(shown in Figure 13) appears to be located close to the transmembrane region of 
fJAM-A and relatively far away from the FCV binding site and dimerisation 
interface implying that the glycosylation is not involved in these interactions. 
The previous structures of FCV bound to fJAM-A (at 9Å resolution), as solved by 
cryo-electron microscopy and three-dimensional reconstruction, showed high 
occupancy binding demonstrating the absence of any steric hindrance between 
fJAM-A ectodomains. Upon fJAM-A binding, a conformational change is apparent 
in the capsid. The P domains of the capsid appear to rotate 15 anticlockwise 
when bound to fJAM-A. The majority of the contacts between FCV and fJAM-A 
occur in D1 of the ectodomain as shown in pink in Figure 13 (Bhella and 
Goodfellow, 2011). In support of these observations of conformational changes, 
Ossiboff et al reported an increase in hydrophobicity upon FCV-fJAM-A 
incubation consistent with a change in protein structure (Ossiboff et al., 2010). 
These previous structures were not of sufficient resolution to allow the 
visualisation of secondary structural elements or precise evaluation of 
interacting residues and so prompted the study of this interaction at near atomic 
resolution. 
The fJAM-A proteins are bound to the P2 domain of FCV VP1 in a head to tail 
arrangement, rotated 180 with respect to each other. The density above the   
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Figure 13- JAM-A monomer highlighting key residues for interactions 
Surface representations of human JAM-A with residues involved in dimerisation (turquoise), FCV 
binding (pink) and N-linked glycosylation (orange) highlighted. Different views of the protein are 
shown; top view (A), back view (B), side view (C) and underside view (D). PDB ID: 1NBQ. 
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A/B dimer in the cryo-EM reconstructions is clear and well defined unlike that at 
the C/C dimer suggesting a higher degree of movement/flexibility limiting the 
reconstruction. This suggests that the conformational change observed at the 
A/B dimers is potentially different to that which occurs at the C/C dimers where 
the icosahedral symmetry may be broken, resulting in difficulty refining the 
density. Bhella and Goodfellow suggested that this may be caused by the C/C 
dimer bending away from the two-fold symmetry axis when bound to fJAM-A 
(Bhella and Goodfellow, 2011). The conformational changes seen in the capsid 
upon fJAM-A binding are hypothesised to act as a priming step for uncoating of 
the virus during entry into a host cell via clathrin-mediated endocytosis. 
1.6 Aims 
The broad aim of this project was to characterise the interaction between FCV 
and fJAM-A. One aspect of this was to assess the glycosylation state of fJAM-A 
and also to determine if the previously reported binding to sialic acid on cell 
surfaces was actually a result of FCV binding to a carbohydrate moiety on 
glycosylated fJAM-A (Stuart and Brown, 2007). 
Another aim of the project was to solve both the undecorated (FCV) and 
decorated (FCV bound to fJAM-A) virus structures to near-atomic resolution 
allowing us to determine the mechanism by which fJAM-A induces the previously 
described conformational changes upon binding, and how FCV disrupts fJAM-A 
homodimers (Bhella et al., 2008; Bhella and Goodfellow, 2011). 
The final aim of the project was to investigate the entry pathway of FCV which 
has been previously shown to involve clathrin mediated endocytosis (Stuart and 
Brown, 2006). We aimed to assess the affect of pH on virus structure (both 
undecorated and decorated) in order to investigate the process of viral entry 
and uncoating. Another aspect of this aim was to determine the stoichiometry of 
the virus-receptor interaction as previous studies were performed with fully 
decorated virus particles which is unlikely to be the case during cell binding and 
entry (due to the availability of receptor proteins at the cell surface) (Bhella et 
al., 2008; Bhella and Goodfellow, 2011).   
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2 Materials and Methods 
2.1 Materials 
2.1.1 Antibodies 
2.1.1.1  Primary Antibodies 
Mouse monoclonal anti-feline calicivirus VP1 antibody (Novus Biologicals) was 
used at a dilution of 1 in 1000 for western blotting. 
Goat polyclonal anti-human IgG (Fc specific) antibody (Sigma Aldrich) was used 
at a dilution of 1 in 20,000 for western blotting. 
2.1.1.2  Secondary Antibodies 
Goat anti-mouse DyLight 680 antibody (ThermoFisher Scientific) was used at a 
dilution of 1 in 10,000 for western blotting. 
Donkey anti-goat IRDye 800 antibody (LI-COR Biosciences) was used at a dilution 
of 1 in 10,000 for western blotting. 
2.2 Methods 
2.2.1 Mammalian cell culture 
2.2.1.1  Crandell Rees Feline Kidney cells 
Crandell Rees feline kidney (CrFK) cells were cultured in Dulbeccos’s modified 
eagle medium (DMEM, Life Technologies) with 10% foetal bovine serum (FBS, Life 
Technologies), unless specified otherwise, with 100 units/ml penicillin and 
100g/ml streptomycin (PenStrep, Life technologies) at 37C in an atmosphere 
containing 5% carbon dioxide (CO2).  
Cells were passaged by removal of the culture media followed by washing the 
cells twice with 5ml 1x PBS and incubation with 5ml 0.05% trypsin containing 
EDTA (Life technologies) for 5 minutes at 37C in an atmosphere containing 5% 
CO2. The cells were then removed from the culture flask and 10% were added to 
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a new culture flask containing 30ml media and cultured at 37C in an 
atmosphere containing 5% CO2 for 3-4 days. 
2.2.1.2  Chinese Hamster Ovary cells 
Chinese hamster ovary (CHO) cells stably expressing a secreted form of the 
fJAM-A ectodomain (amino acid residues 1-237) fused to an Fc tag were cultured 
in Roswell Park Memorial Institute (RPMI, Life Technologies) medium 
supplemented with 10% FBS, PenStrep and 200g/ml hygromycin B (Sigma 
Aldrich). Cells were cultured at 37C in an atmosphere containing 5% CO2 and 
passaged as described in 2.2.1.1. 
2.2.2 Virus Purification 
2.2.2.1  Feline Calicivirus 
2.2.2.1.1  Infection and virus propagation 
FCV (strain F9) was grown and purified from CrFK cells under the conditions 
outlined in 2.2.1.1. Eight confluent T175cm3 cell culture flasks containing 
confluent CrFK cells were trypsinised as outlined in 2.2.1.1. These cells were 
then added to 16 T850 roller bottles containing 100ml cell culture media and 5% 
CO2. The cells were incubated at 37C for 3 days until confluent. The culture 
media were removed and the cells infected with FCV at a multiplicity of 
infection (MOI) of 5 in the presence of 20ml culture medium supplemented with 
2% FBS and PenStrep. The cells were then incubated at 37C for 18 hours and the 
supernatant collected for FCV purification. 
2.2.2.1.2  Virus Purification 
The supernatant collected from the infected roller bottles was firstly 
centrifuged at 420 xg for 10 minutes at 4ºC to remove any cell debris. The 
supernatant was then centrifuged at 54200 xg for 2 hours at 4 ºC to pellet the 
virus particles (SureSpin 630 rotor from ThermoFisher Scientific). The 
supernatant was poured off and the pellets resuspended in 500l 1x PBS at 4C 
overnight. The resuspended material was then layered over a 1.3-1.45 g cm-3 
caesium chloride gradient and centrifuged at 98700 xg for 16 hours at 12ºC (TH-
641 rotor from ThermoFisher Scientific). The band containing virus particles was 
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then extracted and pelleted by centrifugation at 50400 xg for 2 hours at 4 ºC and 
the pellet resuspended in approx. 100l 1x PBS at 4C overnight. 
The protein concentration of the sample was then determined (see 2.2.2.1.3) 
and the virus titrated (see 2.2.2.1.4). 
2.2.2.1.3  Protein quantification 
Protein quantification was performed using a NanoDrop One (Thermo Scientific) 
by measuring UV absorbance at 280nm (using the appropriate calculated 
extinction coefficients to calculate an accurate protein concentration). 
2.2.2.1.4  Titration by plaque assay 
CrFK cells were seeded at 75% confluency in 6 well cell culture plates and 
incubated at 37C in an atmosphere containing 5% CO2 for 24 hours. 10-fold serial 
dilutions of virus (final volume 1ml) were then made in serum free cell culture 
medium. The media was removed from the plates and the cells washed with 1x 
PBS followed by the addition of 400l of the corresponding serial dilution prior 
to incubation at 37C in an atmosphere containing 5% CO2 for 1.5 hours. Equal 
volumes of 2x overlay media (14.3g DMEM powder, 3.7g Sodium Bicarbonate and 
1.1915g HEPES in 500ml deionised water) and 2% low melting point agarose 
(LMA) were then combined, with 2ml added to each well after removal of the 
viral serial dilution. The cell culture plates were then incubated at room 
temperature for 20 minutes to allow the agarose overlay to solidify. The plates 
were then inverted and incubated at 37C in an atmosphere containing 5% CO2 
for 18 hours.  
The cells in the 6 well plates were then fixed with 1% formaldehyde in deionised 
water (ThermoFisher Scientific) for 1 hour at room temperature, after which the 
fixative was removed and the wells washed with 1x PBS prior to the removal of 
the agar plugs from the individual wells. Cell monolayers were then stained for 1 
hour to detect the presence of plaques using Giemsa stain (Sigma Aldrich). The 
plates were then washed with water following removal of the stain and left to 
dry before counting the plaques and calculating the virus titre. 
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2.2.3 Feline Junctional Adhesion Molecule A expression and 
purification 
2.2.3.1  Expression of fJAM-A ectodomain 
CHO cells expressing a secreted form of the fJAM-A ectodomain fused to an Fc 
tag were provided by Professor Ian Goodfellow (University of Cambridge). The 
fJAM-A ectodomain was separated from the Fc tag by a factor Xa cleavage site. 
Cells were grown as described in 2.2.1.2 for 7 days and the supernatant 
containing secreted Fc-fJAM-A collected. 
2.2.3.2  Purification of fJAM-A ectodomain 
The supernatant collected from CHO-fJAM-A cells was filtered and degassed at 
room temperature alongside 1x PBS, 0.1M citrate pH5 and 0.1M glycine pH2.5. 
The Fc-fJAM-A protein was purified by protein A affinity chromatography using a 
1ml HiTrap Protein A column (GE Healthcare Life Sciences) connected to an Äkta 
pure chromatography system. The system and column were equilibrated with 1x 
PBS and the filtered cell supernatant passed over the column at a rate of 
1ml/min. The column was then washed with 10ml 1x PBS and the contaminating 
bovine IgG (from FBS in cell culture media) eluted using 10ml 0.1M citrate pH5. 
The column was subsequently washed with 20ml 1x PBS and the Fc-fJAM-A 
eluted using 8ml 0.1M glycine pH2.5 in 0.5ml fractions. The pH of each fraction 
was then neutralised with 75l 1.5M Tris pH8 and the protein concentration 
determined as in 2.2.2.1.3.  
2.2.3.3  Removal of Fc tag from fJAM-A ectodomain 
The Fc tag was removed from the fJAM-A ectodomain by cleavage with Factor Xa 
(New England Biolabs: NEB). Fc-fJAM-A was incubated at 23°C in the presence of 
1x factor Xa cleavage buffer (100mM NaCl, 50mM Tris and 5mM CaCl2) with a 
25:1 ratio of protein:factor Xa (g) for 18 hours.  
In order to remove the factor Xa, the sample was then incubated with Xarrest 
Agarose (Novagen) at a ratio of 1g factor Xa: 25l agarose (pre-washed with 10 
volumes 1x factor Xa cleavage buffer) for 10 minutes at room temperature. The 
sample was then centrifuged at 1000 xg for 5 minutes (at room temperature) and 
the supernatant removed. The agarose pellet was washed with 1ml 1x factor Xa 
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cleavage buffer and centrifuged as before, repeating the wash once. 
The sample was then combined with the two washes and the protein 
concentration determined as described in 2.2.2.1.3. 240g protein was then 
combined with 1ml protein A Dynabeads (Life Technologies) and incubated with 
rotation for 10 minutes. A magnet was then applied to the sample, the 
supernatant removed from the beads and the fJAM-A ectodomain protein 
concentration determined (see 2.2.2.1.3). The beads were then washed in 1x 
PBS and the Fc portion of the protein eluted from the beads using 50mM glycine 
pH2.5 following incubation at room temperature for 2 minutes. Purified protein 
was stored at 4°C until use. 
2.2.4 Western Blotting 
2.2.4.1  SDS-PAGE 
Four 12% resolving gels were made by combining 8ml 30% acrylaminde/bis 
solution 37.5:1 (BIO-RAD), 6.6ml deionised water, 5ml 1.5M Tris pH8.8, 0.2ml 
10% sodium dodecyl sulphate (SDS), 0.2ml 10% ammonium persulfate (APS) and 
0.025ml N,N,N',N'-tetramethylethane-1,2-diamine (TEMED) in glass casting plates 
(BIO-RAD).  
Four 5% stacking gels were made by combining 1ml 30% acrylaminde/bis solution 
37.5:1 (BIO-RAD), 4.2ml deionised water, 0.76ml 1M Tris pH6.8, 0.06ml 10% SDS, 
0.06ml 10% APS and 0.01ml TEMED.   
Once the resolving gels had set, the stacking gel could be made, layered on top 
and a comb inserted while the stacking gel solidified at room temperature. 
Protein samples were prepared by the addition of 2x Laemmli loading buffer and 
incubation at 95°C for 7 minutes. Samples were then loaded into the wells of 
the gels alongside Precision Plus Protein Kaleidoscope Prestained protein 
standards (BIO-RAD). Gels were run in the presence of 1x running buffer (3g Tris 
Base, 14.4g glycine and 1g SDS per litre in deionised water) at 80mA for 
approximately 1 hour. 
If gels were not used for western blotting, the gels were removed from the glass 
plates, washed in deionised water and stained with Imperial protein stain 
(ThermoFisher Scientific) for 1 hour followed by destaining in deionised water. 
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2.2.4.2 Western Blotting 
SDS PAGE gels were run as described in 2.2.4.1 and transferred onto 
nitrocellulose membrane using an Invitrogen Novex mini cell with an XCell II blot 
module at 25 volts for 1hour. The membranes were blocked for 1 hour with 5% 
FBS in PBS followed by incubation with the appropriate primary antibody in 0.1% 
Tween 20 in PBS (PBS-T) containing 5% FBS for 1 hour at room temperature. The 
membranes were subsequently washed 3 times in PBS-T before incubation with 
the appropriate secondary antibody in opaque tubes in PBS-T containing 5% FBS 
for 1 hour at room temperature. The membranes were then washed 3 times in 
PBS-T, 2 times in PBS and 2 times in deionised water, each wash lasting 5 
minutes. Membranes were then stored in deionised water until visualisation on a 
LI-COR Odyssey CLx. 
2.2.5 Deglycosylation of fJAM-A 
2.2.5.1  In vitro deglycosylation of fJAM-A 
2.2.5.1.1  Alpha2-3,6,8,9 Neuraminidase A 
To deglycosylate a protein with Alpha2-3,6,8,9 Neuraminidase A, 1g protein 
was incubated in the presence of 1l 10x Glycobuffer 1 (NEB), 1l Alpha2-3,6,8,9 
Neuraminidase A (NEB) and deionised water to a final volume of 10l at 37C for 
1 hour. 
2.2.5.1.2  Beta1-4 Galactosidase 
1g protein was combined with 1l 10x Glycobuffer 1 (NEB), 2l Beta1-4 
Galactosidase (NEB) and deionised water to a final volume of 10l at 37C for 1 
hour. 
2.2.5.1.3  Endoglycosidase H 
5g protein was combined with 2l 10x Glycobuffer 3 (NEB), 5l Endoglycosidase 
H (EndoH; NEB) and deionised water to a final volume of 10l at 37C for 1 hour.  
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2.2.5.1.4  Remove-iT PNGase F 
5g protein was combined with 2l 10x Glycobuffer 2 (NEB), 3l Remove-iT 
PNGase F (NEB) and deionised water to a final volume of 20l at 37C for 1 hour.  
To remove the PNGase F enzyme from samples, 1l of chitin magnetic beads 
(NEB) per 100U of enzyme were washed in column binding buffer (500mM NaCl, 
20mM Tris-HCl, 1mM EDTA and 0.05% Triton-x-100 at pH8) and applied to a 
magnet before removing the supernatant. The sample is then added to the beads 
and mixed with rotation for 1 hour at 4C. The magnet is then applied to the 
sample and the enzyme free sample removed and stored at 4C until use. 
2.2.5.1.5  Beta-N-Acetylglucosaminidase 
1g protein was combined with 1l 10x Glycobuffer 1 (NEB), 2l Beta-N-
Acetylglucosaminiadse (NEB), 1l 10x bovine serum albumin (BSA) and deionised 
water to a final volume of 10l at 37C for 1 hour.  
2.2.5.1.6  O-glycosidase 
5g protein was combined with 2l 10x Glycobuffer 2 (NEB), 2l 10% NP-40, 2l 
Alpha2-3,6,8,9 Neuraminidase A (NEB) and 5l O-glycosidase (NEB) and deionised 
water to a final volume of 20l at 37C for 1 hour.  
2.2.5.2  Immunoprecipitation of FCV by fJAM-A 
5g Fc-fJAM-A was bound to 50l Protein A Dynabeads (Life Technologies) by 
incubation in 200l PBS-T with rotation at room temperature for 10 minutes. The 
magnet was then applied to the sample and the supernatant removed. 380g 
FCV was then added to the beads and mixed prior to incubation with rotation for 
10 minutes at room temperature. The magnet was then reapplied, the 
supernatant removed and the beads washed 3 times with 200l PBS-T. The beads 
were then resuspended in 30l 2x Laemmli loading buffer and incubated at 95C 
for 7 minutes. The magnet was then applied to the sample and the supernatant 
loaded into SDS-PAGE gels and subsequently blotted for both Fc (Fc-fJAM-A) and 
FCV VP1 (as described in 2.2.4). 
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2.2.5.3 Neutralisation assay 
Neutralisation assays were performed with an MOI of 3 for FCV in 6 well cell 
culture plates with confluent CrFK cells. Both Fc-fJAM-A and deglycosylated Fc-
fJAM-A (PNGase F treated; see 2.2.5.1.4) were used in a side by side 
comparison. FCV (0.66g) was incubated with varying dilutions of Fc-fJAM-A or 
deglycosylated Fc-fJAM-A (0.66g, 0.33g (1 in 2 dilution), 0.22g (1 in 3 
dilution), 0.165g (1 in 4 dilution) or 0.132g (1 in 5 dilution)) on ice for 1 hour. 
The samples were then added to individual wells in the plates and incubated at 
37C for 1.5 hours. The protocol for titration by plaque assay was then followed 
(as per 2.2.2.1.4) and the plaques counted. Neutralisation assays were 
performed in triplicate. 
2.2.6 Size Exclusion Chromatography 
Fc-fJAM-A was purified as described in 2.2.3.2 and the Fc tag removed (if 
specified) as described in 2.2.3.3. A Superdex 200 Increase 10/300 column (GE 
Healthcare Life Sciences) was used with an Äkta pure system and the sample 
loaded onto the column using a 500l superloop. The sample was passed through 
the column in 1x PBS at a flow rate of 0.45ml/min and collected in 0.5ml 
fractions. 
2.2.7 pH dependent RNA release assay 
2g FCV was combined with 2g Fc-fJAM-A in 1x VB buffer (1 litre of 1xVB: 8.75g 
NaCl, 1.2g Tris base and 2g MgCl2 in deionised water) of the appropriate pH along 
with 10l Syto9 nucleic acid binding dye (final concentration 5M, ThermoFisher 
Scientific) to a final volume of 100l in a black 96 well plate (ThermoFisher 
Scientific). For positive control wells, 550ng FCV RNA (provided by Imogen 
Herbert) was added in place of the FCV and Fc-fJAM-A samples. A PHERAstar FS 
(BMG Labtech) was used with a 485/520 filter cube to take fluorescence 
measurements every 5 minutes for 4 hours. The data was then normalised to the 
corresponding FCV only data in order to eliminate any background signal. All RNA 
release assays were performed in triplicate. 
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2.2.8 Small angle x-ray scattering 
Small angle x-ray scattering (SAXS) is a structural biology technique used to 
elucidate the low resolution structures of macromolecules in solution. SAXS 
offers the advantage that the protein may remain in its native state in solution 
as opposed to forming a crystal lattice where proteins must all be present in the 
same orientation, possibly under non-biologically relevant conditions. High 
pressure liquid chromatography (HPLC) has been added to the SAXS pipeline 
(HPLC-SAXS) in order to increase the reliability and sensitivity of the data 
collected. The inclusion of HPLC ensures that any aggregated protein is 
separated away from the sample prior to the SAXS experiment. As the sample 
flows off the HPLC, it is directed through the SAXS flow cell where an x-ray 
beam is passed through the moving sample. As the sample is continuously moving 
during HPLC-SAXS, the sample receives less radiation damage and so the data 
recorded is of higher quality. As the x-ray beam passes through the sample, it is 
scattered by the scattering centres/atoms of the sample. These scattered rays 
(and their angles of scattering) are recorded on a detector to form a diffraction 
pattern which contains structural information about the sample. The measured 
scattering from a sample containing only buffer is then subtracted from the 
protein data and analysed in order to extract the structural information such as 
the molecular mass and shape of the protein (Malaby et al., 2015; Mathew et al., 
2004). 
2.2.8.1 Small angle x-ray scattering experimental methodology 
The Fc tag was removed from the Fc-fJAM-A protein as described in 2.2.3.3 and 
the fJAM-A ectodomain was dialysed into PBS containing 0.01% sodium azide, 1% 
sucrose and 10mM potassium nitrate at a concentration of 7.47mg/ml. Samples 
were then taken to the Diamond Light Source where high pressure liquid 
chromatography (HPLC) small angle x-ray scattering (SAXS) experiments were 
performed by Professor Olwyn Byron. The HPLC column was equilibrated with 
the buffer for 1 hour and the sample loaded onto the column from a 96 well 
plate. After coming off the column, the sample was passed through a capillary 
where an X-ray beam was passed through the sample and the diffraction data 
collected. The data was analysed by Professor Olwyn Byron and a three 
dimensional model produced using DAMMIF (Franke and Svergun, 2009). The 
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human fJAM-A ectodomain (PDB: 1NBQ) was fitted into the SAXS structure by 
Prof Olwyn Byron using PyMOL (The PyMOL Molecular Graphics System, Version 
1.7.4.5 Schrödinger, LLC). 
2.2.9 Isothermal titration calorimetry 
Isothermal titration calorimetry is a technique employed to measure the energy 
associated with a reaction whether it be endothermic or exothermic, for 
example, protein-protein interactions or ligand binding. The reaction is triggered 
by changing the chemical composition of the sample by the injection/titration of 
one of the binding partners being investigated. Two cells are present in the 
calorimeter, the sample cell and the reference cell. The reference cell contains 
the relevant buffer while the sample cell contains the macromolecule in the 
relevant buffer into which the ligand is then titrated by small volume injection. 
The calorimeter measures the amount of power (microcalories per second) 
necessary to maintain a constant temperature between the reference and 
sample cells. These readings are plotted as a function of time with the peaks 
become progressively smaller as the macromolecule becomes saturated with the 
injected ligand (Freire et al., 1990; Leavitt and Freire, 2001). This data can then 
be normalised to a buffer only control to account for any heat produced by the 
dilution of the macromolecule or by the stirrer during the experiment. This is 
then used to calculate the association (and dissociation) constant for the 
macromolecule and ligand, providing a measure of how strongly the two bind to 
each other. 
2.2.9.1  Isothermal titration calorimetry experimental methodology 
Isothermal titration calorimetry (iTC) was performed with Dr Sharon Kelly using a 
MicroCal iTC200 (GE Healthcare). All samples and solutions (1x PBS) were 
degassed at room temperature prior to experiments being performed. 13M FCV 
in PBS was added to the chamber and 13M fJAM-A in PBS was added to the 
injector of the MicroCal iTC machine at 25C. Twenty injections of 2l fJAM-A 
were performed, each lasting 4 seconds with a spacing of 180 seconds and a 
stirring speed of 750 rpm. Control experiments were also performed in order to 
account for any heats of dilution that may be observed. These data were 
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subtracted from sample data and plotted using Origin (OriginLab, Northampton, 
MA). 
2.2.10 Biacore 
Biacore is a surface plasmon resonance (SPR) technique that uses biosensor 
based technology to investigate the interaction kinetics and affinities of 
macromolecular complexes. A biacore system is formed of a sensor microchip, a 
laser light source, a fluid handling system and a position sensitive detector 
(Raghavan and Bjorkman, 1995). The sensor chip is formed of glass coated in a 
gold film and a carboxymethylated dextran matrix onto which biomolecules such 
as proteins of interest or capture antibodies can be bound using amine coupling. 
Once the capture molecule is bound to the flow cell of the chip, the sample 
molecule is flowed over the cell and any changes in refractive index measured. 
Binding of molecules to the capture molecules in the flow cell results in an 
increased mass and therefore a change of refractive index and also in the SPR 
angle which is then recorded by the detector. SPR angle changes are measured 
as response units (RU) and plotted against time in a sensorgram to allow real-
time observation of cumulative association/dissociation events (1000RU 
corresponds to a change in SPR angle of 0.1º and a 1ng mm-2 surface mass 
change) (Raghavan and Bjorkman, 1995). Analysis of the sensorgram allows 
conclusions to be drawn, for example, on aspects such as comparative 
dissociation rates if the buffer pH was altered after an equilibrium was reached. 
2.2.10.1 Biacore experimental methodology 
Biacore experiments were performed with Dr Sharon Kelly. 
Cm5 chips were docked into a Biacore 2000 and primed with PBS. The chip was 
then normalised with 40% glycerol prior to activating the chip with 35μl EDC (1-
Ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride) and NHS (N-
Hydroxysuccinimide) at a flow rate of 5μl/min.  
After activating the chip with EDC and NHS, an antibody was bound to the chip 
(an anti-herpes virus antibody for the negative control, anti-Fc antibody for 
experiments). Ethanolamine was then used to block any available sites remaining 
on the chip. Fc-fJAM-A (either glycosylated or deglycosylated) was then flowed 
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over until approximately the same amount was bound to all flow cells (measured 
by response units). Ethanolamine was then used to block any further available 
sites prior to flowing FCV over all of the flow cells and measuring the change in 
response units, representing the amount of virus bound to the Fc-fJAM-A. 
2.2.11  Electron Microscopy 
Transmission electron microscopy (TEM) was first used in the study of biological 
macromolecules and viruses as early as the 1930’s. Samples may be stained 
directly on grids (known as positive staining) although a more widely adopted 
method is negative staining which stains around the sample rather than the 
sample itself and was developed in 1959 (Brenner and Horne, 1959). The field 
was further revolutionised in 1984 when the imaging of frozen hydrated 
specimens was described (Adrian et al., 1984). 
2.2.11.1 Preparation of samples for electron microscopy 
For routine imaging of macromolecular assemblies, negative staining with heavy 
metal solutions provides high contrast images in the transmission electron 
microscope. Negative staining EM involves adding a sample onto an EM grid with 
a carbon support film and embedding it in a thin film of heavy metal salt 
solution such as uranyl acetate or ammonium molybdate. Uranyl acetate 
produces the most contrast from all the negative stains although others preserve 
sample integrity to a higher extent or perform better staining at low pH (Booth 
et al., 2011). Negative staining with a heavy metal salt solution results in the 
stain being deposited around the surface of the sample and so macromolecules 
are visualised by the appearance of a lack of stain rather than the dark contrast 
produced by the stain itself. Although negative staining EM produces high 
contrast images, staining causes dehydration, shrinkage and distortion of the 
biological macromolecules in the sample (Orlova and Saibil, 2011). The 
resolution of any imaging is also restricted by the size of the heavy metal salt 
grains (Nogales and Scheres, 2015). 
Electron microscopy grids are 3.05mm round metal (usually copper) supports 
that contain square ‘holes’ in the metal. The metal strips across the grid are 
known as grid bars. The grids are coated in a thin layer of carbon to which the 
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sample adheres during negative stain sample preparation. Grids used for cryo-EM 
contain regular arrays of circular holes in the carbon within the squares of the 
grid, such as C-flats or Quantifoils (see Figure 14). 
Cryogenic transmission electron microscopy, or CryoEM, involves embedding the 
sample in a thin layer of vitreous ice such that it is preserved in a frozen-
hydrated state, allowing visualisation of the sample in as close to a native state 
as is possible in the vacuum of the electron microscope. The vitreous ice layer is 
prepared on a Holey carbon support film on EM grids (often copper). Imaging of 
the ice embedded material is through the holes, reducing background noise that 
is produced when imaging through a carbon film. 
The carbon around the holes, however, increases stability of the sample and 
allows the formation of very thin layers of vitrified sample (Adrian et al., 1984). 
Grids are glow discharged prior to preparation to remove any hydrocarbons and 
therefore make them hydrophilic, allowing the sample to coat the grid 
efficiently and evenly (Grassucci et al., 2007). Samples are then added to the 
grids, blotted with filter paper to produce a thin film of approximately 50-100 
nm and plunged into an effective cryogen such as liquid ethane or propane 
cooled by liquid nitrogen. This process of vitrification is frequently performed 
using a vitrification robot such as the vitrobot (FEI). This rapid cooling (106 
ºC/second) results in the sample being trapped in its native state in vitreous ice 
when cooled to below -140ºC. Between -140ºC and -100ºC, cubic ice is formed 
which appears as a mosaic of small crystals and above -100ºC, hexagonal ice 
crystals are formed. 
Vitreous ice has no apparent structure, hence its use to preserve and image 
biological macromolecules (Dubochet et al., 1988). After plunging into a 
cryogen, such as ethane, grids are transferred into liquid nitrogen prior to either 
storage or visualisation in the electron microscope. Transfer of the grids into the 
cryo-specimen holder must also occur under liquid nitrogen (LN2) once the 
holder has been cooled to near LN2 temperature in order to prevent the 
introduction of contaminating ice crystals and the formation of frost (caused by 
condensation of atmospheric vapour on the grid). Frost and ice contamination 
may be introduced at all steps during sample preparation and transfer so these 
stages must be performed under liquid nitrogen and as quickly as possible. 
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Figure 14- Schematic of a cryo-EM grid 
A diagrammatical representation of a cryo-EM grid such as a C-flat showing the relationship 
between the 3.05mm grid and the grid bars/squares to the holey carbon film and particles 
suspended in vitreous ice. 
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Cryo-electron microscopes are equipped with an anti-contaminator which is 
cooled by an externally mounted dewar containing liquid nitrogen. The anti-
contaminator is placed in the area of the specimen (within the microscope 
column) to ensure that any contaminants present condense on the anti-
contaminator as opposed to the specimen. The holder can then be inserted into 
the electron microscope where high vacuum and the anti-contaminator both 
reduce the amount of ice contamination on the sample (Dubochet et al., 1988). 
Cryo-EM provides many advantages over negative staining EM such as avoiding 
the dehydration and distortion of the sample although it does present some 
other challenges. Frozen hydrated specimens must be kept at a temperature 
near to that of LN2 to avoid the warming of the sample and the transition to 
cubic or hexagonal ice. However, as the samples are not stained, they produce 
substantially lower contrast when imaged in the electron microscope. 
2.2.11.2 Imaging in a transmission electron microscope 
A typical transmission electron microscope consists of an electron gun, numerous 
electromagnetic lenses to focus the electrons released from the gun and a 
detector to record images of the sample (as shown in Figure 15).  
The short wavelength of electrons allows high resolution imaging to be 
performed. However, radiation damage to the sample occurs due to interactions 
with the electrons from the beam. Three types of interactions can be described 
between electrons and the sample (see Figure 16). Electrons may pass through 
the sample without forming any interactions, electrons may be deflected away 
by the atom nuclei’s electrostatic field or electrons may collide directly with the 
atom nuclei. Elastic scattering of electrons occurs when electrons interact with 
the specimen but are scattered without losing any energy. Inelastic scattering, 
conversely, occurs when interacting electrons lose energy/transfer energy to the 
specimen. This inelastic scattering can cause damage to the specimen in forms 
such as ionisation, x-ray emission, chemical bond rearrangement or induction of 
secondary electron scattering. 
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Figure 15- Schematic of a typical electron microscope. 
A simplified diagrammatic representation of the major components of a transmission electron 
microscope. Taken from Orlova and Saibil, 2011. 
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Figure 16- Interactions of electrons with the sample. 
Schematic showing the different types of interactions that may occur between electrons and the 
sample within the electron microscope. Electrons may collide with atoms in the sample, leading 
to inelastic scattering and energy loss or electrons may be elastically scattered by either not 
interacting with the sample or by deflection from the electron cloud of the sample. Image taken 
from Orlova and Saibil, 2011. 
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Inelastic scattering is one of the main limitations observed when imaging 
biological macromolecules at high resolution, so sample thickness and beam 
exposure are reduced to attempt to limit this and the introduction of  noise 
(Orlova and Saibil, 2011). 
Electron sources/guns are generally one of three types, a tungsten filament, a 
Lanthanum hexaboride filament or a field emission gun (FEG). A tungsten 
filament is heated to 2000-3000ºC (by passing a high voltage through the 
filament) where the electron energy is higher than the tungsten work function 
(the amount of energy required to emit electrons). This heating results in the 
emission of electrons which are then accelerated down the microscope column 
by an electric field. Lanthanum hexaboride filaments are also thermal filaments 
although they are more efficient than tungsten filaments due to their lower 
work function. Field emission electron sources are generally used in high 
performance microscopes and use a single crystal tungsten with a very small tip 
radius of 10-25nm which is coated with zirconium oxide to lower the work 
function (Schottky FEG). Cold FEGs are also available which are considered 
‘cold’ as they emit more electrons than can be emitted using thermal emission 
alone. Cold FEGs result in increased beam brightness as well as lower energy 
spread of the electrons which may help to improve resolution. Cold FEGs are, 
however, less stable than standard/schottky FEGs due to residual gases around 
the tip although an evacuation procedure has been developed to overcome this. 
The electrons emitted from FEGs are generally extracted at 200-300kV as 
opposed to <200kV for tungsten filament electron sources. FEGs also provide a 
brighter and more coherent beam than that from a tungsten filament (Orlova 
and Saibil, 2011). 
Electron microscopes contain multiple series of lenses, most notably the 
condenser and objective lenses. The condenser lens system serves to focus the 
electron beam parallel to the column and onto the specimen. The specimen 
generally sits within the objective lens system which provides the primary 
magnification of 20-50x and focuses the beam onto the image plane after passing 
through the sample. The objective aperture is in the back focal plane of the 
objective lens and improves contrast by preventing any electrons that have been 
scattered to a high angle from reaching the image plane. The intermediate and 
projection lenses then magnify the image further which is then recorded by a 
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detector. Three main types of lens aberrations have been described: spherical, 
chromatic and astigmatic. Spherical aberration occurs when the outer edges of 
the lens focus the beam more strongly than the centre of the lens. Chromatic 
aberration occurs when a lens focuses longer wavelengths more strongly than 
shorter ones and is caused by variation in the voltage of the electron source. 
Astigmatism is a result of a lens being stronger in one direction than in the 
perpendicular direction and is caused by the lens magnetic field being 
asymmetric, resulting in an elliptical image (which can be compensated for using 
stigmator coils) (Orlova and Saibil, 2011). 
An energy filter may be added in order to try to improve contrast of the images 
recorded. Electrons that have been inelastically scattered by the specimen have 
a lower energy than those that have been elastically scattered which results in 
them being focussed into different planes (also known as chromatic aberration). 
These inelastically scattered electrons result in the blurring and increased 
background noise of the image. Due to this, energy filters have been developed 
to prevent these electrons from contributing to the final image recorded and can 
be inserted either within the microscope column or post column (Orlova and 
Saibil, 2011). 
Historically, images/electron micrographs were recorded on photographic film 
and then scanned/digitised but charge coupled device (CCD) based digital 
cameras are now the most common detectors in use. The CCD camera uses a 
phosphor scintillator to detect the incoming electrons and release photons in 
their place which are then transmitted to a charge coupled device and 
converted into a digital electronic signal. CCDs are more convenient detectors 
than recording data on film as it can be immediately inspected and processed. 
Recently, direct detection devices (DDD) have been developed which can be 
exposed directly to the electron beam, unlike CCDs which require a scintillator 
layer, reducing sensitivity. DDDs can be monolithic active pixel sensors (MAPS) or 
hybrid pixel detectors but MAPS are becoming the more prevalent choice for 
DDDs. In MAPS, the signal produced is proportional to electron energy detected 
and the detectors also have a smaller pixel size. As the DDDs do not require a 
scintillator layer, the signal to noise ratio (SNR) is greatly improved and the 
devices also show good tolerance to high levels of radiation, allowing their use 
with 200-300kV electron microscopes. DDDs are being developed to incorporate 
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aspects of CMOS (complementary metal oxide semi-conductor) which would 
allow a faster readout rate by permitting the local conversion of charge to 
voltage. This is possible due to each pixel in the detector containing an 
amplifier. DDDs/MAPS have a high read-out rate, allowing many frames for one 
image to be recorded which allows for later frames that received a higher 
electron dose to be removed if necessary as well as movie processing to correct 
for any sample movements. These improvements can be adopted during 
processing of the images (McMullan et al., 2014; Orlova and Saibil, 2011).  
2.2.11.3 Image Formation 
Contrast is formed in an image due to the interaction of electrons with the 
specimen. The electron wave is diffracted by regions of the sample and 
therefore result in its interaction with the undiffracted portion of the electron 
wave in the image plane. There are 2 different types of contrast: amplitude 
contrast and phase contrast. Amplitude contrast is caused by the interaction of 
electrons with the sample and causing them to be scattered beyond the 
acceptance angle of the objective aperture. Biological molecules produce little 
amplitude contrast as they are made of light atoms (H, O, N and C) so they do 
not absorb or highly scatter electrons from the beam, however they do interact 
so still change the electron properties as it proceeds through the specimen. 
Phase contrast is caused by the presence of a phase shift between the diffracted 
and undiffracted waves. The sample contributes to this phase shift as the 
electron passes through it as well as factors associated with the microscope such 
as spherical aberration and the level of defocus applied (Orlova and Saibil, 
2011).  
Imperfections in the microscope and its lens systems results in a modulation of 
the recorded image by the contrast transfer function (CTF). The CTF is the 
Fourier transform of the PSF (point spread function) of the microscope which is 
convoluted with the specimen projection to form the recorded image. Due to 
the affect of the PSF, CTF correction must be performed on all images prior to 
processing and three dimensional reconstruction. The CTF is a description of the 
relationship between the sample and the recorded image. The oscillating CTF is 
dependent on the accelerating voltage of the microscope, any spherical 
aberrations as well as the level of defocus applied by the user. At certain spatial 
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frequencies in the CTF, the oscillations result in zero contrast although this 
changes for differing levels of defocus (increased defocus results in CTF 
oscillations with peaks closer together/occurring more rapidly) and so less high 
resolution information will be recorded). The relationship between defocus and 
CTF is illustrated in Figure 17. To compensate for this, the phases below zero 
may be flipped to produce only positive oscillations. Data collected at differing 
levels of defocus result in overlapping CTFs to compensate for the regions 
approaching zero in a given CTF. 
2.2.11.4 Data Processing/3D reconstruction 
Projection theorem states that the Fourier transform of a 2D projection of the 
sample is a slice through the centre of the 3D Fourier transform of the structure 
of the sample/object. This means that, once CTF corrected, the Fourier 
transform of a micrograph represents a central slice through the 3D Fourier 
transform of the specimen structure (Nogales and Scheres, 2015). In single 
particle analysis of a sample, objects are assumed to be identical but differently 
oriented. This means that imaging the sample with its many orientations, 
provides many central slices through the 3D Fourier transform of the object, 
allowing the transforms to be combined and a 3D reconstruction computed. High 
symmetry objects are very efficient in this manor as fewer views/orientations 
are needed to elucidate the structure owing to repeating subunits and orders of 
symmetry. 
The first steps required in the processing of micrographs are to determine the 
defocus value using the Thon rings on the Fourier transform by fitting the 
modelled CTF to the power spectrum (the square of the Fourier transform 
amplitudes). The simplest method of CTF correction is known as phase 
correction and involves flipping the phases in the regions where the spectra have 
negative values. This provides reliable data when micrographs are recorded at 
differing levels of defocus as the information lost at the zero’s is restored from 
other micrographs. Micrographs can also be corrected for any motion recorded 
between frames due to factors such as drift at this early stage of image 
processing. 
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Figure 17- Carbon film images and their diffraction patterns 
Images of carbon film at either 0.5 or 1µm defocus showing their diffraction patterns below the 
respective micrographs. The diffraction patterns show the Thon rings and their CTF curves, 
illustrating that the CTF oscillations are closer to the origin/occur more rapidly when further 
away from focus. Taken from Orlova and Saibil, 2011. 
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Particle coordinates must then be selected either by manual particle picking or 
automated particle picking. Semi-automated options also exist where the user 
manually selects particles from a subset of micrographs and these are then used 
as a template for the automated particle picking such as that in RELION 
(Scheres, 2015). Manual and semi-automated particle picking results in the 
introduction of less false positives although it is more time consuming. Individual 
particles must then be extracted from the micrographs in boxes, the width of 
which is provided by the user. Differences in image contrast can arise from many 
factors including specimen particle orientation, sample thickness and SNR so 
these must be normalised to allow further downstream averaging and processing. 
Particles are normalised to a common mean and standard deviation to allow 
efficient subsequent alignment and classification.  
RELION implements a maximum likelihood method and iterative classification 
where images are compared with all references (generated from averages or 
random subsets in reference free alignment) in all orientations possible and 
calculates probability weights for each possible orientation. Weighted averages 
for all orientations are then used to produce class averages which are the input 
for the next iteration. The only user input here in the 2D classification is the 
number of classes to generate and the process usually iterates 25 times before 
producing a final set of class averages where false positives are usually classified 
separately. This allows the selection of ‘good’ particles/data and the exclusion 
of ‘bad’ data that would potentially limit the resolution further downstream. 3D 
classification may also separate out different conformations if a heterogeneous 
population is present within the sample. The user can select which classes to 
take forward in different pipelines in order to process data from differing 
conformations separately if that is desirable. 3D classification is performed with 
a user defined number of classes and a low resolution starting model. A similar 
known structure can be used as a starting model although the model must be 
filtered in order to prevent model bias occurring during the reconstruction 
process. It has previously been shown that a model can significantly affect the 
outcome of image processing. Shatsky et al showed that when an image of 
Einstein was used as the initial model and 1000 images of noise were averaged 
and processed with the model, the resulting image showed the depiction of 
Einstein (Shatsky 2009). This illustrates the issue of model bias which must be 
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overcome in order to generate an accurate structure from data. One way to 
reduce model bias is to heavily filter the model structure before use (typically to 
around 60 angstroms) so very few details remain. This ensures that any details 
present in the final reconstruction have come from the data and not from the 
model. 
Typically, this process is iterated 25 times to maximise accuracy. The user may 
then select which data they wish to continue processing by selecting the 3D 
classes containing the ‘best’ data or selecting different conformations to 
proceed with in separate processing pipelines. A 3D refinement step is then 
performed for a number of iterations until the optimal particle orientations and 
the log-likelihood values no longer change (Scheres, 2010).  
The resolution of the reconstructions can then be calculated using ‘gold 
standard’ Fourier Shell Correlation (FSC). FSC compares the Fourier transforms 
of two three dimensional volumes over different shells as a function of spatial 
frequency. FSC indicates at which spatial frequency (the inverse of which gives a 
resolution estimate) information above the random noise level is observed. 
More traditional methods of FSC calculation have led to overfitting of noise 
where resolution estimates were not accurate for the given structure. In 
traditional FSC, the data are divided into two halves and a single model is used 
to determine the orientations of all the particles. Gold standard FSC, however, 
avoids model bias by only using the model in the first iteration. The degree of 
agreement between the FSC curves of the two halves of the data set is then 
calculated and used to provide a measure of resolution. The spatial frequency 
where the gold standard FSC passes the 0.143 mark is seen to be a good 
indicator of resolution (Scheres, 2012; Scheres and Chen, 2012). In RELION, this 
process is performed at the end of each 3D refinement iteration.  
At high resolution, structures may have lost signal due to factors such as beam 
induced movement, radiation damage or computation inaccuracies. This loss of 
resolution was traditionally modelled by a Gaussian decay of structure factors 
with a B-factor (also known as a temperature factor). These ‘lost’ high 
resolution features may be rebuilt/sharpened in the map in a process known as 
B-factor correction. One method of performing B-factor correction involves 
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estimating the amplitude decay of the structure factors by comparison with an 
approximate theoretical scattering curve (Fernandez et al., 2008).  
Local resolution analysis can also be performed in order to assess whether 
certain areas of the reconstruction are at higher or lower resolution. Higher 
resolution may indicate stability when compared to lower resolution components 
which may be flexible or adopt different conformations and therefore limit the 
resolution achievable.  Known atomic structures can also be docked into the map 
in order to inspect the secondary structure elements of the sample. This may be 
needed if the resolution of the map is limited as a resolution of 6-9Å is needed 
to observe alpha-helices and beta-strands are only visible beyond 4.5Å. The 
detail of smaller amino acid side chains is only visible in very high resolution 
structures i.e. below 4Å resolution (Orlova and Saibil, 2011).  
Once a high resolution structure has been obtained, molecular modelling may be 
applied in order to model the amino acid structures into the protein density of 
the structure. If a homologous structure is already known, this can be 
computationally fitted into the density of the map. The positions of the amino 
acids and their side chains can then be optimised to better fit the experimental 
data/density or even replaced if the sequence differs to that of the homologous 
model used (using software such as Coot (crystallographic object-orientated 
toolkit)) (Emsley and Cowtan, 2004). 
2.2.11.5 Negative Staining electron microscopy methodology 
2.2.11.5.1 Sample preparation 
400 Square Mesh Copper 3.05mm electron microscopy grids (Agar Scientific) 
were formvar and carbon coated then glow discharged prior to negative staining 
electron microscopy. To formvar coat grids, 0.25g formvar was dissolved with 
50ml chloroform to make a 0.5% formvar solution. Standard glass microscope 
slides were cleaned with alcohol and inserted into the formvar solution for a few 
seconds. The slides were then removed and allowed to air dry. A diamond 
marker was then used to score along all 4 edges of the slide. A large vessel was 
filled with deionised water and the slide slowly inserted into the water while 
blowing warm air onto the slide-water interface to assist in the floating of the 
thin formvar layer onto the surface of the water. Electron microscopy grids were 
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then placed onto the floating formvar film and a large microscope cover slip 
pressed onto one edge of the film and flipped out of the water. The slide 
containing the formvar and coated grids was then allowed to dry before carbon 
coating. A Quorum Q150T turbo pumped carbon coater was then used to deposit 
a thin layer of carbon onto the formvar coated grids by applying 45 amps through 
two touching sharpened carbon rods. Grids were glow discharged at 25 mAmps 
for 1 minute using an EMITECH K100X glow discharger before addition of the 
sample and staining. 
Five microliters of sample was added to each grid and incubated for 2 minutes at 
room temperature. Excess sample was removed by blotting the side of the grid 
with filter paper followed by washing 3 times on drops of deionised water, 
blotting in between each wash. Grids were then washed on 3 drops of 2% uranyl 
acetate, blotting in between each wash, before a final drop of uranyl acetate 
was added to each grid and incubated for 5 minutes prior to blotting away any 
excess stain. Grids were then allowed to dry before visualisation in an electron 
microscope.  
2.2.11.5.2 Imaging conditions 
Negative staining electron microscopy grids were imaged in a JEOL 1200 EXII 
Transmission Electron Microscope at a range of magnifications. Images were 
recorded on a Gatan Orius camera. 
2.2.11.6 Cryo-electron microscopy methodology 
2.2.11.6.1 Sample preparation 
Five microlitres of the sample of interest was added to a C-flat Advanced Holey 
Carbon Film Grid (ProtoChips, glow discharged as previously described) and 
blotted for 4 seconds (with a blot force of 25) to remove any excess sample. An 
FEI Mark IV Vitrobot was used (at 100% humidity and 4°C) to plunge the grids 
into liquid nitrogen cooled liquid ethane. Grids were then transferred to liquid 
nitrogen for storage prior to imaging. 
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2.2.11.6.2 Imaging 
A JEOL JEM-2200FS Field Emission Electron Microscope was used to image virus 
particles for cryo-electron microscopy (using liquid nitrogen to ensure a constant 
temperature of -180°C) under low electron dose conditions. Vitrified samples 
were imaged in a Gatan 626 cryo-stage with an energy filter slit width of 20eV at 
200kV. 
Feline calicivirus was imaged as above, with a Direct Electron DE20 direct 
detection device or on an FEI Titan Krios TEM with a Falcon III detector (as 
specified). The DE20 direct detection device was used to image virus particles at 
x50,000 magnification resulting in a pixel size of 1.09Å per pixel. Images were 
recorded at a defocus of 1.5-2.5m. Additional acquisition parameters are 
specified in Table 1. 
An FEI Titan Krios with a Falcon III detector was used at 300kV at a magnification 
of x75,000 resulting in a pixel size of 1.065Å per pixel. Images were taken with 
defocus values of 1.2-3.5m (operated by Dr Rebecca Thompson, University of 
Leeds). Additional acquisition parameters are specified in Table 1. 
2.2.11.6.3 Image processing 
2.2.11.6.3.1 Icosahedral reconstruction using PFT2 
Images of FCV particles at pH4 and pH5 were contrast transfer function (CTF) 
corrected and the particles extracted from the micrographs using the BSoft 
program, Bshow (Heymann, 2001). The polar Fourier Transform (PFT2) method 
was then used to determine the origins and orientations of the particles before 
the creation of 3D reconstructions using the EM3DR2 program (Baker and Cheng, 
1996; Bubeck et al., 2005). The resolution of the maps was estimated by 
splitting the data set into two and producing 3D reconstructions for each half of 
the data set. Bresolve was then used to compare the two reconstructions and to 
calculate the Fourier Shell Correlation (FSC) where a cut off of 0.5 was applied. 
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Data Set Microscope Dose rate 
(e-/pix/s) 
Dose rate 
(e-/A2/s) 
No. of 
frames 
Total dose 
(e-/A2) 
FCV FEI Titan 
Krios 
1.26 42 50 63 
FCV+fJAM-A FEI Titan 
Krios 
1.26 42 50 63 
FCV+fJAM-A 
(10:1) 
JEOL JEM-
2200FS 
1.47 25.12 48 70.34 
FCV+fJAM-A 
(11:1) 
JEOL JEM-
2200FS 
1.25 21.24 48 59.48 
FCV+fJAM-A 
(12:1) 
JEOL JEM-
2200FS 
1.36 23.22 48 65.02 
Table 1- Electron microscopy data acquisition parameters 
The microscopy conditions for each data set are provided alongside the microscope used. Dose 
rates (electrons per pixel per second as well as electrons per angstrom2 per second), total doses 
(electrons per angstrom2) and the number of frames collected per micrograph are also provided. 
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2.2.11.6.3.2 RELION 
MotionCor2 was used to correct micrographs for any drift that may have 
occurred and the defocus/CTF estimated using Gctf. Relion 2.0.3 was used 
thereafter for image processing and 3D reconstruction. Particles were picked 
from the micrographs and reference free 2D class averaging was performed to 
yield 60 class averages. The classes of interest were then selected and 3D 
classification was performed followed by 3D refinement (with I2 icosahedral 
symmetry imposed). Post processing was then performed in order to carry out B-
factor correction followed by local resolution estimation using the built in 
RELION module. 
2.2.11.6.4 Visualisation of structures 
2.2.11.6.4.1 UCSF Chimera visualisation and calculation of correlation values 
UCSF Chimera was used for the visualisation of all three dimensional structures 
observed (Pettersen et al., 2004). For lower resolution maps, an isosurface 
threshold of the mean plus 1 standard deviation was used whereas higher 
resolution maps were rendered to optimally represent visible amino acid side 
chains. The ‘Fit in Map’ function of UCSF chimera was used to calculate 
correlation values between 2 maps and to measure the degrees of rotation of 
capsid proteins where specified. 
2.2.11.6.4.2 Model building 
The FCV5 VP1 crystal structure was used alongside the F9 VP1 sequence to 
generate a model of the FCV VP1 capsid protein (using SWISS-MODEL) which was 
then fitted into the density map using Coot (Arnold et al., 2006; Emsley and 
Cowtan, 2004). The density was then used to refine the positions and 
orientations of the amino acids in the sequence using Phenix (Adams et al., 
2010). RMSD values for overlaid structures were calculated in UCSF Chimera 
(Pettersen et al., 2004). 
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3 Investigating the influence of fJAM-A 
glycosylation and oligomerisation on FCV binding 
The ectodomain of both human and murine forms of JAM-A have been shown to 
be dimeric in solution and contain an N-linked glycosylation site. Stuart et al. 
(2007) proposed alpha 2-6 linked sialic acid as a receptor for FCV and so we 
hypothesised that this sialic acid receptor could be present as a glycosylation of 
fJAM-A. Here we show that fJAM-A is N-glycosylated and, using a variety of 
techniques, that deglycosylation of the fJAM-A ectodomain purified from CHO 
cells does not affect virus binding in vitro. Using size exclusion chromatography 
and SAXS, we also show that fJAM-A is dimeric in solution and forms similar 
structures to that of its human and murine homologues.  
3.1  Purification of bivalent and monovalent forms of 
fJAM-A 
To investigate the nature of the interaction between FCV and fJAM-A, we set out 
to purify the soluble extracellular domain (ectodomain) of fJAM-A fused to an Fc 
tag. As previously described, members of Prof Ian Goodfellow’s lab (University of 
Cambridge) generated a mammalian protein expression vector containing the 
coding sequence for the ectodomain of fJAM-A fused to a C-terminal Fc tag 
(from human IgG1). A factor Xa cleavage site was engineered between the fJAM-
A coding sequence and the Fc tag to allow downstream removal of the tag and 
purification of the fJAM-A ectodomain. This construct was transfected into CHO 
cells and a stable cell line expressing the secreted form of the fusion protein 
(Fc-fJAM-A) established by Prof Ian Goodfellow (University of Cambridge) (Bhella 
et al., 2008).   
Stably transfected CHO cells were incubated for 7 days prior to harvesting the 
media containing the secreted Fc-fJAM-A protein. Supernatant was filtered 
through a 0.22µm vacuum system prior to protein A purification (see 2.2.3.2). 
The chromatogram showing the absorbance at 280nm is shown in Figure 18 
where panel A represents the chromatogram as a whole, while B shows a zoomed 
section highlighting the absorbance peaks visible at the right-hand side of panel 
A. As cells were grown in the presence of 10% FBS, any contaminating bovine 
immunoglobulins were removed using a citrate elution with intermediate pH (see 
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# in panel B). Following a PBS wash, the Fc-fJAM-A fusion protein was eluted in 
0.1M glycine buffer pH2.5 (see * in panel B) and the fractions neutralised with 
Tris pH8. Figure 18 (A and B) shows the tight, clean peak produced as the fusion 
protein is eluted from the column in only three 0.5ml fractions. All eluted 
fractions, including input controls, were then analysed by SDS-PAGE (C) and 
western blotting (D) showing the high purity of the samples with very few 
contaminating proteins visible. By both SDS-PAGE and western blot, a smaller 
protein of approximately 32kDa is visible in the later stages of purification. This 
32kDa band is visible using an anti-Fc antibody for detection by western blotting 
and so we assumed that this was a population of Fc which was not fused to  
fJAM-A.  
We hypothesise that the Fc-fJAM-A protein will be bivalent in form due to the 
linkage of Fc regions by disulphide bridges as is seen for antibodies including IgG. 
For this reason, the Fc tag was cleaved and removed from the samples to yield 
the monovalent form of fJAM-A. To cleave the Fc domain from the fJAM-A, Fc-
fJAM-A was incubated with factor Xa overnight and the enzyme subsequently 
removed using factor Xa removal resin (see 2.2.3.3).  
Fc proteins were removed from the sample using protein A dynabeads, as per 
manufacturers instructions, resulting in the collection of fJAM-A in the ‘flow 
through’ and the elution of Fc from the beads, confirming the identity of the 
contaminating band (see Figure 18E). Using a combination of protein A 
purification, factor Xa cleavage and protein A dynabead purification, a pure 
sample of the fJAM-A ectodomain can be produced and used for downstream 
investigations such as in vitro assays as well as cryo-EM. 
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Figure 18- Purification of fJAM-A 
Fc-fJAM-A was purified by protein A affinity chromatography followed by factor Xa cleavage to 
remove the Fc tag. The absorbance during protein purification (A and B (B: zoom of peaks in A)) 
shows the removal of contaminating bovine immunoglobulins (#) followed by the elution of the 
Fc-fJAM-A protein (*) into three 0.5ml fractions. All fractions were run on an SDS-PAGE gel (C) 
and western blotted (D) using an anti-Fc antibody to detect the fusion protein (L: Precision Plus 
Protein Kaleidoscope ladder (BIO-RAD), 1: negative control cell culture medium, 2: Fc-fJAM-A 
supernatant (input), 3: flow through, 4: first wash, 5: citrate elution of bovine immunoglobulins, 
6: second wash, 7-9: eluted fractions of Fc-fJAM-A). Panels C and D together show the high 
purity of the Fc-fJAM-A protein although smaller bands corresponding to Fc alone can also be 
seen of approximately 32kDa. The Fc-fJAM-A fusion protein was cleaved using factor Xa and all 
fractions run on an SDS-PAGE gel as shown in panel E (L: Precision Plus Protein Kaleidoscope 
ladder (BIO-RAD), 1: undigested Fc-fJAM-A, 2: Factor Xa, 3: Fc-fJAM-A and factor Xa cleavage 
reaction, 4: sample post-resin removal of factor Xa, 5: Factor Xa removal resin, 6: protein A 
purification flow through (containing fJAM-A), 7, 8 and 9: protein A washes, 10: Fc elution, 11: 
concentrated fJAM-A). A doublet is visible in lane 6 illustrating that some Fc still remained in the 
sample and so the protein A dynabead step was repeated to successfully remove any residual Fc. 
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3.2  Deglycosylation of fJAM-A 
Sialic acid has previously been identified as a potential receptor for FCV on CrFK 
cells despite fJAM-A being accepted as the main cellular receptor for the virus 
(Makino et al., 2006; Stuart and Brown, 2007). We hypothesised that the sialic 
acid to which FCV binds could perhaps be present as a carbohydrate moiety on 
fJAM-A rather than being present as a separate entity or receptor. This was a 
possibility as fJAM-A contains a putative glycosylation site at position 184 (N), 
which is present in the ectodomain and therefore our purified soluble fragment. 
This presented a tool for the study of both the glycosylation of fJAM-A but also 
the effect that receptor glycosylation may have on FCV binding. 
3.2.1 fJAM-A is N-glycosylated 
To firstly confirm the glycosylation of fJAM-A, and to secondly determine the 
type of glycosylation present, if any, a panel of six deglycosylation enzymes was 
screened for their effect on fJAM-A size using SDS-PAGE. fJAM-A was incubated 
with either alpha 2-3,6,8,9 Neuraminidase A, Beta1-4 galactosidase, 
Endoglycosidase H (Endo H), PNGase F, Beta-N-Acetylglucosaminidase or O-
glycosidase (in combination with alpha 2-3,6,8,9 Neuraminidase A) to determine 
if the protein contained an N-linked glycosylation (Endo H and PNGase F) or an 
O-linked glycosylation (O-glycosidase). As shown in Figure 19, the only enzymes 
which had an effect on the molecular weight of fJAM-A were alpha 2-3,6,8,9 
Neuraminidase A and PNGase F. A slight reduction in molecular weight was seen 
upon treatment with O-glycosidase but this is a result of the required co-
incubation with alpha 2-3,6,8,9 Neuraminidase A. These reductions in fJAM-A 
molecular weight from approximately 32kDa to around 29-30kDa upon incubation 
with these two enzymes illustrates that fJAM-A is glycosylated and this 
glycosylation is N-linked. This supports the identification of a predicted N-linked 
glycosylation site at position 184 of the fJAM-A ectodomain. 
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Figure 19- Deglycosylation of fJAM-A and its effect on FCV binding 
To determine the glycosylation state of fJAM-A, purified ectodomain was incubated with a panel 
of six deglycosylation enzymes, as per manufacturer’s instructions, and analysed by SDS-PAGE 
(A). Panel A shows the effect of these enzymes on fJAM-A molecular weight (L: Precision Plus 
Protein Kaleidoscope ladder (BIO-RAD), 1: untreated fJAM-A and fJAM-A treated with 2: alpha 2-
3,6,8,9 neuraminidase A, 3: beta1-4 galactosidase, 4: Endo H, 5: PNGase F, 6: beta-N-
acetylglucosaminidase and 7: O-glycosidase (in combination with alpha 2-3,6,8,9 neuraminidase 
A). Bands above 50kDa represent the corresponding enzymes as well as the bottom band of 
29kDa in lane 4 (corresponding to Endo H). Together, these banding patterns reveal that only 
alpha 2-3,6,8,9 neuraminidase A and PNGase F have the ability to effect the size of fJAM-A and 
therefore its glycosylation state, indicating the presence of an N-linked glycan on fJAM-A. Panel 
B shows the effect of alpha 2-3,6,8,9 neuraminidase A on Fc-fJAM-A (L: Precision Plus Protein 
Kaleidoscope ladder (BIO-RAD), 1: untreated Fc-fJAM-A and 2: alpha 2-3,6,8,9 neuraminidase A 
treated Fc-fJAM-A) showing the slight decrease in molecular weight upon incubation with the 
enzymes, demonstrating that the carbohydrate moieties can also be removed from the fusion 
protein. Panel C shows the outcome of an immunoprecipitation experiment where Fc-fJAM-A was 
bound to protein A dynabeads following incubation with the aforementioned deglycosylation 
enzymes. Protein bound beads were then incubated with FCV and analysed by western blotting 
to assess the extent to which the enzymes affected virus binding (1: untreated Fc-fJAM-A, 2: 
negative control (no Fc-fJAM-A), Fc-fJAM-A treated with 3: alpha 2-3,6,8,9 neuraminidase A, 4: 
beta1-4 galactosidase, 5: Endo H, 6: PNGase F, 7: beta-N-acetylglucosaminidase and 8: O-
glycosidase (in combination with alpha 2-3,6,8,9 neuraminidase A).  
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PNGase F treated FcJAM-A (lane 6) was seen to produce multiple bands, likely due to the PNGase 
F enzyme deglycosylating both fJAM-A and Fc to varying extents. FCV VP1 was detected in all 
samples except the negative control indicating that the glycosylation of Fc-fJAM-A does not 
influence FCV binding. Panel D shows a biacore sensorgram illustrating that glycosylated Fc-
fJAM-A (blue) is able to bind to flowing FCV to the same extent as alpha 2-3,6,8,9 neuraminidase 
A treated Fc-fJAM-A (red) with limited non-specific binding seen to a negative control antibody 
(anti-HSV: grey). 
 
 
3.2.2 fJAM-A glycosylation does not affect virus binding in vitro 
To test whether glycosylation of fJAM-A had any effect on virus binding in vitro 
we used a virus pull-down assay. These experiments exploited the presence of 
an Fc domain on our bivalent Fc-fJAM-A fusion protein. The ability to 
deglycosylate this fusion protein was therefore evaluated by incubation with 
alpha 2-3,6,8,9 Neuraminidase A and analysis by SDS-PAGE (see Figure 19B). 
Following confirmation of our ability to use bivalent Fc-fJAM-A in place of the 
monovalent ectodomain (fJAM-A), Fc-fJAM-A was incubated with the previously 
mentioned six deglycosylation enzymes before binding to protein A dynabeads as 
per manufacturer’s instructions. Purified FCV particles were then added to the 
sample and incubated prior to washing the beads. Any bound protein/virus was 
then removed from the beads by incubation in laemmli buffer at 95C and 
analysed by SDS-PAGE. Separated proteins were then transferred to a 
nitrocellulose membrane and western blotted to detect FCV VP1 or Fc (Fc-fJAM-
A). Figure 19C shows the presence of FCV VP1 in all samples indicating that the 
deglycosylation of Fc-fJAM-A did not disrupt virus binding.  
To confirm that fJAM-A glycosylation status does not affect virus binding we used 
surface plasmon resonance analysis (Biacore). Three separate experiments were 
performed in which glycosylated Fc-fJAM-A, alpha 2-3,6,8,9 Neuraminidase A 
treated Fc-fJAM-A or a negative control ligand (anti-HSV IgG) was bound to a 
flow cell in a Biacore chip. Purified virus particles were flowed over the cells to 
assess the amount and rate of analyte binding to each ligand. As shown in Figure 
19D, little, if any, virus bound to the negative control (grey), however, virus was 
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shown to bind to both glycosylated Fc-fJAM-A and desialylated Fc-fJAM-A to very 
similar extents (blue and red, respectively). This supports the previous 
immunoprecipitation experiments which suggested that the glycosylation (or 
rather the deglycosylation) does not affect the ability of FCV to bind to fJAM-A. 
This does not, however, rule out the possibility that the glycosylation may affect 
the strength of the virus binding to its receptor or the possibility that the 
glycosylation is present only to stabilise the protein.  
3.2.3 The glycosylation state of soluble fJAM-A does not affect 
virus neutralisation 
Makino et al. demonstrated that soluble ectodomain fragments of fJAM-A were 
able to neutralise FCV (Makino et al., 2006). We sought to test whether 
glycosylation status influences the ability of soluble fJAM-A fragments to 
neutralise FCV. FCV was pre-incubated with Fc-fJAM-A or deglycosylated Fc-
fJAM-A and then inoculated onto CrFK cells. No significant difference in plaque 
number was seen between infections with fJAM-A neutralised virus and virus 
treated with deglycosylated receptor. This shows that the glycosylation state of 
fJAM-A does not reduce the avidity of the ligand as the glycosylated fJAM-A on 
cells was not able to compete off the bound deglycosylated fJAM-A. Figure 20 
shows a slight reduction in plaque number (incorporating the four normalised Fc-
fJAM-A dilutions in triplicate) although the difference between these data was 
not statistically significant and so no meaningful conclusions can be drawn 
except the agreement with the previous data suggesting that the glycosylation of 
fJAM-A does not affect FCV binding.  
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Figure 20- Neutralisation of FCV by Fc-fJAM-A 
Fc-fJAM-A was either untreated or PNGase F treated as per manufacturer’s instructions prior to 
incubation at various dilutions with FCV (MOI: 3). FCV with either Fc-fJAM-A or deglycosylated 
Fc-fJAM-A was incubated for 1hour at 4ºC and added onto a confluent CrFK monolayer in 6-well 
plates in triplicate. Plates were treated as a plaque assay thereafter. Plaques from each form of 
Fc-fJAM-A and each dilution were counted and normalised to the corresponding undiluted Fc-
fJAM-A sample prior to analysis of the data. No significant (p=0.005) effect on FCV neutralisation 
was seen with deglycosylated Fc-fJAM-A. 
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3.3 Oligomerisation state of monovalent and bivalent 
soluble forms of fJAM-A 
Both murine and human JAM-A ectodomains have been shown to be dimeric, by 
crystallography and size exclusion chromatography (Kostrewa et al., 2001; Prota 
et al., 2003). We hypothesised that the ectodomain of fJAM-A likely also formed 
dimers although the bivalent form (Fc-fJAM-A) may form dimers and/or 
aggregates due to a combination of both fJAM-A dimerisation and Fc 
dimerisation by disulphide bonds (like that seen with antibodies; see Figure 21). 
To test the oligomeric state of fJAM-A, size exclusion chromatography was 
performed on both the glycosylated protein and on deglycosylated protein 
(PNGase F treated). The Fc-fJAM-A fusion protein and the fJAM-A ectodomain 
were analysed under both conditions. Figure 22 shows that both Fc-fJAM-A and 
the fJAM-A ectodomain form dimers in solution (as depicted in Figure 21A and 
B). Interestingly, the Fc-fJAM-A proteins did not form the aggregates illustrated 
in Figure 21C as predicted. This may be due to the conformation of fJAM-A 
linked to an Fc tag or due to steric hindrance caused by the almost equivalent 
size of the Fc tag. It may also be possible that the fJAM-A from two linked Fc-
fJAM-A proteins may dimerise together, similar to that seen with the monovalent 
form (Figure 21B). Interestingly, treatment of either form of the protein with 
PNGase F did not alter the oligomeric species observed, with both glycosylated 
and deglycosylated proteins also forming dimers. Volumes at which the peaks 
were eluted and the calculated molecular weights (and corresponding number of 
fJAM-A proteins) are presented in Table 2. 
All molecular weights calculated were approximately twice the value of the 
monomer (62kDa for Fc-fJAM-A and 32kDa for fJAM-A) suggesting that all forms 
of the protein tested formed dimers in solution. The calculated numbers of 
fJAM-A proteins for the deglycosylated forms of the protein were slightly 
reduced compared to the glycosylated fJAM-A proteins due to the apparent 
reduction in molecular weight following removal of the carbohydrate moiety (as 
seen in SDS-PAGE: see Figure 19). 
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Figure 21- Hypothesised oligomerisation states of bivalent and monovalent 
fJAM-A 
The fJAM-A ectodomain (pink) was expressed with a C-terminal Fc tag (orange) which likely 
forms dimers due to disulphide bond formation (grey) as seen in antibody production. We 
therefore hypothesise that the expressed bivalent Fc-fJAM-A will form a dimer (A) and may 
aggregate due to additional interactions between the fJAM-A ectodomains, resulting in the 
linkage of many Fc-fJAM-A proteins (C). The monovalent form of JAM-A has been shown to be 
dimeric (B) in solution and so we hypothesise that fJAM-A will also form these dimeric 
complexes. 
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Figure 22- Size exclusion chromatography shows fJAM-A is dimeric 
Size exclusion chromatography was performed to determine the oligomeric state of fJAM-A. 
Previous column calibrations performed by Samuel Stokes (Boutell group - CVR) were used to 
estimate the molecular weights of the proteins as they formed visible peaks and were eluted 
from the column at given volumes. Both Fc-fJAM-A (A) and fJAM-A (B) were analysed as well the 
PNGase F treated Fc-fJAM-A (C) and fJAM-A (D). All samples were eluted at a peak corresponding 
to the approximate calibrated size expected for a dimer (124kDa for Fc-fJAM-A and 64kDa for 
fJAM-A: see Table 2). 
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Sample Peak elution  
(ml) 
Calibrated MW 
(kDa) 
Number of 
fJAM-A proteins 
Fc-fJAM-A 12.79 138.12 2.22 
fJAM-A 14.4 62.8 1.96 
Degly Fc-fJAM-A 13.2 113 1.82 
Degly fJAM-A 14.35 59.8 1.87 
Table 2- Peak elutions in size exclusion chromatography 
Volumes at which the protein peaks were visualised during size exclusion chromatography are 
given for the four samples; Fc-fJAM-A and fJAM-A both glycosylated and deglycosylated by 
treatment with PNGase F (deglycosylated). The calculated molecular weights corresponding to 
the calibrated elution volumes are also given along with the number of Fc-fJAM-A or fJAM-A 
proteins that the molecular weight (MW) corresponds to. 
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To confirm the oligomerisation state of the fJAM-A ectodomain and evaluate the 
nature of the dimer, we performed small angle x-ray scattering (SAXS) to 
calculate a low-resolution solution structure of the protein. The analysis was 
performed on glycosylated fJAM-A by Prof Olwyn Byron. The shape of the 
assembly was found to be consistent with that seen in previous X-ray 
crystallography studies of the mouse and human forms of the protein. The 
human JAM-A crystal structure (Figure 23C and D) was manually docked into the 
SAXS envelope as a dimer, confirming the similar arrangement of the human and 
feline forms of JAM-A (Figure 23). The dimerisation interface of murine JAM-A 
has been shown to contain two salt bridges formed between Arg58 on one 
monomer and Glu60 on the other as well as a surrounding hydrophobic stacking 
interaction (Kostrewa et al., 2001). These interactions were also found in human 
JAM-A involving Arg59 and Glu61 which can be found in the centre of the 
cavity/hole which comprises the dimerisation interface between the D1 domains 
of two JAM-A proteins (see centre of Figure 23D) (Prota et al., 2003). 
Both SAXS and size exclusion chromatography confirm that the fJAM-A 
ectodomain forms dimers in solution as previously reported for related proteins. 
It is hypothesised that the dimeric form seen in solution represents that seen at 
the cell surface in tight-junctions. It is further thought that these cis-dimers 
participate in trans interactions across tight junctions, contributing to barrier 
formation (Kostrewa et al., 2001). It is interesting to note however that the 
interaction that occurs between the monovalent fJAM-A ectodomain fragments 
leading to the formation of dimers, does not appear to arise in the Fc-fJAM-A 
form (between fJAM-A ectodomains of separate Fc-fJAM-A dimers). fJAM-A – 
fJAM-A interactions in the bivalent form might otherwise be expected to lead to 
the formation of higher-order aggregates. 
As we have shown that the fJAM-A ectodomain produced in our expression and 
purification system is similar to other soluble forms, we can confidently use the 
protein for structural studies on the fJAM-A binding of FCV as well as in other 
non-structural in vitro assays. 
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Figure 23- fJAM-A is dimeric in solution by SAXS 
Small angle x-ray scattering (SAXS) was performed by Prof Olwyn Byron on soluble fJAM-A 
ectodomain with the glycosylation present. The fJAM-A structure as elucidated by SAXS is shown 
in blue spheres (A: side view, B: top view). The human fJAM-A ectodomain (pink; C: side view, D: 
top view; PDB ID: 1NBQ) was fitted into the SAXS structure of fJAM-A and the side view (E) and 
top view (F) shown. Panels E and F show that most of the two protein structures overlap, 
suggesting that they are very similar in structure as well as oligomeric state. 
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3.4 Thermodynamic properties of the FCV-fJAM-A 
interaction 
Isothermal calorimetry is used to measure the energy required or emitted when 
two proteins bind/form a complex by holding one protein of interest in a 
chamber and injecting small volumes of the second protein and observing the 
heats produced during injections. Control samples of one protein injected into 
the appropriate buffer are performed and these values subtracted from the final 
data set produced to determine a dissociation constant which is a measure of 
how strongly the two proteins bind. For example, a dissociation constant in the 
single figure nM range is 1000 times stronger than one in the single figure µM 
range.  
To determine the strength and kinetics of the FCV-fJAM-A interaction, 
isothermal calorimetry was performed with Dr Sharon Kelly at the University of 
Glasgow. FCV was placed into the chamber of the calorimeter at a concentration 
of 13µM while 13µM fJAM-A was added into the injector. 20 injections of 2µl 
were performed at room temperature every 3 minutes and any heats produced 
from the reaction recorded. The experiments shown in Figure 24 were 
preliminary due to the small heats observed during the fJAM-A injections 
(possibly due to sub-optimal protein concentrations) as well as the presence of 
the Fc tag on the glycosylated fJAM-A which was removed from the 
deglycosylated form of the protein.  
Isothermal calorimetry experiments were performed in the presence and 
absence of the Fc tag for both glycosylated and deglycosylated proteins although 
some challenges were encountered which resulted in only two of the samples 
reliably producing data upon buffer profile extraction. The major challenge 
encountered during the production of large quantities of samples was the 
workable scale due to loss of protein during each of the purification steps. 
Another challenge was the precipitation of the protein upon removal of the Fc 
tag and/or deglycosylation of the proteins. Removal of the Fc tag and 
carbohydrate moiety at different stages of the purification process were tested 
along with different buffers such as Tris-HCl and PBS. After purification and 
deglycosylation optimisation, two samples were reliably purified; glycosylated 
Fc-fJAM-A and deglycosylated fJAM-A. It is possible that the deglycosylation of 
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the Fc region caused precipitation of the protein, allowing only the purification 
of the untagged form of deglycosylated fJAM-A. The issue affecting the 
production of glycosylated fJAM-A was likely protein yield or possible 
contaminating Fc, causing non-linear data points upon subtraction of the buffer 
negative control data.  
Despite these discrepancies, dissociation constants were determined for the 
interaction of FCV (VP1) with the two forms of fJAM-A. FCV was shown to bind 
very strongly to glycosylated Fc-fJAM-A, producing a dissociation constant of 
12.9nM. The interaction of FCV with deglycosylated fJAM-A was also strong 
recording a dissociation constant of 128.7nM, 10-fold lower to that observed 
with the glycosylated form of the protein. It must be noted that the Fc present 
on the glycosylated fJAM-A likely acted to lower the dissociation constant due to 
its bivalent form. It is possible that one of the two fJAM-A ectodomains could 
bind to FCV and then detach, allowing the other fJAM-A ectodomain to bind 
(i.e., one jumping on while the other detached). Although these two data sets 
are not directly comparable, both dissociation constants measured are at least 
100-fold lower/stronger than that described for the interaction between two D1 
domains of human JAM-A and are more comparable to that described for the 
interaction of the D1 domain with the 1 reovirus protein (2.4nM) (Guglielmi et 
al., 2007; Kirchner et al., 2008). 
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Figure 24- Isothermal calorimetry of FCV and fJAM-A 
Isothermal calorimetry was performed by Dr Sharon Kelly in which FCV was added to the 
chamber of the calorimeter and injections of either glycosylated Fc-fJAM-A or deglycosylated 
(PNGase F treated) fJAM-A performed at room temperature. The heats produced during fJAM-A 
injections are shown (top sections) as well as the kinetic rates of the binding (bottom sections). 
Panel A shows the binding of glycosylated Fc-fJAM-A to FCV resulting in a dissociation constant of 
12.9nM, indicating a very strong interaction. Panel B shows the binding of deglycosylated fJAM-A 
to FCV and, although the reaction did not go to completion/saturate as in panel A, a dissociation 
constant of 128.7nM was recorded. 
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3.5 Discussion 
Feline junctional adhesion molecule A (fJAM-A) has previously been shown to be 
a functional receptor for FCV with expression in non-permissive cells rendering 
them susceptible to FCV infection in vitro. fJAM-A has been shown to be present 
in intracellular tight junctions of epithelial and endothelial cells (as well as on 
the surface of leucocytes and platelets) (Pesavento et al., 2011). Here, we have 
described an efficient method for the expression and purification of the fJAM-A 
ectodomain fused to the Fc region of IgG1 (Fc-fJAM-A) as well as the removal of 
the Fc tag. We have demonstrated that the fJAM-A ectodomain is dimeric in 
solution by both size exclusion chromatography as well as small angle x-ray 
scattering, with the U-shaped structure resembling that of both the human and 
murine homologues, the latter of which has been shown to form cis interactions 
via an R(VIL)E motif at the dimer interface (Kostrewa et al., 2001). Kirchner et 
al. presented a dissociation constant of 11M for the D1-D1 human JAM-A dimer 
interaction, however, the dissociation constant of the reovirus 1 head domain 
with the D1 domain of human JAM-A was shown to be 2.4nM (Guglielmi et al., 
2007; Kirchner et al., 2008). This dissociation constant showed >1000-fold 
stronger binding to the reovirus 1 protein, similar to our preliminary findings of 
12.9nM for the interaction of FCV with Fc-fJAM-A. A notable difference, 
however, is that the reovirus 1 protein binds to JAM-A via the dimerisation 
interface whereas FCV binds to the outer surface of the fJAM-A dimer as 
depicted in Figure 25.  
The stronger interaction between JAM-A and viral attachment factors compared 
to JAM-A homodimer formation in cis is of significance with respect to JAM-A 
dimer disruption upon virus binding. This is further supported by the apparent 
binding of two monomeric fJAM-A proteins (although added as dimers in 
solution) to the FCV VP1 capsomeres shown here by cryo-EM and three-
dimensional reconstruction. The reovirus 1 protein has been shown to compete 
off JAM-A homodimers which may have an effect on triggering endocytosis 
(Kirchner et al., 2008). This has been shown for the adenovirus knob protein 
which competes to bind CAR homodimers and induces cellular uptake/viral entry 
via endocytosis (Salinas et al., 2014). 
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Figure 25- Model of the FCV binding site and D1 dimerisation motif on JAM-A 
The dimeric structure of two human JAM-A ectodomains are shown with one monomer 
represented as blue surfaces and one as a green ribbon diagram, highlighting the location of the 
dimerisation site between the D1 domains of two JAM-A proteins. The structure of the VP1 
capsid protein (chain A) is represented as a red ribbon diagram and highlights the different 
locations of the FCV binding site and the dimerisation site on JAM-A. 
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A putative N-linked glycosylation site has been previously identified in fJAM-A at 
position 184, which we have confirmed (Makino et al., 2006). As sialic acid has 
been proposed as a cellular receptor for FCV, we proceeded to investigate the 
possibility that this sialic acid could be present as the glycosylation of fJAM-A 
(Stuart and Brown, 2007). Here we show via surface plasmon resonance, 
immunoprecipitation assays and neutralisation assays that removing the 
glycosylation from fJAM-A in vitro does not affect the ability of FCV to bind to 
fJAM-A. It must be noted, however, that the sialic acid linkage produced in CHO 
cells (2,3 linked) differs to that to which FCV has been shown to bind (2,6 
linked) (Lee et al., 1989; Stuart and Brown, 2007). 
N-linked glycosylation has been shown to be dispensable for JAM-A transport but 
is a key regulator of dimerisation, JAM-A stability as well as increased barrier 
function. Protein homodimerisation has been shown to be regulated by N-linked 
glycosylation for a number of proteins including E-cadherin, PECAM-1 and N-
cadherin. A conserved glycan profile has been suggested for JAM-A including 
sialic acid as well as fucose on epithelial cells (Scott et al., 2015). Stuart et al 
presented 2,6 linked sialic acid as a receptor for FCV and found that this sialic 
acid was not linked to a glycolipid and was present as an N-linked glycosylation 
of a cellular membrane protein where it may act as an attachment factor for 
FCV to initially capture the virus and tether it to the membrane (Stuart and 
Brown, 2007). This may be present on the cell surface and act as an attachment 
factor to transport FCV to tight junctions where fJAM-A is found or alternatively, 
the glycoprotein may be found within tight junctions alongside fJAM-A to allow 
for co-operative and/or sequential binding to occur. 
JAM-A has also been identified as the receptor for the newly discovered Hom-1 
calicivirus as well as reovirus (Prota et al., 2003; Sosnovtsev et al., 2017). Hom-1 
calicivirus has been identified as the first calicivirus to efficiently replicate in 
human cells in culture following the accidental inoculation of a laboratory 
employee with purified San Miguel sea lion virus 5 virions (Sosnovtsev et al., 
2017). Reovirus has been shown to bind to JAM-A via the viral 1 protein and 
some reoviruses use carbohydrate based co-receptors to aid in cell entry, for 
example, type 3 reoviruses utilise -linked sialic acid as their co-receptor (Prota 
et al., 2003). This may be a commonality between reoviruses and FCV in their 
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binding and entry pathways but more investigation is needed into the sialic acid 
to which FCV binds. In contrast to FCV, reovirus has been shown to bind to JAM-A 
at the dimer interface (in the D1 domain) while FCV binds on the outer face of 
fJAM-A D1 (see Figure 25). Encephalomyocarditis virus (a picornavirus) also binds 
to sialic acid prior to engagement of its receptor VCAM-1 (vascular cell adhesion 
molecule 1) and other viruses such as hepatitis C virus (HCV) also utilise 
carbohydrate receptors such as heparin sulphate as well as many other cellular 
receptors during virus entry (Bhella, 2015). The use of an additional receptor or 
attachment factor to deliver the virus from the cell surface to tight junctions 
where other receptors are located was first proposed for group B coxsackie 
viruses (CVBs). CVBs bind to DAF (decay-accelerating factor/CD55) on the apical 
cell surface resulting in remodelling of the actin cytoskeleton which delivers the 
virus to the tight junctions of cells where it engages the coxsackie and 
adenovirus receptor (CAR) prior to virus entry by caveolin-mediated endocytosis 
(Coyne and Bergelson, 2006). FCV may utilise a similar mechanism by binding to 
an as yet unknown glycoprotein receptor (containing sialic acid) at the cell 
surface, possibly inducing cellular rearrangements resulting in the delivery of 
FCV to tight junctions where it binds to fJAM-A prior to entry via clathrin-
mediated endocytosis. 
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4 Structural characterisation of undecorated FCV 
and fJAM-A decorated FCV by cryo-electron 
microscopy 
The receptor for feline calicivirus (FCV) has been identified as feline junctional 
adhesion molecule A. Previous work on FCV has shown that upon binding to the 
soluble ectodomain of fJAM-A, a conformational change is seen in the capsid 
which may be important during viral entry. A rotation in the P domains of the 
capsid proteins was identified as well as a tilting of the C/C dimer P-domains 
away from the 2-fold symmetry axes. We aimed to solve the structure of FCV 
both undecorated and decorated with the fJAM-A ectodomain to near atomic 
resolution. Model-based classification has previously allowed the separation of 
images of fJAM-A decorated FCV into classes reflecting intermediate stages of 
the conformational change, leading to the calculation of a series of low 
resolution 3D reconstructions. Here we present near atomic-resolution three-
dimensional reconstructions of undecorated and decorated FCV alongside the 
modelled protein structure of the VP1 major capsid protein. Using cryo-EM and 
three-dimensional reconstruction, the FCV capsid structure was solved to 3.0Å 
resolution while the decorated capsid was resolved at 3.55Å although movement 
in the P domains limited the resolution of the spike and receptor density. We 
were also able to resolve both the pre and post conformational change states of 
the decorated structure which allowed us to measure the P domain rotation as 
19º. The high resolutions achieved allowed us to perform modelling of the 
protein structure as well as comparison of the S domains under the two 
conditions. The undecorated structure was also compared with that of FCV-5, a 
virulent systemic strain, although only variations in the NTA and the P2 domain 
were seen. 
4.1 Structure of FCV 
The structure of FCV strain 5 was determined to 3.6Å resolution by x-ray 
crystallography revealing similar morphology to the F9 strain (Ossiboff et al., 
2010). The structure of the feline calicivirus vaccine strain (F9) has previously 
been solved to 7Å resolution by cryo-electron microscopy and shows the 
characteristic calicivirus morphology with cup-shaped depressions on the surface  
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Figure 26- Negative staining electron microscopy of feline calicivirus particles 
Virus samples were incubated on formvar-carbon coated, glow discharged grids for two minutes 
prior to removal of the sample by blotting, washing of the grid with deionised water droplets and 
staining with droplets of uranyl acetate for five minutes (see 2.2.11.5.1). Grids were imaged in a 
JEOL 1200 EXII TEM with a Gatan Orius camera. Virus samples were imaged at 40,000 x 
magnification (A) and 100,000 x magnification (B) to assess the purity and integrity of the virus 
particles, determining their suitability for downstream applications such as cryo-EM. 
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of the capsid (formed by the protruding P domains of the VP1 capsid proteins) 
(Conley et al., 2017).  
FCV is the type member of the Vesivirus genus within the Caliciviridae and is 
often used to represent the genus when comparing different viruses, either by 
sequence or by structure. To characterise the structure of FCV bound to its 
cellular receptor fJAM-A, we first set out to solve the structure of undecorated 
strain F9 virions. As well as informing our study of the receptor bound structure, 
this would allow direct comparison with the X-ray structure of FCV-5. 
Feline calicivirus (F9) particles were purified (see 2.2.2.1.2) from CrFK cells. 
Cells were infected at an MOI of 5 and incubated at 37°C with 5% CO2 for 16 
hours, by which point most of the cells appeared lysed with no remaining 
adherent cells. The supernatant was collected and centrifuged to remove 
cellular debris prior to ultracentrifugation. The pellet (containing virus particles) 
was then resuspended and centrifuged through a caesium chloride gradient for 8 
hours. The virus containing band was extracted from the gradient and 
concentrated by ultracentrifugation. The resultant pellet was resuspended and 
assessed by negative staining electron microscopy for purity and particle 
concentration (see Figure 26).  
Once a pure and concentrated virus sample had been confirmed by negative 
staining EM, vitrification for cryo-EM was performed. As described in 2.2.11.6.1, 
virus particles were added to a glow-discharged C-flat Holey Carbon Film Grid 
(Protochips) and plunged into liquid ethane cooled by liquid nitrogen. This rapid 
freezing of the sample prevents the formation of cubic or hexagonal ice and 
preserves the sample in a close to native state for imaging by cryo-EM. 
Feline calicivirus particles were imaged in an FEI Titan Krios equipped with a 
Falcon III detector at 75,000 x magnification (resulting in a pixel size of 1.065Å). 
5198 micrographs of FCV were collected at a range of defocus values (see 
2.2.11.6.2). A representative micrograph is shown in Figure 27A and shows the 
high purity, integrity and concentration of the purified virus particles. The 
respective power spectrum for the presented micrograph is shown in Figure 27B 
and demonstrates clearly visible Thon rings. The plots shown in Figure 27C  
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Figure 27- Validation of FCV data set quality 
A representative micrograph for the data set is shown (A) with a scale bar measuring 100nm. The 
power spectrum of the micrograph is shown (B) with the white circle representing the maximum 
extent of measured Thon rings and hence the likely resolution that can be achieved with data 
from this micrograph. These values for the whole data set are presented (C: green bars) 
alongside the measures of astigmatism from the Fourier transforms (C: multi-coloured dots and 
blue bars). Script written by Astbury Biostructure Laboratory (University of Leeds). 
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represent the quality of the data set by demonstrating the low levels of 
astigmatism and the maximum estimated resolution of each micrograph 
determined by measuring the extent of Thon rings from the power spectra 
(white circle in Figure 27B). These data show that a near-atomic resolution 
structure was possible from the acquired data set. Data were analysed using the 
RELION package. Each micrograph was first motion-corrected using MotionCor 2, 
followed by defocus estimation using GCTF. To generate a template for 
automated particle picking a small subset of particles were manually picked and 
processed to calculate a set of 2D class-averages. The best class averages were 
used for automated particle picking of the entire dataset.  
59,531 particles were extracted from the 5198 micrographs recorded and used as 
the input for 2D classification where the data was split into 60 self-similar 
classes. Figure 28 shows the clarity of the class averages calculated in both the 
2D (A) and 3D (B) classification steps, with distinct features of the viral capsid 
visible even at the early stages of data processing. Those 2D classes that showed 
clear high-resolution features were selected (see Figure 28A: 55,945 particles) as 
input for 3D classification, which required a reference map of a similar 
structure. We used a previous intermediate resolution structure of FCV solved on 
a JEOL JEM-2200FS TEM as the reference map and applied a 60Å filter to 
eliminate any model bias (Conley et al., 2017). Following 3D classification, the 
class containing the most data (41,436 particles) was selected and is shown in 
Figure 28B. The central section through the density map produced by 3D 
classification appears very detailed, particularly in the S domain of the capsid 
proteins, illustrating the high resolution that was achieved.  
3D refinement was then performed with the same reference map as for 3D 
classification. The output map from the 3D refinement was visualised using UCSF 
chimera and the lowest threshold that did not result in the appearance of ‘dust’ 
used to create a mask of the map (Pettersen et al., 2004). This mask was then 
used in a post-processing step to provide a final resolution estimate of 3.0Å 
based on the gold-standard FSC criterion with a cut-off of 0.143 (see Figure 
29B). Post-processing also produces an estimate of the most appropriate 
sharpening factor (B-factor). Local resolution estimation was performed using 
RELION to filter parts of the map to their estimated resolution (Scheres, 2012).  
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Figure 28- Class averages produced during FCV icosahedral reconstruction 
RELION was used to calculate (A) 2D and (B) 3D class averages of feline calicivirus particles. 
Panel A shows representative 2D class averages, showing that there was a good distribution of 
views of the FCV virion. Panel B shows a central section through the 3D reconstruction following 
25 iterations of classification. Data from this reconstruction were taken forward for further 
refinement. 
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This local resolution processing of the structure prevents over-sharpening of the 
lower resolution elements of the structure avoiding the possible inaccurate 
representation of poorly resolved regions of the reconstruction. 
The 3.0Å structure of FCV (in stereo view (C) and a cross-section (A)) is shown in 
Figure 29. FCV exhibits T=3 icosahedral symmetry with the stereo images shown 
viewed along the 2-fold symmetry axis (Figure 29C). The P2 dimers of the capsid 
proteins are known to form rhomboid structures at the outer face of the virus 
particles, shown in Figure 29C, with approximately 2 loop regions on each capsid 
protein (4 per capsomere) protruding above the rest of the P domain. These 
protrusions appear to be less well resolved, indicated by an estimated resolution 
of 3.4Å compared to 3.1Å for most of the P domain. The outer surface of the 
capsomeres (P2) forms the receptor binding site for fJAM-A and so it is likely 
that these protruding residues may contribute to receptor and/or attachment 
factor binding. These surfaces correspond to the hyper-variable regions of the 
capsid proteins which are responsible for receptor binding and are likely 
involved in antibody neutralisation by an infected host. At the centre of each of 
the 5 and 3-fold icosahedral symmetry axes, a slightly raised circular region can 
also be seen.  
The S domain of the FCV capsid appears to resolve to higher resolution 
(approximately 2.85Å) than the P domains (3.2-3.4Å), shown in red and 
turquoise/blue, respectively, in Figure 29C. This implies that the shell of the 
capsid forms a more rigid structure with some degree of flexibility seen in the P 
domains. This scope for flexibility is supported by previous work which has 
shown that the P domains of the capsid proteins undergo a rotation when 
engaged with their receptor, fJAM-A (Bhella et al., 2008; Bhella and Goodfellow, 
2011).  
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Figure 29- 3.0Å resolution structure of feline calicivirus by cryo-EM 
Feline calicivirus particles were imaged using an FEI Titan Krios with a Falcon III detector at 
75,000 x magnification with a range of defocus values. A cross section of the three-dimensional 
reconstruction is shown in panel A with the Fourier shell correlation plot shown in panel B. The 
3.0Å structure of FCV is shown in stereo view looking down the 2-fold symmetry axis (C/C dimer) 
in panel C. The structure is coloured by resolution following local resolution analysis performed 
in RELION from red (2.85Å) through to blue (3.4Å) showing that the S domain of the VP1 capsid 
protein was solved to higher resolution than the P (particularly P2) domain of the capsid. 
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4.2 Modelling of protein structure into the cryo-EM 
density map of FCV 
Solving the structure of a protein or capsid to near atomic resolution allows the 
fitting/modelling of the amino acid sequence into the resolved density. As the 
undecorated FCV structure presented here was solved to a resolution of 3.0Å, we 
aimed to use protein modelling to determine the structure of the major capsid 
protein VP1. 
To determine the protein structure of the FCV F9 major capsid protein, VP1, the 
known structure of FCV-5 VP1 was used alongside the F9 VP1 amino acid 
sequence (UniProtKB: P27406) to generate a homology model of the protein 
structure using SWISS-MODEL (Arnold et al., 2006). This model was then fitted 
into the density map solved by cryo-EM and refined using Coot and Phenix to 
yield the protein structure of FCV F9 VP1 (Adams et al., 2010; Emsley and 
Cowtan, 2004). 
The structures of the A, B and C conformations of VP1 are presented in Figure 
30A revealing modest differences in the N-terminal arm (NTA) as well as the 
previously established slight variations causing the bent A/B and flat C/C dimers 
(B and C). Example slices through the S and P domains of chain B are shown in 
grey in Figure 30F and G, respectively, with the modelled protein structure 
represented in pink to illustrate the goodness of fit in the model. The slices 
illustrate that the protein backbone fits within the density well with aromatic 
side chains clearly visible. The structure of the asymmetric unit (chains A, B and 
C) presented contains 0% outliers with a map correlation coefficient around 
atoms of 0.858, describing the high probable accuracy of the structure modelled 
into the cryo-EM density. 
The NTA’s of the three different chains of VP1 show some slight variations in the 
lengths of the alpha helices and at the N-terminus of the protein where the 
structure is less well-ordered. The S domains of the VP1 capsid proteins show the 
previously identified eight-stranded ß-barrel structure which is formed of two, 
four-stranded ß-sheets (termed BIDG and CHEF). 
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Figure 30- FCV VP1 protein structure determined by amino acid modelling 
The FCV VP1 capsid protein structure was determined by modelling into the cryo-EM density map 
using Coot and Phenix. The structures of VP1 chains A, B and C are shown (A: red, green and 
blue, respectively) alongside the A/B (B) and C/C (C) capsomeres. A side view (D) and top view 
(E) of the asymmetric unit are shown, illustrating the interactions between the 3 conformations 
of VP1. Representative sections through the density map in the S domain (F) and the P domain 
(G) are shown in grey with the protein structure shown in pink, illustrating the accuracy of the 
protein structures determined. 
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The two alpha helices between strands C and D and stands E and F have also 
been resolved. The P1 domains appear to be formed predominantly of ß-strands 
with 2 alpha helices visible. The previously described six stranded ß-barrel in the 
P2 domain is also visible although this region has been described to vary in 
orientation and strand length.  
4.3 Structural comparison of FCV F9 and FCV-5 
FCV-5 is known to be a strain of the virus capable of causing virulent systemic 
disease in cats while F9 is a vaccine strain. Structures of the two FCV strains 
have previously been resolved although that of the F9 strain was of intermediate 
resolution. The structure of F9 decorated with the soluble ectodomain of fJAM-A 
has also been solved (Bhella and Goodfellow, 2011; Conley et al., 2017; Ossiboff 
et al., 2010).  
After determining the structure of FCV F9 VP1 by modelling of the protein 
structure into our cryo-EM density map, we aimed to perform a structural 
comparison of the VP1 capsid proteins from each strain. To aid in this 
comparison, the structures of VP1 chains A, B and C from F9 and FCV-5 were 
overlaid in UCSF Chimera as shown in Figure 31A. The RMSD values of the two 
maps were then calculated for each chain and the F9 structure coloured by RMSD 
value as a visualisation tool for comparing the two structures (see Figure 31B).  
Figure 31 shows that the S domains and P1 domains of the VP1 capsid proteins 
from F9 and FCV-5 are very similar with most of the major structural variations 
occurring within the P2 domain. Some slight variations are seen within the NTA’s 
of the proteins with chain A of F9 (Figure 31A: red) resolving an alpha helix 
while the corresponding structure of FCV-5 did not contain any secondary 
structural elements. The NTA’s of chains B and C form alpha helices in both 
structures although of slightly differing conformations. 
The S domains of the two proteins appear very similar with slight variations seen 
in the outer loop regions of chains A and C (between ß-strands H and I). The 
flexible hinge region connecting the S domain to the P1 domain appears to be 
highly conserved between the two strains of FCV.  
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Figure 31- Comparison of FCV F9 against FCV-5 
Structures of the FCV F9 VP1 capsid protein were overlaid with the structure of the 
corresponding chains of FCV strain 5 (PDB ID: 3M8L). VP1 chains A, B and C are shown (A; F9: red, 
green and blue, respectively. FCV-5: yellow). The RMSD of the two overlaid structures was 
determined and the F9 VP1 structure coloured by RMSD using UCSF Chimera (B: Chains A, B and C 
respectively). The colour key represents RMSD values of 0 (red), 1.5 (green) and 3 (blue). Chains 
A and B of FCV F9 and FCV-5 were fitted into the cryo-EM density to illustrate the most varied 
regions with the top of the capsomere (P2) shown (red and green: FCV F9 A and B, respectively 
and FCV-5 shown in yellow). 
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The P1 domains of the two strains appear to adopt very similar conformations 
with the secondary structure conserved within all three chains. The P2 domain 
shows the most variation between the two strains although this is expected as it 
is the site of receptor binding and antibody neutralisation. The bottom portion 
of P2 does not appear to differ significantly between F9 and FCV-5, however the 
loop regions at the top of P2 appear quite different in their conformations, likely 
due to the presence of a hyper-variable region (see Figure 31C). 
The colouring of the F9 strain VP1 structure by RMSD (see Figure 31B) allows the 
easy visualisation of the most variable regions when comparing it to that of FCV-
5. Regions shown in red are highly conserved while green are moderately 
conserved and blue are less conserved (RMSD values of 0, 1.5 and 3.0 
respectively). Colouring of the structure in this way confirms the observations 
made by eye when overlaying the structures (see Figure 31A) and re-iterates 
that the most conserved regions of the proteins are the S domain, particularly 
the ß-barrel motif, and the P1 domain. The most variable regions are confirmed 
as parts of the NTA as well as the areas within the top of the P2 domain.  
This structural comparison shows that the vaccine strain, F9 and a virulent 
systemic strain, FCV-5, are very similar in structure. Most of the two proteins 
adopt the same structure and conformations with the main variability seen in 
the NTA’s and in the top of the P2 domains. This variability in the P2 domains is 
expected due to the presence of a hyper-variable region responsible for receptor 
binding and antibody neutralisation.  
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4.4 Structure of FCV decorated with fJAM-A 
Feline junctional adhesion molecule A (fJAM-A) has been demonstrated to be an 
essential cellular receptor for FCV with expression in non-permissive cells 
rendering them susceptible to FCV infection (Makino et al., 2006). The cryo-
electron microscopy structure of FCV decorated with the soluble ectodomain of 
fJAM-A has previously been determined to 9Å resolution and a conformational 
change identified in the capsid proteins when bound to fJAM-A. An anticlockwise 
rotation of 15° in the VP1 P domains of FCV F9 was determined as well as the 
tilting of the C/C dimer resulting in the breaking of icosahedral symmetry and 
limiting the resolvable density in these regions of the map. Stages of the 
conformational change/rotation were separated computationally although 
remained at intermediate resolution, limiting the interpretation of the data 
(Bhella and Goodfellow, 2011). 
We aimed to determine the structure of FCV decorated with the soluble 
ectodomain of fJAM-A to near atomic resolution. Moreover, we sought to 
calculate separate reconstructions for each of the stages of the conformational 
change and to characterise the conformational changes that take place as a 
prelude to uncoating at the atomic level. 
To elucidate the structure of FCV decorated with fJAM-A, the soluble 
ectodomain of fJAM-A was purified as described in 2.2.3 and combined with FCV 
for 1 hour at 4°C. Samples were then plunge frozen and imaged in an FEI Titan 
Krios equipped with a Falcon III detector (see 2.2.11.6.2) at a magnification of 
75,000 x yielding a pixel size of 1.065Å/pixel. Micrographs were collected at a 
range of defocus values from 1.2 to 3.5μm. A representative micrograph is shown 
in Figure 32A alongside the corresponding power spectrum (B) showing the 
maximum resolution achievable from the micrograph (white circle). The virus 
particles in the micrograph appear to be ‘spiky’ around their perimeter, 
confirming their decoration with the soluble fJAM-A ectodomain and clear, sharp 
Thon rings are visible in the power spectrum. The maximum resolution of each 
micrograph and the levels of astigmatism observed, as calculated by GCTF, are 
shown in Figure 32C (green and multi-coloured/blue, respectively). 
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Figure 32- Validation of FCV-fJAM-A data set quality 
A representative micrograph for the data set is shown (A) with a scale bar measuring 100nm. The 
power spectrum of the micrograph is shown (B) with the white circle representing the maximum 
resolution that can be achieved from this micrograph. These values for the whole data set are 
presented (C: green bars) alongside the measures of astigmatism from the Fourier transforms (C: 
multi-coloured dots and blue bars). Script written by Astbury Biostructure Laboratory (University 
of Leeds). 
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60,137 particles were extracted from 6673 micrographs as described previously 
for FCV (see 4.1) using RELION following the motion correction and defocus 
estimation of the recorded micrographs (Scheres, 2012). Particles were 
submitted to 2D classification and the sharply resolved classes were selected 
(40,580 particles: Figure 33A) and 3D classification performed to separate out 
the data into self-similar classes. Initially, we specified the number of classes as 
6, although not all classes contained particles. Additionally, of those classes that 
did contain data, most were not highly detailed or ‘FCV-like’ apart from one 
class which contained 88% of the input data from the 2D classification and was 
used for further downstream processing (35,843 particles: Figure 33B). It is clear 
from the 3D classification cross section (Figure 33B) that extra density is present 
on the outer surface of all of the visible capsid proteins (bound to the P2 
domains). The bound fJAM-A appears as a V-shaped density in the outer portions 
of the cross section where two fJAM-A proteins have bound to each VP1 dimeric 
capsomere. The S domain density appears to be much more detailed and sharply 
resolved than that of the P domains or fJAM-A, suggesting a degree of rigidity in 
the viral capsid shell and the movement/flexibility induced in the P domains 
upon receptor binding. 
Following 3D refinement against a previously determined intermediate resolution 
structure of FCV decorated with fJAM-A, a mask was created and post-processing 
used to yield a final resolution of 3.55Å for the fJAM-A decorated FCV structure 
(see Figure 34) (Bhella and Goodfellow, 2011). The cross section through the 3D 
reconstruction (shown in Figure 34A) shows the additional density above each of 
the P domains of the capsid proteins as also illustrated in Figure 33B. Density 
attributed to the P-domain and fJAM-A is blurred compared to the S-domain 
density, strongly suggesting that this feature is incoherently averaged, possibly 
due to movement or a mixed population of conformations. Figure 34B shows the 
reconstruction calculated following 3D refinement prior to sharpening, allowing 
better visualisation of the blurred features. Sharpening emphasises the high 
resolution features of the S-domain (Figure 34C), however the P-domain and 
fJAM-A density are now less well represented. Local resolution estimation was 
performed in RELION and a low-pass filter applied to the lower resolution regions 
of the density map (Scheres, 2012). Figure 34C shows the stereo-paired view of 
the 3.55Å resolution structure of FCV decorated with fJAM-A (coloured by  
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Figure 33- Class averages of fJAM-A decorated FCV particles 
RELION was used to classify fJAM-A decorated feline calicivirus particles in two dimensions (A) 
and, following selection of certain classes, three dimensions (B). Panel A shows the different 
views of the decorated FCV particles imaged while panel B shows a cross section of the final 
three dimensional class of data used for further processing of fJAM-A decorated FCV. 
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Figure 34- 3.55Å structure of fJAM-A decorated FCV solved by cryo-EM 
Decorated FCV particles were imaged using an FEI Titan Krios equipped with a Falcon III detector 
at 75,000 x magnification and at a range of defocus values. A cross section of the three-
dimensional reconstruction is shown in panel A. Panel B shows the 3D refined structure of fJAM-A 
decorated FCV to allow the visualisation of the lower resolution features (e.g. fJAM-A: coloured 
by radius). The 3.55Å structure of FCV decorated with the soluble fJAM-A ectodomain (B factor 
sharpened) is shown in stereo view looking down the 2-fold symmetry axis (C/C dimer) in panel 
C. The structure is coloured by resolution following local resolution analysis performed in RELION 
from red (3.1Å) through to blue (5.1Å) showing that the viral capsid was solved to higher 
resolution than fJAM-A, possibly due to the previously described conformational change. The FSC 
plot of the structure is shown in panel D. 
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Figure 35- Side by side comparison of undecorated and decorated FCV 
structures. 
A side by side comparison of the 3.0Å undecorated FCV structure (A) and the 3.55Å fJAM-A 
decorated FCV structure (B) coloured by radial density. 
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resolution). It is immediately clear that the resolution of the decorated 
structure is lower than that of the undecorated virus structure shown in the side 
by side comparison presented in Figure 35Figure 29. This is due to the presence 
of a conformational change that has been previously reported to occur in the 
capsid upon fJAM-A binding (Bhella et al., 2008; Bhella and Goodfellow, 2011). 
The fJAM-A structure appears to be of much lower resolution (5.1Å) than that of 
the S domain of the capsid (3.1Å) although the P domain was resolved to a 
resolution intermediate between the two (4.1Å), suggesting an increase in 
flexibility/movement as you move further out from the S domain. Less density 
was resolved above the C/C dimers than the A/B dimers suggesting an additional 
movement in these capsomeres that does not occur in the A/B capsomeres. 
Bhella et al proposed a tilting of the C/C capsomere resulting in the breaking of 
icosahedral symmetry in this region, accounting for the loss in resolvable density 
(Bhella and Goodfellow, 2011). 
Overlaying of the undecorated FCV structure with the fJAM-A decorated FCV 
structure allows the visualisation of not only the fJAM-A density but also the 
conformational change induced upon fJAM-A binding (see Figure 36). The stereo-
paired view of the overlaid structures in Figure 36A shows the predominant 
fJAM-A decorated FCV density (purple) although clear patches of undecorated 
FCV (yellow) are visible, showing the regions affected by the conformational 
change on a scale of the whole viral capsid. Figure 36B and C shows two 
different views of an A/B capsomere with the V-shaped fJAM-A density clear 
when looking from one end of the dimer (C) rather than looking side on at the 
dimer (B). The side view shown in panel B, however, more effectively illustrates 
the movement of the P domains as a lot of the density appears only in the 
undecorated structure (yellow) when visualised in this way. Likewise, the side 
view of the C/C capsomere (D) demonstrates the movement or lack of resolved 
density upon fJAM-A binding with mostly undecorated FCV P domain structure 
visible and little visible fJAM-A density bound to the outer face of the P2 
domain.  
A solid sphere was applied (with a diameter of 18nm, using UCSF Chimera) to the 
centre of the structure to obscure the details in the S domain and allow easier 
visualisation of details in the P domains and fJAM-A as seen in Figure 36E. When 
viewing the top of the A/B capsomere it is less easy to distinguish the  
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Figure 36- Comparison of undecorated and fJAM-A decorated FCV structures 
Both undecorated (yellow) and fJAM-A decorated (purple) structures were visualised in UCSF 
Chimera and overlaid to illustrate the effect of fJAM-A binding on capsid structure. The Stereo 
view of the two overlaid structures is presented in panel A with the side view (B) and end view 
(C) of an A/B dimer shown as well as the side view of a C/C dimer (D). Panel E shows the top 
view of an A/B dimer with an icosahedral surface of 18nm applied to allow clear visualisation of 
the conformational change induced upon fJAM-A binding.  
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fJAM-A binding orientation on the P2 domain, although it is clear upon inspection 
of different views of the capsomeres that a conformational change occurs in the 
P domains of the capsid proteins upon fJAM-A binding.  
Upon fitting of the modelled FCV P domain A/B dimer into the undecorated and 
decorated virus structures, it was possible to determine the degree of rotation 
that occurs in the P domains upon fJAM-A binding. Overlaying of the two 
structures reveals an anti-clockwise rotation of the P domains of the VP1 capsid 
proteins. This anti-clockwise rotation from the undecorated FCV structure to the 
fJAM-A decorated FCV structure was determined to be of 19° using UCSF 
Chimera (Pettersen et al., 2004). This rotation is clearly visible when spherical 
sections of the two structures are compared as in Figure 37. Changes are seen in 
both the P1 and P2 domains which appear to rotate anti-clockwise upon fJAM-A 
engagement (Figure 37A to D).  
Bhella et al have previously resolved the structure of fJAM-A decorated FCV at 
several stages during the conformational change. As we did not achieve this with 
unsupervised 3D classification of the data, 3D classification was attempted again 
on the selected 3D class containing 88% of the data (35,843 particles), to try to 
separate these data into the 5 or 6 classes shown previously (Bhella and 
Goodfellow, 2011). Repeated iterations of unsupervised classification did not 
yield classes of differing conformations however. To separate labelled virion 
images, the previously resolved structures were used in a multi-reference 3D 
classification. This produced only two classes of differing conformations which 
were further processed in RELION (Scheres, 2012). To ensure that the differing 
conformations were not due to model bias introduced in the 3D classification, an 
undecorated FCV structure was used as the reference map for a final round of 3D 
refinement of the two classes. Using this method, the pre- and post-
conformational change structures of fJAM-A decorated FCV were determined. 
While the post-conformational change structure was resolved to 3.65Å (25,984 
particles), the pre-conformational change data set was very small, consisting of 
only 258 particles, resulting in a lower resolution of 6Å. This shows that under 
these experimental conditions, only a small subset of virus particles did not 
undergo the conformational change upon fJAM-A binding. 
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Figure 37- Spherical sections to compare undecorated FCV against fJAM-A 
decorated FCV 
Spherical sectioning was performed in UCSF chimera with varying radii to allow the visualisation 
of the P1 domains (A and B) and P2 domains (C and D) for the undecorated and fJAM-A decorated 
structures respectively. Pink boxes highlight changes between the two structures with the 19º 
rotation visible in both the P1 and P2 domains of the capsid proteins (A to D). 
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Figure 38A shows the pre-conformational change structure coloured by 
resolution, indicating the lower resolution of the P domains and fJAM-A even in 
the pre-conformational change state. The pre-conformational change structure 
(gold) was overlaid with the post-conformational change structure (pink) and 
shown in stereo view (B) as well as the top views of an A/B capsomere (C) and a 
C/C capsomere (D). The anti-clockwise rotation of 19° from the pre to post-
conformational change structure is clearly visible in panel C when observing the 
top of an A/B dimer. The lack of resolved density at the C/C dimer for the post-
conformational change structure is obvious in panel D. This structural overlay 
allows us to hypothesise that fJAM-A binds to the P2 domains of the C/C 
capsomeres in the same orientation as the A/B dimers prior to induction of 
movement in the C/C dimers, breaking the icosahedral symmetry, and resulting 
in weaker density due to this movement/flexibility.  
Overlaying of the pre-conformational change structure onto the undecorated 
FCV structure (Figure 38, panels E and F: purple and yellow, respectively) allows 
the visualisation of how fJAM-A binds to the P2 domains of both the A/B (E) and 
C/C (F) capsomeres. Despite fJAM-A being predicted to form cis (and trans) 
dimers at the tight junctions between cells, fJAM-A appears to bind to FCV VP1 
in a monomeric form. Figure 38, panels E and F, show that 2 fJAM-A proteins 
bind to each VP1 dimer/capsomere in a head to tail arrangement i.e. with D1 of 
one fJAM-A monomer laying adjacent to D2 of another fJAM-A monomer and vice 
versa.  It is interesting that in all previous experiments described here, fJAM-A 
was present in a dimeric form, however, in electron microscopy experiments, it 
appears to bind to FCV in a monomeric form (2 fJAM-A proteins bind to 2 VP1 
capsid proteins). 
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Figure 38- A comparison of the pre and post-conformational change 
structures of fJAM-A decorated FCV 
The pre-conformational change structure is shown in stereo (A: coloured by resolution, B: gold) 
as well as overlaid with the post-conformational change structure of fJAM-A decorated FCV 
(pink), also presented in stereo view (B). The top view of an A/B dimer (C) and C/C dimer (D) in 
the overlaid structures are also shown. The A/B (E) and C/C dimers (F) of the undecorated FCV 
structure (yellow) overlaid with the pre-conformational change structure (purple in E and F) 
effectively illustrates the orientation in which fJAM-A binds to the P2 domains of the FCV VP1 
capsomeres (panels C-F are shown with an icosahedron surface of 18nm). 
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The VP1 protein structure modelled here (see 4.5) was docked into both the pre 
and post-conformational change structures alongside an fJAM-A homology model 
previously produced using the structure of human JAM-A (Bhella 2011). Chain A 
of VP1 is shown bound to fJAM-A in Figure 39 for both the pre (A) and post-
conformational change states (B). UCSF Chimera was used to find contacts 
between the two proteins in both stages of the conformational change. Contact 
residues identified in VP1 are shown in Figure 39 (C: pre and D: post-
conformational change structures). Although chain C of VP1 was not resolved in 
the post-conformational change structure (shown in white), many of the contact 
residues remain consistent between the structures. Fewer contacts were 
determined in the post-conformational change state although this may reflect 
the lower resolution in these regions of the map.  
As most contact residues appear to be the same between the two stages of the 
conformational change, it is likely that the fJAM-A does not move once bound to 
VP1 and that the P domain and fJAM-A rotate together on the virus capsid. The 
contact residues on the fJAM-A proteins were also identified and are shown in 
Figure 39 (E: pre and F: post-conformational change). Again, the contact 
residues between the two structures/stages of the conformational change 
appear to be very similar and support the rigidity of the P-fJAM-A complex upon 
the virus-receptor interaction. 
The contact residues identified are shown in Figure 40 for the 3 VP1 chains (A) as 
well as fJAM-A (B) in both the pre and post-conformational change structures. 
Some variation is apparent although certain residues are clearly important for 
the virus receptor interaction such as 434D and 495N in VP1 and 33S in fJAM-A. 
Some differences are evident in the fJAM-A contact residues although the region 
spanning 43K to 48S appears to be important with very few differences between 
the pre and post-conformational change states. 
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Figure 39- Determination of contact residues between FCV VP1 and fJAM-A 
Modelled VP1 protein structures (see 4.5) and an fJAM-A homology model (Bhella 2011) were 
docked into both the pre-conformational change structure (A, C and E) and the post-
conformational change structure (B, D and F; P domains only fitted due to rotation in relation to 
the S domain). VP1 chain A is shown bound to fJAM-A for the pre (A) and post (B) conformational 
change states. Contact residues were calculated using UCSF Chimera and coloured yellow on 
both the VP1 asymmetric units (C: pre-conformational change and D: post-conformational 
change, top view shown) and the fJAM-A proteins (E: pre-conformational change and F: post-
conformational change, underside/interacting face shown). VP1 proteins and their interacting 
fJAM-A proteins were coloured by chain (chain A: red, chain B: green, chain C: blue) with chain C 
in the post-conformational change state coloured white as these positions could not be 
determined due to the movement and therefore loss of resolution/density in the map. 
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Figure 40- Contact residues identified on both VP1 and fJAM-A 
Sequences of FCV VP1 (A) and fJAM-A (B) are presented with the determined contact residues 
highlighted in red. The residues are shown separately for each VP1 chain (A, B or C) as well as 
for the pre and post-conformational change states. Chain C in the post-conformational change 
structure could not be resolved sufficiently to allow docking of the protein structures and so has 
been omitted here. 
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4.5 Protein structure modelling into the fJAM-A decorated 
FCV cryo-EM density map 
As the structure of FCV decorated with the soluble ectodomain of fJAM-A was 
resolved to 3.55Å resolution, we aimed to model the protein structure of VP1 
when bound to fJAM-A in order to further characterise the conformational 
change in the P domains and to map the interaction between the two proteins. 
Following the determination of the FCV F9 VP1 structure by modelling, we aimed 
to also model the structure of VP1 when decorated/bound to the soluble 
ectodomain of fJAM-A. The cryo-EM structure of decorated FCV was resolved to 
a slightly lower overall resolution of 3.55Å although the S domain appeared to be 
around 3.3Å. However, the P domains were only resolved to approximately 4.0Å 
with the fJAM-A ectodomain resolving to around 4.6-5.1Å. The high resolution of 
the S domains supported modelling in these regions, however, the lower 
resolution of the P domains and fJAM-A was more challenging. 
The previously determined structure of the FCV F9 VP1 asymmetric unit was 
fitted into the cryo-EM density map and modelled as previously described using 
Coot and Phenix. Unfortunately, the P domains and fJAM-A density were of too 
low resolution to allow for protein modelling. Some ß-strand density was visible 
in the P domains although no distinguishable side chains or nearby density was 
resolved in order to build in the amino acid structure for those regions. 
However, the density of the S domains for the asymmetric unit (decorated with 
fJAM-A) were sufficiently resolved to allow modelling of the protein structure in 
these domains.  
Figure 41 shows the structure of the S domains of the asymmetric unit 
determined by modelling of the protein structure into the fJAM-A decorated FCV 
VP1 density. The S domains of the decorated capsid proteins show the eight-
stranded ß-barrel structure previously described which is formed of two, four-
stranded ß-sheets (formed of strands: BIDG and CHEF). The two alpha helices 
between strands are also clearly visible. 
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Figure 41- Modelling of the S domain in the fJAM-A decorated FCV structure 
The S domain of the VP1 capsid protein when bound to the soluble ectodomain of fJAM-A was 
determined by modelling into the cryo-EM density map using Coot and Phenix. The structure of 
the S domains of the asymmetric unit (decorated with fJAM-A) are shown in red (A). A 
representative slice through the density (grey) showing the modelled structure of the S domain 
(pink) is shown in panel B. The S domains determined by modelling into the decorated structure 
of FCV VP1 (red) were overlaid with those modelled into the undecorated structure (purple) and 
are shown in panel C. 
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Figure 41B shows a representative slice through the density (grey) illustrating 
the accuracy of the modelled amino acid structure (pink). The high accuracy of 
the modelled structure is further supported by a map correlation coefficient 
around atoms of 0.845 with 0.0% outliers. Figure 41C shows the determined S 
domain structures from the decorated virus (red) overlaid with those from the 
undecorated virus (purple). The structures of the S domains of the two 
asymmetric units are almost identical with an RMSD (root-mean-square 
deviation) of 0.47 and the only slight changes being in the NTA and the outer 
loop of the S domains. These slight variations were visualised in both density 
maps and no significant variations were identified, suggesting that the slight 
differences seen are due to the modelling and are of no structural significance. 
The similarity of these structures suggests that the binding of the soluble 
ectodomain of fJAM-A to FCV does not result in a conformational change in the S 
domains of VP1 and that the rotation of the P domains as well as the possible 
tilting of the C/C dimers must be limited to only the P domains themselves. The 
observation that no change is seen in the S domain even upon the 19° rotation of 
the P domains suggests that the flexible hinge region between the two domains 
likely allows for this movement while retaining S domain structure and capsid 
integrity. 
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4.6 Discussion 
The structure of FCV F9 has previously been presented at intermediate 
resolution showing the characteristic calicivirus morphology of the capsid 
proteins (Bhella et al., 2008; Bhella and Goodfellow, 2011; Conley et al., 2017). 
The structure of FCV (F9) decorated with the soluble ectodomain of its cellular 
receptor, fJAM-A, has also been presented at intermediate resolution showing an 
anti-clockwise rotation of the P domains of the capsid proteins as well as a 
possible tilting of the C/C dimers away from the icosahedral axis (Bhella and 
Goodfellow, 2011).  
Here, we present the structure of FCV at 3.0Å resolution as well as the structure 
of FCV decorated with the soluble ectodomain of fJAM-A at 3.55Å resolution. 
Although we were unable to separate out the stages of the conformational 
change, a pre-conformational change state was solved to 6Å, allowing further 
characterisation of the FCV-fJAM-A interaction. Key residues in VP1 were 
identified as 434D and 495N with fJAM-A residues 33S and between 43K to 48S 
also being important in the virus-receptor interaction. The conformational 
change was determined as an anti-clockwise rotation of 19º in the P domains of 
the capsid proteins. This was previously identified as an anti-clockwise rotation 
of 15º although that structure was of intermediate resolution and so our near 
atomic resolution structure provides a more accurate model for calculating the 
extent of rotation that occurred in the P domains upon engagement by fJAM-A 
(Bhella and Goodfellow, 2011). The C/C dimer also appears to be less well 
resolved in the structures solved by us and others in the post-conformational 
change state suggesting that the movement/tilting of the capsomere results in 
the breaking of the icosahedral symmetry which is why those regions are poorly 
resolved (Bhella and Goodfellow, 2011). This is supported by our findings that in 
the pre-conformational change state, the C/C dimers appear similar to the A/B 
dimers with the fJAM-A visible bound to the P2 domains.  
The structure of FCV decorated with the soluble ectodomain of fJAM-A shows 
that 2 fJAM-A proteins bind to each VP1 dimer in a head to tail arrangement 
(Bhella and Goodfellow, 2011). This is different to that seen in solution (and 
predicted in the tight junctions between cells) where the fJAM-A ectodomain 
forms homodimers as shown in Figure 23 (Kostrewa et al., 2001; Prota et al., 
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2003). When dimeric, the D1 domains of the two fJAM-A proteins interact while 
the D2 domains remain separated. However, upon FCV binding, the D1-D1 
interaction is abolished and each monomer binds to each VP1 capsid protein, 
rotated 180º from the neighbouring fJAM-A monomer. Interestingly, the region of 
fJAM-A to which FCV binds is located on a different face/area of the protein to 
the dimerisation domain (see Figure 13 and Figure 25). The affinity of the D1-D1 
interaction (11µM) has been shown to be much higher than that between hJAM-A 
and reovirus 1 protein (2.4nM) (Guglielmi et al., 2007; Kirchner et al., 2008). 
Likewise, our findings suggest a dissociation constant in the nM range for FCV 
and fJAM-A. Together, these findings suggest that the lower affinity between 
two fJAM-A proteins may result in the breakage of the dimer upon engagement 
in a stronger interaction with a viral protein which may explain the monomeric 
form of fJAM-A found on decorated FCV particles. Dimeric CAR (coxsackievirus 
and adenovirus receptor) has also been shown to be disrupted upon binding of 
the adenovirus fibre knob protein which, interestingly, triggered endocytosis 
(Salinas et al., 2014). More investigation is needed, however, to determine if 
this mechanism also plays a role in FCV internalisation/entry.  
Upon comparison of the VP1 capsid protein structures of FCV F9 and FCV-5, they 
appear very similar, particularly in the S domain and the P1 domain. Some slight 
variations exist in the N-terminal arm of the protein although the major 
variations are seen in the top most region of the P2 domain which is responsible 
for receptor engagement and antibody neutralisation. It is not unreasonable to 
speculate that these variations in the P2 domains of the VP1 capsid proteins may 
affect the dissemination of FCV-5, allowing the infection of non-respiratory 
cells/tissues and therefore causing the described virulent systemic disease 
associated with this strain. In contrast, F9 is a vaccine strain of FCV and so the 
highly similar nature of the two proteins is both expected (as they are related 
strains of FCV) and unexpected (due to highly differing disease outcomes for the 
two strains).  
A conformational change in the FCV-5 capsid upon fJAM-A binding has been 
proposed by Ossiboff et al who showed an increase in bis-ANS fluorescence upon 
incubation of the virus and fJAM-A. Interestingly, it was reported that this 
increase in fluorescence, signifying a conformational change and the exposure of 
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hydrophobic regions, was not seen for the F9 vaccine strain upon incubation with 
fJAM-A (Ossiboff et al., 2010). The exposure of hydrophobic regions could come 
from either VP1 or fJAM-A although our data suggests that a conformational 
change in the capsid is more likely than movement of the fJAM-A on the virus. It 
is worth noting, however, that the bis-ANS experiments were performed with 
bacterially expressed fJAM-A and so any post-translational modifications such as 
glycosylation would not be present on the receptor. The structure of FCV-5 
decorated with the soluble ectodomain of fJAM-A would be interesting to 
investigate the presence and degree of any conformational change seen in a 
virulent systemic strain and to compare it with that presented here from the 
vaccine strain, F9.  
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5 Characterisation of FCV attachment and 
uncoating 
The entry pathway of FCV has previously been shown to involve viral uptake by 
clathrin-mediated endocytosis (Stuart and Brown, 2006). We have shown that 
upon receptor engagement, FCV undergoes a conformational change (Bhella et 
al., 2008; Bhella and Goodfellow, 2011). This finding led us to hypothesise that 
receptor engagement may prime the virus for uncoating in the endosome. We 
therefore set out to investigate the effect of pH on FCV virion integrity, in the 
presence or absence of fJAM-A. We also aimed to determine the number of 
fJAM-A proteins required to cause the conformational change seen in the virus. 
5.1 Effect of pH on capsid structure and integrity 
To investigate the effect of pH on FCV capsid structure, both FCV and FCV with 
Fc-fJAM-A were incubated at pH values of 4, 5, 6 and 7 for 1 hour at 4°C. 
Samples were then plunge frozen into liquid ethane cooled by liquid nitrogen 
and imaged in a JEOL JEM-2200FS Field emission electron microscope equipped 
with a Gatan Ultrascan US4000 CCD camera. Samples were imaged at 100,000 x 
magnification at a range of defocus values with a resulting pixel size of 
1.05Å/pixel. We found that undecorated virions could be seen at all pH values 
down to 4, while the FCV-fJAM-A virions appeared to be disrupted at pH 4. To 
test whether undecorated FCV or FCV-fJAM-A had undergone structural changes 
at the different acidity levels, we calculated 3D reconstructions of both the 
undecorated and decorated virus structures.  
The structure of FCV at pH4 was determined from 934 particles (extracted from 
141 micrographs) and solved to 10Å resolution. Our findings when FCV was 
incubated alone at pH4, showed that the viral capsid resembled that at pH7 with 
no structural changes visible as shown in Figure 42. Interestingly, when FCV was 
incubated with Fc-fJAM-A at pH4, no intact virus particles could be seen by cryo-
EM. A representative cryo-micrograph is presented in Figure 42, showing the 
presence of small globular objects which we hypothesise to be capsid proteins 
(purple arrow) as well as long strands of what we hypothesise to be viral RNA 
(pink arrow). This suggested that upon incubation with Fc-fJAM-A at pH4, FCV 
particles disassemble into their component parts. As FCV seemed to  
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Figure 42- Effect of pH on FCV capsid structure by cryo-EM 
FCV was either aliquoted alone or combined with Fc-fJAM-A for investigating the effect of pH on 
capsid integrity. Samples were reduced in pH by the addition of the appropriate volume of pH2 
buffer and incubated for 1 hour at 4°C prior to plunge freezing and imaging. FCV particles 
remained intact at pH4 although when incubated with Fc-fJAM-A, no intact viral particles were 
visible. The presence of proteins and strands of RNA can be seen (purple and pink arrows, 
respectively) in the cryo-EM micrographs. FCV when incubated with Fc-fJAM-A at pH5, however, 
remains intact and adopts the same structure as that previously determined at pH7.  
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fall apart in the presence of Fc-fJAM-A at pH4, we proceeded to investigate the 
structure at pH5. The structure of FCV with Fc-fJAM-A at pH5 was solved to 14Å 
from 643 particles (extracted from 184 micrographs) and shows no difference at 
this resolution to the previously solved structure of the virus-receptor complex 
at neutral pH.  
To confirm our finding that fJAM-A decorated FCV, but not undecorated FCV, 
uncoated at low pH and to further investigate the effect of pH on receptor 
mediated uncoating, we adapted an in vitro assay of virion stability known as 
PaSTRy (Particle Stability Thermal Release assay). The PaSTRy assay was 
developed to measure RNA released from virions following heating, and uses a 
nucleic acid binding dye (Syto9). Syto9 is one of a family of fluorescent 
molecules that undergo enhancement of fluorescence when bound to nucleic 
acids, possibly upon intercalation into the minor groove (personal 
communication with ThermoFisher Scientific). The absorption/emission spectra 
(nm) of the Syto9 nucleic acid binding dye are 486/501. Thus in PaSTRy assays, 
the temperature at which capsid integrity is lost may be determined by 
measuring fluorescence induced by the dye binding to the viral genome. We 
modified this assay to examine the effect of pH rather than temperature such 
that when the pH was sufficiently reduced to cause disassembly of fJAM-A bound 
FCV, the viral RNA released would be bound by the Syto9 reagent, leading to 
enhanced fluorescence. No change in fluorescence intensity would indicate that 
virions had remained intact.  
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Figure 43- RNA release assay to determine the pH at which FCV uncoats 
RNA release assays were performed in triplicate at a range of pH values from 3 to 9. Dye 
(negative) and RNA (positive) controls are averages of all pH values investigated. Equal 
concentrations of FCV and Fc-fJAM-A were combined with Syto9 nucleic acid binding dye in a 
Tris-HCl buffer of appropriate pH and fluorescence measured every 5 minutes over a period of 4 
hours. Fluorescence readings were normalised to an equivalent sample containing FCV and 
nucleic acid binding dye (no Fc-fJAM-A) prior to plotting of the data. P values of <0.0001 upon 
comparison to pH7 data are represented by ****. 
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We had previously established that disassembly occurred up to 1 hour following 
the addition of Fc-fJAM-A to FCV (at pH4). We therefore added one of these two 
critical components of the reaction mixture last and then immediately took 
fluorescence measurements over a period of 4 hours to establish the time taken 
for virion disassembly to occur. 
The RNA release assay was used to test pH values ranging from 3 to 9, examining 
the pH at which viral disassembly occurs. Negative control samples were tested 
that comprised the dye in buffer, while positive controls were tested that 
contained purified FCV RNA. The control data presented represent averages of 
the data collected at all tested pH values due to little variation observed 
between the samples. All samples of FCV and Fc-fJAM-A were normalised to 
controls containing only FCV and nucleic acid binding dye to remove any non-
specific/background fluorescence. 
Figure 43 shows a very low signal for the dye only negative control alongside a 
high fluorescence signal for the positive RNA control confirming the principle of 
the assay. As shown in Figure 43, no increase in fluorescence can be seen when 
FCV and Fc-fJAM-A were combined at pH values of 5, 6, 7, 8 or 9, confirming our 
previous findings by EM that the virus-receptor complex remains intact at pH5 
and at neutral pH (see Figure 42). At pH4, a steady increase in fluorescence 
intensity is observed signifying the previously hypothesised disassembly of the 
virus-receptor complex with maximal uncoating occurring 180 minutes post 
incubation. Only a slight increase in fluorescence is seen 60-90 minutes post 
incubation although, by electron microscopy, this was sufficient time for 
uncoating of most FCV particles to occur. Interestingly, the uncoating seen at 
pH3 appears to occur much more rapidly with maximal uncoating occurring after 
approximately 105 minutes. This confirms our hypothesis that upon incubation 
with Fc-fJAM-A, FCV undergoes disassembly at pH values of 4 and lower which 
may be significant in fully understanding the entry mechanism utilised by 
caliciviruses. 
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5.2 Stoichiometry of FCV-fJAM-A interaction 
To determine the ratio of virus to receptor that would be sufficient to prime 
virions for uncoating at low pH, virion disassembly at pH3 was assessed by RNA 
release assay. As the virus disassembles when incubated at low pH with fJAM-A 
but not at pH5 (although the conformational change is present), we can assume 
that the receptor induced conformational change occurs prior to viral 
disassembly. We can, therefore, use the rapid disassembly we observe at pH3 as 
a measure of the extent of virion destabilisation as a consequence of the 
conformational change induced by differing ratios of receptor to capsid protein. 
To confirm the results of our RNA release assay, we also used negative stain TEM 
to directly visualise virion disassembly at low pH. 
To estimate the minimum ratio of receptor to capsid protein that is necessary to 
induce destabilisation of virions, the RNA release assay previously described was 
adopted. Ratios of VP1 (62kDa) to Fc-fJAM-A (62kDa monovalent or 124kDa 
bivalent) were calculated and virions combined with varying amounts of receptor 
in the presence of pH3 buffer. We hypothesised that virion disassembly would 
occur if sufficient Fc-fJAM-A was present to induce the conformational changes 
previously seen. We also hypothesised that only one fJAM-A ectodomain (of the 
two bivalently linked proteins) would bind to the capsid as we have seen no 
evidence of bivalent binding in our reconstructions. Each sample contained an 
equal concentration of FCV with reducing Fc-fJAM-A concentrations, starting 
from an estimated 1:1 ratio of VP1 to Fc-fJAM-A and ranging to a 22:1 ratio of 
VP1 to Fc-fJAM-A. As previously described, fluorescence was read every 5 
minutes over a period of 4 hours and normalised to a virus only control sample. 
Figure 44 shows the low signal in the dye negative control and the substantial 
increase in fluorescence in samples containing an equal concentration of Fc-
fJAM-A to FCV (1:1) down to, and including, a VP1 to Fc-fJAM-A ratio of 
approximately 7:1. This increase in fluorescence signifies the increase in viral 
RNA released as the virus disassembles and indirectly represents the presence of 
the conformation change in FCV. No increase in fluorescence, and therefore 
disassembly, can be seen with VP1 to Fc-fJAM-A ratios from 16:1 onwards. Figure 
44, therefore, demonstrates that the minimum amount of Fc-fJAM-A needed to  
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Figure 44- RNA release assay to determine the limiting molar ratio of 
receptor induced virion uncoating at low pH. 
RNA release assays were performed in triplicate in the presence of pH3 buffer in order to force 
the virus to disassemble if sufficient Fc-fJAM-A was present (signifying the presence of the 
conformational change in the capsid). All samples contained an equal concentration of FCV while 
Fc-fJAM-A concentration was reduced from a 1:1 down to 22:1 ratio of VP1 to Fc-fJAM-A in PBS. 
Fluorescence of samples was read every 5 minutes for 4 hours and data normalised to an FCV 
only control. P values (when compared to the dye only negative control) are shown with asterisks 
(****: p=<0.0001, ***:p=<0.005 and *:p=<0.05). 
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cause the disassembly (and conformational change) of FCV is a VP1 to Fc-fJAM-A 
ratio of between 9:1 and 14:1. This was then investigated by negative staining 
electron microscopy to further elucidate the lowest ratio of receptor to virus 
that was sufficient to destabilise the virion. Without performing three-
dimensional reconstruction, the conformational change in the capsid (present 
from pH5 upwards) cannot be seen with negative staining EM and so virus 
disassembly at pH3 (but not at pH7) was used as an indicator of the presence of 
the receptor mediated priming event. The presence of the conformational 
change (signified by viral disassembly at pH3) indicated that enough Fc-fJAM-A 
was present and so the stoichiometry of the virus-receptor interaction can be 
taken as the lowest ratio of Fc-fJAM-A that is able to cause the conformational 
change/destabilisation (and disassembly at pH3). Negative staining electron 
microscopy samples of VP1 to Fc-fJAM-A ratios of between 9:1 and 14:1 were 
incubated for 1 hour at 4°C at both pH7 and pH3 to allow the comparison of the 
two pH values.  
Figure 45A shows that FCV particles remain intact when incubated at both pH3 
and pH7, however, when incubated with an equal concentration of Fc-fJAM-A 
(1:1), intact viral particles can only be seen at pH7 with no visible particles 
when incubated at pH3. This demonstrates the occurrence of viral disassembly 
at low pH as well as the presence of the conformational change in the capsid 
when incubated with an equal concentration of Fc-fJAM-A. Likewise, when FCV 
was incubated with a VP1 to Fc-fJAM-A ratio of 9:1 (see Figure 45B), no intact 
viral particles could be seen at pH3 unlike at pH7 where all particles appeared 
undamaged. Interestingly, alongside some broken particles at pH3, smaller 
particles are visible that we hypothesise could be compacted viral RNA, possibly 
in complex with viral proteins such as VP2. Figure 45B demonstrates that a ratio 
of 9:1 of VP1 to Fc-fJAM-A (corresponding to 20 fJAM-A proteins per virion) 
results in viral disassembly at low pH and therefore we hypothesise the 
associated conformational change.  
As shown in Figure 45C, a VP1 to Fc-fJAM-A ratio of 10:1 (corresponding to 18 
proteins per virus particle) was enough to cause viral disassembly at low pH with 
intact viral particles visible at pH7, again indicating the likely presence of the 
conformational change. The previously observed small particles are also visible  
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Figure 45- Negative staining EM to determine the stoichiometry of the virus-
receptor interaction part 1/3 
FCV was incubated with the appropriate dilution of Fc-fJAM-A at 4°C for 1 hour at either pH3 or 
pH7 prior to preparation of the negative staining EM grids and visualisation at both 100,000 and 
200,000 x magnification. Panel A shows FCV only and FCV incubated with an equal concentration 
of Fc-fJAM-A (1:1) at both pH3 and pH7 (all images taken at 200,000x magnification). Panel B 
shows data collected with a ratio of 9:1 of VP1 to Fc-fJAM-A. 
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Figure 45-Negative staining EM to determine the stoichiometry of the virus-
receptor interaction part 2/3 
FCV was incubated with the appropriate dilution of Fc-fJAM-A at 4°C for 1 hour at either pH3 or 
pH7 prior to preparation of the negative staining EM grids and visualisation at both 100,000 and 
200,000 x magnification. Panel C shows FCV incubated with a VP1 to Fc-fJAM-A ratio of 10:1 and 
panel D shows data collected with a ratio of 11:1 of VP1 to Fc-fJAM-A. 
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Figure 45- Negative staining EM to determine the stoichiometry of the virus-
receptor interaction part 3/3 
FCV was incubated with the appropriate dilution of Fc-fJAM-A at 4°C for 1 hour at either pH3 or 
pH7 prior to preparation of the negative staining EM grids and visualisation at both 100,000 and 
200,000 x magnification. Panel E shows FCV incubated with a VP1 to Fc-fJAM-A ratio of 12:1 and 
panel F shows data collected with a 13:1 ratio of VP1 to Fc-fJAM-A. 
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as well as what appears to be protein debris following disassembly of the virus. 
Figure 45D shows FCV incubated with a ratio of approximately 11:1 of VP1 to Fc-
fJAM-A. At pH7, intact viral particles can be seen, however, at pH3 the particles 
appear to be irregular in shape and broken as if they are in the process of falling 
apart. None of the smaller particles previously observed at low pH are visible, 
suggesting that they are produced during the disassembly of the virus. The 
presence of broken and irregular particles with a VP1 to Fc-fJAM-A ratio of 11:1 
(corresponding to 16 proteins per virion) suggests that this is a crucial dilution 
for determining the stoichiometry of the virus-receptor interaction.  
Figure 45E shows the presence of intact viral particles at both pH3 and pH7 
when FCV was incubated with a VP1 to Fc-fJAM-A ratio of 12:1. However, at low 
pH some proteinaceous debris can be seen as well as a small proportion of 
particles appearing broken as seen for all visible particles in Figure 45D. When 
FCV was combined with a 13:1 ratio of VP1 to Fc-fJAM-A (see Figure 45F) only 
intact viral particles can be seen at both pH3 and pH7 suggesting that this 
amount of Fc-fJAM-A was not enough to trigger the conformational change in the 
capsid and uncoating of the virus at low pH. 
Together, Figure 45 suggests that the stoichiometric limit of the virus-receptor 
interaction that primes for uncoating at low-pH lies between a ratio of VP1 to 
Fc-fJAM-A of 10:1 and 12:1. As broken and irregular particles were observed with 
an 11:1 ratio, we therefore suggest that this was the minimum concentration of 
Fc-fJAM-A needed to prime the capsid and therefore might represent the 
minimum number of fJAM-A proteins required to be bound by the virus during 
entry into a host cell. 
To further investigate the presence or absence of the conformational change in 
the FCV capsid when incubated with these Fc-fJAM-A ratios, samples were 
prepared as previously described at pH7 and plunge frozen for cryo-EM imaging 
and three-dimensional reconstruction to visualise the extent of any 
conformational change. We determined the stoichiometry to be the minimum 
ratio/number of Fc-fJAM-A proteins needed to prime the capsid for uncoating.  
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Figure 46- Cryo-EM structures of FCV decorated with varying Fc-fJAM-A 
concentrations 
FCV particles were incubated with either a VP1 to Fc-fJAM-A ratio of 10:1 (A and D), 11:1 (B and 
E) or 12:1 (C and F) dilution of Fc-fJAM-A for 1 hour at 4°C prior to plunge freezing grids for 
cryo-EM. Samples were imaged in a JEOL JEM-2200FS field emission electron microscope 
equipped with a DE20 direct detection device. Data was processed and reconstructed using 
RELION. Central slices through the reconstructions are shown in A-C while the corresponding 
reconstructed maps are shown in D-F. Maps were visualised in UCSF Chimera with a threshold of 
the mean density plus one standard deviation. 
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Figure 47- Spherical sections of FCV reconstructions incubated with varying 
ratios of VP1 to Fc-fJAM-A 
Spherical sections were rendered in UCSF chimera for the VP1 to Fc-fJAM-A ratios of 10:1, 11:1 
and 12:1 and compared to the undecorated (1:0) and decorated (1:1) structures presented in the 
previous chapter). Visualisation of the P1 domain and P2 domains is aided by the addition of pink 
shapes outlining an area of interest. 
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Figure 46A and D show the structure of the Fc-fJAM-A decorated FCV capsid 
calculated from 2298 particles extracted from 209 micrographs using RELION as 
previously described following motion and CTF correction. After 2D 
classification, relevant data classes were selected (2285 particles) and 3D 
classification performed. The detailed classes were selected (1606 particles) and 
used to refine the structure to 6.5Å. The structure illustrates the presence of 
the conformational change when FCV was incubated with a 10:1 ratio of Fc-
fJAM-A (18 proteins per virus particle). The presence of the conformational 
change is visible in Figure 47, highlighting the rotation of the both the P1 and P2 
domains upon incubation with Fc-fJAM-A. 
For FCV incubated with an 11:1 ratio of VP1 to Fc-fJAM-A (16 proteins per virus 
particle), 1175 particles were extracted from 384 micrographs. Following 2D and 
3D classification, 699 and 438 particles, respectively, were selected and refined 
to a resolution of 9Å using RELION. Figure 46B and E suggest a lack of a 
conformational change in the capsid upon incubation with an 11:1 ratio of VP1 to 
Fc-fJAM-A indicating that 16 fJAM-A proteins are sufficient to cause viral 
uncoating at low pH but not a conformational change in the capsid. 
When FCV was incubated with a VP1 to Fc-fJAM-A ratio of 12:1, 885 particles 
were extracted from 111 micrographs and post classification, 568 particles were 
used for refinement of the structure against the undecorated reference map. 
The resulting structure, shown in Figure 46C and F, was resolved to 7.5Å using 
RELION. The structure suggests the absence of a conformational change in the 
capsid when incubated with a 12:1 ratio of VP1 to Fc-fJAM-A (14 proteins per 
virus particle) predicted by the lack of viral uncoating seen at pH3 (see Figure 
45E).  
The spherical sections presented in Figure 47 possibly show hybrid density arising 
from capsomeres in different conformations, resulting in blurring of the density. 
This suggests that the conformational changes previously seen may be formed of 
local changes/destabilisation rather than a concerted, capsid wide 
conformational change. The lack of structural change seen in the S domains of 
the undecorated and decorated virus structures (see 4.5) supports the hypothesis 
of local changes as opposed to a concerted conformational change. 
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VP1:Fc-fJAM-A 
ratio 
S domain P domain Fc-fJAM-A 
1:1 1 0.783 0.744 
10:1 1 0.850 0.501 
11:1 1 0.928 0.453 
12:1 1 0.938 0.456 
1:0 1 0.980 - 
Table 3- Fc-fJAM-A occupancy in three-dimensional reconstructions 
Structures were re-scaled to allocate density values between 0 (least intense) and 1 (most 
intense) and masks applied to separate out the S domains, P domains and Fc-fJAM-A. All S 
domains showed an occupancy of 1 as they contained the highest density values. Structures of 
decorated FCV (1:1, see previous chapter), FCV incubated with VP1 to Fc-fJAM-A ratios of 10:1, 
11:1 and 12:1 as well as undecorated FCV (1:0, see previous chapter) were investigated. 
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Co-operative binding of the Fc-fJAM-A proteins could have been possible and so 
to test for this, 3D classifications of the data sets were performed with 2 
starting models, the undecorated virus structure and the decorated virus 
structure (see previous chapter). If co-operative binding were occurring, we 
would expect to classify the data into two classes; one containing FCV with no 
Fc-fJAM-A bound and one class containing decorated particles. Upon 3D 
classification of all 3 data sets (10:1, 11:1 and 12:1 ratios of VP1 to Fc-fJAM-A) 
no subsets of undecorated particles were classified indicating that no co-
operative binding was occurring in these experiments.  
The central sections of the reconstructions (shown in Figure 46A-C) show the 
reduced occupancy of fJAM-A in each population. The fJAM-A density in the 
central sections appears as weaker density than the VP1 density, showing that 
the virus particles were not saturated with fJAM-A as in previous experiments 
(see previous chapter). The fJAM-A density also appears to fade upon each 
dilution of the receptor, confirming that each of the three reconstructions 
contained less fJAM-A and that the virus particles were not saturated with the 
receptor. To approximate the Fc-fJAM-A occupancy in each of the 
reconstructions, the structures were re-scaled to between 1 and 0. Masks were 
applied to separate out the S domains, P domains and the Fc-fJAM-A density and 
then the maximum density in each region of the map determined as previously 
described (Kandiah 2012) (see Table 3). As the S domains in all of the structures 
contained the highest density values, occupancy levels of 1 were assigned. 
Interestingly, increasing P domain density values were recorded with decreasing 
Fc-fJAM-A occupancy suggesting that the binding of Fc-fJAM-A and the induction 
of the conformational change resulted in a decrease of P domain density likely 
due to the movement incurred causing blurring of the density. The levels of Fc-
fJAM-A occupancy support the addition of less Fc-fJAM-A to each subsequent 
sample in Table 3 although reductions were not in line with the calculated ratios 
of VP1 to Fc-fJAM-A. This could be due to the saturation of the virus particle 
upon incubation with a calculated 1:1 VP1 to Fc-fJAM-A ratio. The occupancy 
levels calculated for the 11:1 and 12:1 VP1 to Fc-fJAM-A ratios are very similar 
suggesting that the experiment may not have been accurate when combining the 
FCV and Fc-fJAM-A. A significant difference between these ratios, however, is 
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notable from Figure 45 showing the partial disassembly of particles with an 11:1 
ratio but no disassembly with a 12:1 ratio of VP1 to Fc-fJAM-A. 
To conclude, Figure 45 shows that no viral disassembly seems to occur when FCV 
is incubated with a VP1 to Fc-fJAM-A ratio of 13:1, however broken particles are 
seen with an 11:1 ratio and some particle irregularity is observed with a 12:1 
ratio of VP1 to Fc-fJAM-A. The presence of a receptor mediated priming event of 
the capsid upon incubation of FCV with Fc-fJAM-A ratios of 10:1, 11:1 and 12:1 
was confirmed by cryo-electron microscopy and three dimensional 
reconstruction as shown in Figure 46. Taken together, these data suggest that 
the minimum number of fJAM-A proteins required to bind to FCV to induce viral 
uncoating is approximately 16 (an 11:1 ratio of VP1 to Fc-fJAM-A) although local 
conformational changes in the capsid can be seen with lower ratios of VP1 to Fc-
fJAM-A.  
We hypothesise that during entry into a host cell, FCV attaches to the cell 
surface at tight junctions (possibly mediated by an attachment factor containing 
sialic acid) where it binds to approximately 16 fJAM-A proteins. The virus may 
initially bind to fewer fJAM-A proteins on the cell surface and engage more 
during endocytosis due to the induction of membrane curvature. This binding to 
fJAM-A destabilises the capsid and induces a local conformational change which, 
upon endocytosis and a reduction in pH, may contribute to the delivery of the 
viral genome into the cytoplasm of the host cell, possibly by the formation of a 
pore. 
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5.3 Discussion 
Here, we show that FCV particles remain intact at low pH (pH4) by cryo-EM, 
however upon incubation with fJAM-A at pH4, no intact viral particles were seen 
in cryo-micrographs. The observation of proteins and strands of RNA in the 
micrographs (see Figure 42) together with no visible virus particles suggests viral 
disassembly upon incubation with fJAM-A at low pH. Interestingly, upon 
incubation of FCV with fJAM-A at pH5, intact decorated virus particles were 
observed and the structure elucidated by three-dimensional reconstruction 
shows a structure resembling that at neutral pH with the conformational change 
in the capsid visible. An RNA release assay was developed to test this effect of 
pH on capsid integrity which confirmed the release of viral RNA from the capsid 
(likely during viral disassembly) upon incubation with fJAM-A below pH5 (pH 
values of 3 and 4 were tested). The stability of the virus-receptor complex from 
pH5 to neutral pH was also confirmed as well as showing that the virus-receptor 
complex remains intact at pH values above 7 (values up to pH9 were tested). 
These pH values below 5 could represent the pH encountered by the virus-
receptor complex upon entry into host cells via clathrin-mediated endocytosis. It 
has previously been shown that endosomal acidification is necessary for viral 
uncoating and release of the viral genome into the cytoplasm (Stuart and Brown, 
2006). However, there appears to be some discrepancy in the pH values of the 
endocytic pathway reported by different authors although a consensus seems to 
suggest a pH value of around 6 for early endosomes, 5-6 for late endosomes and 
<5 for endo/lysosomes (Cossart and Helenius, 2014; Lozach et al., 2011). This 
suggests that FCV uncoating may occur in the endo-lysosome although a 
narrower pH range must be tested to elucidate the exact pH at which the virus 
uncoats.  
The entry of FCV into CrFK cells results in their permeabilisation as previously 
reported for poliovirus and reovirus (Stuart and Brown, 2006). Feline JAM-A has 
been shown to be partially redistributed throughout the cytoplasm of cells at 
early time points of FCV infection with some expression remaining at cellular 
tight junctions (Pesavento et al., 2011). This redistribution may represent the 
internalisation of fJAM-A bound to FCV during clathrin-mediated endocytosis. 
This hypothesis is supported by our observation that fJAM-A bound to FCV 
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appears to be monomeric in form and that fJAM-A dimers have been shown to be 
disrupted at pH values below 6 (Monteiro et al., 2014). 
As an indirect method of visualising the presence of the conformational change, 
the RNA release assay was adopted at pH3 with varying VP1 to fJAM-A ratios to 
force the virus to disassemble if enough fJAM-A was present. Negative staining 
and cryo electron microscopy were also used to look at virus structure upon 
incubation with a range of fJAM-A ratios at either pH3 (negative staining EM) or 
pH7 (cryo-EM) to observe the presence or absence of the conformational change. 
Together, these findings suggest that a VP1 to Fc-fJAM-A ratio of 11:1,  
corresponding to 16 fJAM-A proteins per virus particle, is the minimum required 
to cause the local destabilisation/conformational changes of the P domains of 
the FCV capsid proteins and viral uncoating at low pH. 
We propose a model of FCV entry where FCV binds to fJAM-A within tight 
junctions, inducing a conformational change in the capsid. Clathrin mediated 
endocytosis is then triggered and, if not previously bound, additional fJAM-A 
proteins may bind to the virus during the curvature/internalisation of the 
membrane resulting in approximately 16 fJAM-A proteins bound to each virus 
particle. Upon movement through the endocytic pathway, the environment in 
which the decorated virus particles are held will reduce in pH. This reduction in 
pH to below 5 induces the release of the viral genome into the cytoplasm 
(possibly by pore formation and/or by inducing the permeabilisation of the 
endosomal membrane). 
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6 Discussion 
This thesis presents the results of a biophysical characterisation of the 
attachment and entry process of an important member of the Caliciviridae – 
feline calicivirus. This virus was selected as it is a tractable model for calicivirus 
biology owing to it being readily propagated in cell culture and having a known 
protein cellular receptor. Virus entry is the critical first step of the infectious 
process and is therefore an important area of study. The attachment of FCV to 
its cellular receptor, fJAM-A, is followed by uptake via clathrin mediated 
endocytosis. The mechanism of viral uncoating and endosome escape is poorly 
understood. Previous structural studies on FCV bound to fJAM-A have revealed 
the presence of a conformational change thought to prime the virion for genome 
release. Here, we present the results of a high-resolution structural 
characterisation of purified FCV virions, both undecorated and labelled with the 
soluble ectodomain fragment of fJAM-A.  These data allowed us to build an 
atomic model of the FCV major capsid protein VP1 and confirmed the presence 
of conformational changes upon receptor engagement. These included an anti-
clockwise rotation of 19º in the P domains of the capsid proteins at the A and B 
quasi equivalent positions. This conformational change is also apparent at pH5 
although upon lowering the pH further, viral disassembly was observed. This 
phenomenon was further explored to estimate the number of fJAM-A proteins 
required to prime the virion for uncoating. Receptor binding was shown to occur 
via the monomeric form of fJAM-A although we have shown it to be dimeric in 
solution. This led us to propose a mechanism by which FCV may induce 
endocytosis to initiate the infectious process. Finally, we have identified a 
carbohydrate moiety on fJAM-A produced in CHO cells and shown that it does not 
affect the virus-receptor interaction in vitro. 
6.1 Investigating the influence of fJAM-A glycosylation and 
oligomerisation on feline calicivirus binding 
Feline junctional adhesion molecule A (fJAM-A) has previously been shown to be 
a functional receptor for FCV with expression in non-fJAM-A cells rendering them 
susceptible to FCV infection in vitro. Feline JAM-A was shown to be present in 
intracellular tight junctions of epithelial and endothelial cells (as well as on the 
surface of leucocytes and platelets) (Pesavento et al., 2011). We have shown 
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that the fJAM-A ectodomain is dimeric in solution by both size exclusion 
chromatography as well as small angle x-ray scattering. The U-shaped structure 
resembles that of both the human and murine homologues, the latter of which 
has been shown to form cis interactions via an R(VIL)E motif at the dimer 
interface (Kostrewa et al., 2001). Kirchner et al presented a dissociation 
constant of 11M for the D1-D1 human JAM-A dimer interaction (Kirchner et al., 
2008), however, the dissociation constant of the reovirus 1 head domain with 
D1 domain of human JAM-A was shown to be 2.4nM (Guglielmi et al., 2007). This 
dissociation constant of >1000-fold stronger binding to the reovirus 1 protein 
represents a similar phenomenon as seen here with a dissociation constant of 
12.9nM for the interaction of FCV with Fc-fJAM-A. A similar occurrence is seen 
with a μM dissociation constant for homophillic CAR interactions while both 
coxsackie virus and adenovirus have both been shown to bind to CAR with nM 
affinity (Coyne and Bergelson, 2005; Goodfellow et al., 2005; van Raaij et al., 
2000). This appears to be a common feature among viruses that utilise tight 
junctional proteins as receptors. 
The stronger binding of these viral proteins to JAM-A compared to homo-dimer 
formation in cis suggests a mechanism for JAM-A dimer disruption upon virus 
binding. This is evidenced by the binding of the monomeric form of fJAM-A to 
VP1 shown here by cryo-EM and three-dimensional reconstruction. Adenovirus 
knob fibre protein has also been shown to disrupt homodimers of the tight-
junction protein CAR, leading to the induction of endocytosis (Salinas et al., 
2014). We therefore hypothesise that dimer disruption upon FCV binding may 
provide the mechanism by which FCV gains entry to the cell. Further 
investigation of this disruption of fJAM-A dimerisation is therefore warranted to 
elucidate its role, if any, in the induction of viral uptake by clathrin mediated 
endocytosis.  
Another receptor, α2,6 linked sialic acid, was proposed for FCV although it is 
unknown whether this is present as part of fJAM-A or not. To investigate this, we 
proceeded to purify fJAM-A from CHO cells and enzymatically remove the 
carbohydrate moiety on the protein. It must be noted, however, that CHO cells 
reportedly cannot produce α2,6 linked sialic acid and produce α2,3 linked 
instead. Although this was not optimal, it allowed us to elucidate that the 
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glycosylation present on the fJAM-A was not needed for virus binding and did not 
affect the oligomerisation state of the proteins. A dissociation constant of 
128.7nM was determined for the deglycosylated protein and FCV although the 
dissociation constant calculated for glycosylated protein was done so in the 
presence of the Fc tag (12.9nM) and so these cannot be directly compared (as 
the bivalent form of Fc-fJAM-A may lead to one fJAM-A protein dissociating while 
its bivalent ‘partner’ binds). Both of these values, however, are significantly 
lower than that of the D1-D1 interaction in human JAM-A (11μM) supporting the 
hypothesis that FCV may have the ability to compete off fJAM-A homodimers as 
seen for both reovirus (with JAM-A) and adenovirus (CAR) (Kirchner et al., 2008; 
Salinas et al., 2014).  
It is possible that the presence of α2,6 linked sialic acid on fJAM-A may behave 
differently although we are able to conclude that it is not essential for FCV 
binding due to our interaction studies lacking this sialic acid linkage. 
Furthermore, previous investigations have utilised fJAM-A expressed in bacteria 
which would contain no carbohydrate moieties, also suggesting that the sialic 
acid on fJAM-A is not required for FCV binding and may function as a regulator of 
fJAM-A half-life among other roles (Ossiboff et al., 2010; Scott et al., 2015). 
Together, data suggest that an α2,6 linked sialic acid moiety may be present on 
the surface of cells that aids in the entry of FCV into host cells. It is possible 
that this moiety may be present on a different, as yet unidentified cellular 
protein receptor. Another possibility, other than a separate receptor, is that the 
carbohydrate moiety may act as an attachment factor for FCV and aid in the 
delivery of virus particles from the cell surface into tight junctions where they 
can engage with fJAM-A. Reovirus entry has also been shown to involve binding 
to sialic acid, facilitating the delivery of the virus to the tight junction where it 
can encounter JAM-A (Bergelson, 2009). Additionally, Coxsackie B virus has been 
shown to initially bind to DAF (complement decay accelerating factor) on the 
apical surface of cells resulting in the movement of the DAF bound virus to tight 
junctions where it engages CAR (Bergelson et al., 1995; Coyne and Bergelson, 
2006). 
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6.2 Structural characterisation of undecorated FCV and 
fJAM-A decorated FCV by cryo-electron microscopy 
Bhella et al (2008, 2011) have previously shown the intermediate resolution 
structures of FCV and FCV decorated with fJAM-A demonstrating a 
conformational change in the VP1 capsid proteins upon fJAM-A engagement. An 
anti-clockwise rotation of 15° was reported in the A/B capsomeres as well as the 
possibly tilting of the C/C capsomeres resulting in the breakage of icosahedral 
symmetry and a less well defined structure (Bhella et al., 2008; Bhella and 
Goodfellow, 2011). Here we present near-atomic resolution structures for both 
the undecorated and decorated virus particles allowing the determination of the 
rotation as 19° anti-clockwise.  The high resolution structure of undecorated 
FCV permitted the modelling of atomic coordinates for the capsid protein VP1 
into the reconstructed density. Unfortunately, the P domains and fJAM-A in the 
decorated virus structure were not of sufficient resolution to allow their 
modelling, however, the S domains were well defined. Comparison of the two 
reconstructions as well as the modelled protein structures showed no apparent 
changes in the S domains of the VP1 capsid proteins upon fJAM-A engagement. 
This may not be expected if the virus fully uncoats as a genome delivery 
mechanism although the combination of the conformational change and low pH 
environment is likely needed to cause such structural changes and allow the 
formation of a pore, disruption of the endosomal membrane and/or complete 
uncoating of the virus.  
Both our findings and previous studies have demonstrated that 2 fJAM-A proteins 
appear to bind to each VP1 capsomere in a head to tail arrangement (Bhella and 
Goodfellow, 2011). This is different to the oligomerisation state and protein 
structure determined for feline, human and murine JAM-A in solution where 
homodimers are formed via the dimerisation interface which is located away 
from the FCV binding site (Kostrewa et al., 2001; Prota et al., 2003). Human 
JAM-A dimers have been shown to dissociate upon incubation at low pH which 
may represent what occurs during viral entry via clathrin-mediated endocytosis 
although our experiments were conducted at neutral pH (Kirchner et al., 2008). 
It is more plausible that the higher affinity of FCV for fJAM-A than homotypic 
interactions between fJAM-A proteins allows the dissociation of the fJAM-A 
dimers upon virus binding. Tight junction proteins demonstrating a higher 
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affinity for certain viral proteins than their dimeric counterparts have been 
described previously and may allude to a common binding and/or entry 
mechanism. This has also been demonstrated for reovirus with JAM-A and for 
coxsackie virus and adenovirus interactions with CAR (Coyne and Bergelson, 
2005; Goodfellow et al., 2005; Guglielmi et al., 2007; van Raaij et al., 2000). As 
our data suggest FCV binding to approximately 16 fJAM-A proteins, this would 
involve the disruption of 8-16 fJAM-A cis-dimers and the binding to 8-16 VP1 
capsomeres during viral entry. However, these experiments were performed in 
solution and so differing amounts of membrane anchored fJAM-A may be 
required to trigger capsid destabilisation and uncoating. 
Docking of our modelled VP1 structure as well as a previously described fJAM-A 
ectodomain homology model allowed the prediction of contact residues between 
the two proteins (Bhella and Goodfellow, 2011). We identified 434D and 495N as 
important residues in VP1 as well as fJAM-A residue 33S and an area 
encompassing 43K to 48S although differential binding was seen at these 
residues between VP1 chains and/or stages of the conformational change. Many 
additional contact residues between the two proteins were proposed previously 
although they were calculated by docking a homology model into a lower 
resolution map of fJAM-A decorated FCV (Bhella and Goodfellow, 2011). 
Structure guided mutations have previously been introduced into the fJAM-A 
ectodomain that resulted in a decreased binding to FCV-5. Key residues that 
upon mutation resulted in reduced virus binding were identified as 42D, 43K and 
97S (Ossiboff and Parker, 2007). In our docking investigations, only 33S was 
commonly identified as a contact residue although neighbouring residues 
between 43K and 48S were routinely identified. FCV-5 VP1 capsid proteins that 
became resistant to fJAM-A neutralisation in vitro have also been characterised 
with the main recurring mutated residues being identified as G329, T438, K480, 
V516 and K572 (Ossiboff et al., 2010). Residue G329 forms part of the flexible 
hinge region between the S and P1 domain while K572 is located at the VP1 
dimer interface. Residues T438, K480 and V516 are located in the P2 domain 
although were not identified in our contact residue screen. This suggests that a 
different conformational change may occur in FCV-5 than in the F9 vaccine 
strain used here although neutralisation mutants may differ from conformational 
change mutants and so these data sets must be compared with caution. It was 
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also proposed that upon fJAM-A binding, FCV-5 underwent a conformational 
change resulting in the exposure of hydrophobic regions which was not seen for 
FCV F9. Personal communication has also suggested uncoating of FCV-5 in the 
presence of fJAM-A at neutral pH. These investigations, however, were 
performed with bacterially expressed fJAM-A ectodomain resulting in the lack of 
any post-translational modifications. It is also noteworthy that the fJAM-A used 
to select the neutralisation mutants contained an N-terminal GST tag (located at 
the D1/virus binding and dimerisation domain) which may have impacted the 
dimerisation of fJAM-A proposed here and for the human and mouse homologues 
of the protein (Kostrewa et al., 2001; Ossiboff et al., 2010; Prota et al., 2003). 
Interestingly, when the same method of docking was used for FCV-5 as was 
utilised here, similar residues were identified to those predicted here (Bhella 
and Goodfellow, 2011). Near-atomic resolution structures of the P2-fJAM-A 
interactions, however, are needed to reliably determine the contact residues 
between the virus and receptor. 
Upon comparison of the FCV F9 VP1 protein structure with that of FCV-5, few 
structural differences are apparent with the most unique portions mapping to 
the upper P2 domain. This is as expected as this is the region responsible for 
receptor binding and antibody neutralisation and is therefore the location of the 
hypervariable region. As the vaccine strain (F9) and the virulent systemic strain 
(FCV-5) are quite different in the disease (or lack of) that they cause, it is not 
surprising that the region responsible for receptor binding and neutralisation is 
varied. It may, however, be surprising how similar the remaining areas of the 
proteins appear to be with very little variation seen, particularly in the S 
domain. These variations in P2 may fully or partially reflect the different 
contact residues proposed in this region between the two strains although more 
investigation is needed to accurately determine the contacts for both VP1 
proteins with fJAM-A. 
6.3 Characterisation of FCV attachment and uncoating  
Feline calicivirus entry into host cells has been shown to be facilitated by 
clathrin-mediated endocytosis followed by endosomal acidification (Stuart and 
Brown, 2006). Due to this finding, we proceeded to investigate whether a 
reduction in pH would affect the structure of FCV. We have shown here that 
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upon incubation at pH4, FCV remains intact with no structural changes seen from 
the pH7 counterpart at the resolutions achieved. However, upon incubation of 
FCV with Fc-fJAM-A at pH4, the virus receptor complex disassembles with no 
intact viral particles visible by negative staining or cryo-EM. An RNA release 
assay demonstrated that the virus receptor complex remains intact upon 
incubation at pH values between 5 and 9 although under conditions of pH3 or 4, 
the release of viral RNA was observed, signifying viral disassembly as seen by EM. 
Interestingly, human JAM-A dimers have been shown to dissociate at low pH 
(below 5) although it is unknown whether fJAM-A remains bound to FCV during 
uptake by endocytosis (Kirchner et al., 2008). Many viruses utilise endocytosis as 
a means to enter host cells although they can vary in the stage at which they 
escape the compartment. For example, foot and mouth disease virus (FMDV) 
escapes from the early endosome while human papillomavirus-16 (HPV-16) 
escapes from the late endosome where the pH will be even lower (~5-6) (Cossart 
and Helenius, 2014). The estimated pH value in endo-lysosomes/lysosomes is 
thought to be below 5 suggesting that FCV may remain in the endosome until the 
pH is sufficiently reduced before delivering the viral genome into the cytoplasm 
of the host cell. FCV has been shown to have the ability to permeabilise cells 
and so the genome delivery mechanism may involve the formation of a pore in 
the endosomal membrane although this requires further investigation (Stuart and 
Brown, 2006). We hypothesise that binding of FCV to fJAM-A destabilises the 
capsid and induces the conformational change described here and previously 
(Bhella et al., 2008; Bhella and Goodfellow, 2011). This conformational change 
likely primes the capsid for genome uncoating/delivery upon lowering of the 
endosomal pH. 
The mechanism of FCV genome delivery from endosomes into the cytoplasm of 
cells is not yet known although 3 models are generally proposed for non-
enveloped, RNA viruses that enter via endocytosis. One model is that the viral 
genome is released into the endosome and is then transported into the 
cytoplasm either across the membrane or via membrane disruption. Another 
model involves the insertion of viral peptides into the endosomal membrane 
resulting in its disruption and release of the intact viral particle into the 
cytoplasm where the genome is released from the capsid. Rhinovirus-14 (HRV-
14) has been shown to undergo receptor mediated structural changes and cause 
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disruption of endosomal membranes (Schober et al., 1998). A third entry model 
involves viral peptides forming pores in the endosomal membrane allowing 
passage of the viral genome into the cytoplasm. Poliovirus (PV) appears to 
promote the translocation of the viral genome across the endosomal membrane 
through a virally encoded pore/channel (Groppelli et al., 2017). An increase in 
empty viral particles upon lowering of the pH has been reported for slow bee 
paralysis virus (SBPV) as well as rotation of the capsid proteins resulting in the 
formation of a pore at the 3-fold axis of the capsid (Kalynych et al., 2017). FCV 
has previously been shown to permeabilise membranes (Stuart and Brown, 2006). 
This, together with our findings may suggest the uncoating of the virus-receptor 
complex upon lowering of the pH and simultaneous permeabilisation of the 
endosomal membrane to allow delivery of the viral genome into the cytoplasm. 
It is also possible that FCV may form a pore in the endosomal membrane to allow 
delivery of the viral genome although no mechanism/potential viral protein has 
been proposed for this so more investigation into the genome delivery 
mechanism is needed. 
As previous studies of the virus receptor complex involved the saturation of FCV 
with fJAM-A (something unlikely to occur in natural infections) we set out to 
determine the minimum amount of fJAM-A required to cause the conformational 
change observed as well as the uncoating at low pH. Electron microscopy 
(negative staining and cryo-EM) was adopted alongside an RNA release assay 
where FCV was incubated with varying ratios of FCV VP1 capsid proteins to Fc-
fJAM-A proteins. To allow the indirect evaluation of capsid destabilisation, 
samples were incubated at pH3 (alongside pH7 controls) in order to force the 
virus to uncoat if enough fJAM-A was present. This method suggested a VP1 to 
Fc-fJAM-A ratio of between 9:1 and 13:1. Negative staining electron microscopy 
then confirmed the uncoating of the virus-receptor complex upon incubation 
with a 9:1 and 10:1 ratio of VP1 to Fc-fJAM-A. Interestingly, upon incubation of 
FCV with a Fc-fJAM-A ratio of 11:1, irregular particles were observed suggesting 
that they were in the process of uncoating. No uncoating was seen with any 
lower ratios of VP1 to Fc-fJAM-A. An 11:1 ratio of VP1 to Fc-fJAM-A corresponds 
to 16 Fc-fJAM-A proteins per virus particle. It is possible that FCV would bind to 
some receptor proteins at the cell surface with the membrane curvature induced 
upon the induction of endocytosis resulting in more fJAM-A binding to FCV within 
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the endosome. This would trigger the destabilisation of the virus particle 
inducing the conformational change and priming the capsid for 
uncoating/genome delivery at low pH. 
To conclude, here we show that the fJAM-A ectodomain forms dimers in solution 
although it appears to bind to the VP1 capsomeres of FCV in a monomeric form 
(in a head to tail arrangement). The FCV binding site on fJAM-A is distinct from 
the dimerisation site although the binding affinities between these proteins may 
play a role in dimer disruption. The deglycosylation of fJAM-A produced in CHO 
cells does not appear to affect its oligomerisation state or the binding and 
neutralisation of FCV.  
We, therefore, present an entry model for FCV (illustrated in Figure 48) where 
the virus binds to sialic acid (or a glycoprotein containing sialic acid) on the 
surface of cells resulting in the delivery of the virus to tight junctions where it 
can encounter fJAM-A. Upon the induction of endocytosis, brought about by the 
disruption of receptor homodimers, FCV may bind approximately 16 fJAM-A 
proteins resulting in priming of the capsid. Upon lowering of the pH within the 
endosome, the virus either uncoats and disrupts the endosomal membrane or 
forms a pore in order to deliver the viral genome into the cytoplasm.  Further 
investigation is required to test these hypotheses and provide a detailed 
mechanistic view of calicivirus entry.  
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Figure 48- Schematic of FCV entry 
An illustrative representation of our model for FCV entry involving the binding of FCV to sialic 
acid (blue) at the cell surface which is then transported to tight junctions where it can engage 
with fJAM-A (red), causing disruption of the cis and trans fJAM-A dimers. Clathrin mediated 
endocytosis is then triggered which may result in more fJAM-A binding to FCV, causing a 
conformational change in the capsid and, upon lowering of the luminal pH, release of the viral 
genome into the cytoplasm of the cell by an as yet unknown mechanism, possibly involving pore 
formation. 
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